Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3030366	p-kysc	mg/l (mg/l)	10988	52316	0.03%
3030366	s-kysc	mg/l (mg/l)	2476	5489	0.00%
3030366	p-kysc	— (—)	1675	2768	100.00%	Distribution not available
3030366	s-kysc	— (—)	504	885	100.00%	Distribution not available
3030366	p-kysc	mg/l______ (mg/l)	152	554	0.00%
3030366	kystatiinic(4507p-kysc)	mg/l (mg/l)	18	19	0.00%
3030366	kystatiinic(p-kysc)	mg/l (mg/l)	16	17	0.00%

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Heart failure, strict

2017

5409

2.70

322.40

4.2

3.1

2.18

1.53

mg/l

126.63

1824

4886

Type 2 diabetes, wide definition

2502

6689

2.43

318.84

4.1

2.7

1.90

1.40

mg/l

111.72

2288

6144

All-cause Heart Failure

1969

5302

2.69

312.71

4.2

3.1

2.19

1.53

mg/l

124.35

1780

4788

Other heart diseases

1597

3541

3.04

312.54

6.1

4.3

1.65

1.05

mg/l

105.37

1507

3304

Insulin, combination of fast acting with intermediate-acting or long-acting

2217

8496

2.46

311.56

4.8

3.9

2.04

1.46

mg/l

124.60

2025

7787

Diabetic nephropathy, excluding more controls

1207

1652

7.06

307.65

5.7

2.8

2.37

1.54

mg/l

105.92

1147

1490

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

1001

2444

4.41

307.65

10.2

8.4

1.63

1.33

mg/l

19.51

977

2304

Genitourinary diseases

1950

3471

2.91

307.65

7.6

4.0

1.57

1.08

mg/l

107.52

1840

3212

Chronic nephritic syndrome

514

399

18.89

307.65

7.8

3.0

2.00

1.48

mg/l

15.62

500

359

Glomerular disorders in diseases classified elsewhere

1613

1272

18.06

307.65

6.7

3.0

2.19

1.49

mg/l

84.11

1544

1153

Heart failure,strict

1888

4077

3.39

307.65

4.3

2.6

2.19

1.32

mg/l

195.33

1712

3659

Nephropathy related operations

2047

1507

21.64

307.65

11.3

4.2

2.31

1.39

mg/l

175.45

1997

1378

Hypertension

2855

5251

3.19

307.65

6.7

3.0

1.67

1.16

mg/l

159.49

2699

4836

L04AA Selective immunosuppressants

2112

2818

9.08

307.65

11.1

3.4

1.89

1.37

mg/l

98.47

2063

2597

Other septicaemia

1799

4695

3.86

307.65

8.8

3.5

2.05

1.48

mg/l

83.49

1696

4236

Disorders resulting from impaired renal tubular function

627

459

23.57

307.65

11.1

5.1

2.36

1.50

mg/l

43.95

602

424

Cystic kidney disease, including avohilmo

493

423

17.62

307.65

10.0

6.1

1.97

1.43

mg/l

18.97

485

388

Hypertensive diseases

2855

5262

3.19

307.65

6.7

3.0

1.67

1.16

mg/l

159.85

2699

4847

Glomerular diseases

2241

2179

13.70

307.65

8.3

4.0

2.09

1.43

mg/l

115.47

2157

1983

Implicit viral Sepsis, including avohilmo

1302

3815

3.61

307.65

7.1

3.2

1.99

1.43

mg/l

67.19

1225

3419

Implicit bacterial Sepsis, including avohilmo

1916

4884

3.44

307.65

5.5

2.9

2.12

1.47

mg/l

121.80

1774

4373

Congenital malformations of the urinary system, including avohilmo

648

865

9.64

307.65

10.9

9.5

1.86

1.35

mg/l

28.07

636

804

Implicit viral Sepsis

1049

2552

4.45

307.65

7.9

3.3

2.03

1.43

mg/l

57.80

994

2267

Explicit Sepsis

2005

5320

3.64

307.65

8.6

3.4

2.01

1.42

mg/l

102.10

1880

4796

Condition for Implicit Sepsis (Organ dysfunction codes), including avohilmo

3191

8591

2.59

307.65

5.1

3.3

1.83

1.31

mg/l

152.47

2989

7870

GASTRO-related operations

2482

4261

3.01

307.65

6.6

2.4

1.46

1.23

mg/l

30.06

2356

3860

Other and unspecified anaemias

1786

5305

3.34

307.65

5.3

3.3

1.99

1.57

mg/l

53.05

1654

4734

Extracorporeal dialysis

1049

761

23.50

307.65

10.6

4.4

2.56

1.47

mg/l

105.36

1017

692

Polycystic kidney disease

432

306

23.89

307.65

8.9

6.2

2.00

1.47

mg/l

14.24

425

278

Bacterial infection, other or unspecified, including avohilmo

2341

6528

3.08

307.65

6.1

3.2

1.94

1.42

mg/l

97.35

2189

5909

Gout, FINNGEN

1301

3719

3.71

307.65

4.9

2.5

2.26

1.63

mg/l

76.08

1202

3325

Dialysis

805

415

38.46

307.65

14.7

7.5

2.21

1.11

mg/l

130.61

796

383

Secondary hypertension

1201

656

25.95

307.65

9.9

4.3

2.08

1.11

mg/l

143.11

1160

601

Hypertension, essential

2492

4938

2.95

307.65

4.2

2.2

1.69

1.17

mg/l

137.64

2339

4536

Other septicaemia, including avohilmo

1829

4773

3.84

307.65

8.7

3.5

2.04

1.48

mg/l

84.44

1723

4306

First line medication for Crohn's disease

4064

8333

2.72

307.65

7.5

2.7

1.60

1.36

mg/l

48.96

3829

7610

Anaemia in chronic diseases classified elsewhere

315

263

17.39

307.65

10.0

4.5

2.61

1.55

mg/l

35.86

300

235

Acute tubulo-interstitial nephritis

2158

5470

3.47

307.65

6.4

3.0

1.86

1.16

mg/l

193.44

2015

4907

Any gastric operation

2482

4261

3.01

307.65

6.6

2.4

1.46

1.23

mg/l

30.06

2356

3860

Chronic kidney disease

4236

2866

18.74

307.65

7.0

2.9

2.22

1.26

mg/l

307.65

4008

2511

Acute renal failure

1568

2034

8.83

307.65

5.8

2.3

2.30

1.25

mg/l

234.70

1480

1778

Anaemias

1236

1063

8.08

307.65

8.8

3.1

1.72

1.03

mg/l

107.28

1182

1006

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly, including avohilmo

1021

2585

4.23

307.65

10.1

8.0

1.63

1.34

mg/l

17.88

996

2431

All chronic kidney diseases

5379

4360

11.63

307.65

6.3

3.2

2.02

1.15

mg/l

307.65

5075

3897

Gout

1301

3101

3.85

307.65

4.9

2.7

2.26

1.59

mg/l

82.71

1202

2786

Other anaemias

1795

5343

3.32

307.65

5.3

3.3

1.99

1.57

mg/l

53.63

1663

4766

Autoimmune diseases excluding thyroid diseases, strict definition

3286

8291

2.21

307.65

4.5

4.3

1.64

1.39

mg/l

41.79

3079

7622

Aplastic and other anaemias

2055

5649

3.53

307.65

5.8

3.4

2.04

1.56

mg/l

74.28

1913

5055

Dialysis, with operation codes

2092

1196

27.45

307.65

10.5

4.1

2.34

1.16

mg/l

313.22

2040

1091

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

442

430

15.89

307.65

11.4

7.5

1.81

1.43

mg/l

9.20

431

402

All kidney diseases

5700

7261

5.68

307.65

6.2

2.9

1.86

1.11

mg/l

307.65

5364

6598

Other disorders of fluid, electrolyte and acid-base balance

1393

3559

3.93

307.65

5.3

3.2

1.94

1.54

mg/l

36.54

1278

3160

Metabolic disorders

3309

8263

2.48

307.65

4.9

3.7

1.70

1.37

mg/l

68.61

3089

7576

L04AD Calcineurin inhibitors

2015

1437

23.74

307.65

13.7

4.6

1.91

1.30

mg/l

100.53

1995

1344

Cardiovascular diseases (excluding rheumatic etc)

2270

4328

3.11

307.65

8.1

4.2

1.47

1.05

mg/l

105.71

2174

4057

Bacterial infection, other or unspecified

2191

6005

3.24

307.65

6.3

3.1

1.96

1.45

mg/l

86.10

2050

5421

Autoimmune diseases excluding thyroid diseases

3375

8540

2.20

307.65

4.5

4.3

1.64

1.40

mg/l

41.88

3160

7852

Other bacterial diseases, including avohilmo

3738

9355

2.58

307.65

6.7

3.5

1.79

1.32

mg/l

143.05

3501

8590

Malignant neoplasm of head and neck

555

806

7.95

307.65

3.1

2.8

1.22

1.76

mg/l

35.77

541

712

Renal tubulo-interstitial diseases

5440

7058

6.17

307.65

6.0

3.0

1.98

1.14

mg/l

307.65

5105

6389

Azathioprine

882

1906

5.13

307.65

12.8

4.3

1.68

1.36

mg/l

19.44

846

1767

Other bacterial diseases

3662

9191

2.75

307.65

6.8

3.4

1.84

1.35

mg/l

145.48

3416

8423

Transplanted organ and tissue status

1991

1178

30.77

307.65

13.6

4.1

1.93

1.31

mg/l

95.75

1966

1094

Implicit Sepsis, including avohilmo

3065

8254

2.76

307.65

5.2

3.2

1.91

1.35

mg/l

160.46

2855

7523

Cystic kidney disease

485

390

19.59

307.65

10.2

6.3

1.97

1.41

mg/l

20.29

478

360

Congenital malformations of the urinary system

638

834

10.02

307.65

11.1

9.7

1.86

1.34

mg/l

28.51

627

777

Heart failure, not strict

3483

6055

4.13

307.65

5.9

3.2

2.05

1.26

mg/l

307.65

3268

5514

Unspecified kidney failure

804

841

11.26

307.65

6.5

2.4

2.28

1.29

mg/l

105.77

760

719

Condition for Implicit Sepsis (Organ dysfunction codes)

3087

8380

2.65

307.65

5.2

3.2

1.89

1.33

mg/l

159.60

2884

7656

Bacterial Sepsis

1994

5106

3.40

307.65

5.9

3.0

2.11

1.45

mg/l

126.43

1848

4586

Malignant neoplasm of head and neck, including Hilmo

615

999

6.98

307.65

3.1

2.9

1.22

1.75

mg/l

41.72

601

881

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

4004

8536

3.09

307.65

8.0

2.7

1.70

1.33

mg/l

107.78

3757

7848

Nephrotic syndrome

430

414

15.50

307.65

16.6

9.7

1.99

1.26

mg/l

28.99

421

381

Hypertensive Renal Disease

336

279

14.87

307.65

6.0

2.2

2.42

1.41

mg/l

36.91

320

241

Kidney transplant status

1409

690

59.29

307.65

13.9

6.3

2.05

1.22

mg/l

121.25

1396

639

Persons encountering health services for specific procedures and health care

4120

8975

2.81

307.65

6.4

3.4

1.73

1.30

mg/l

136.06

3892

8203

Renal failure

4884

4009

12.56

307.65

6.5

2.7

2.16

1.24

mg/l

307.65

4605

3537

Care involving dialysis

1560

892

31.42

307.65

10.7

4.5

2.47

1.37

mg/l

164.11

1523

816

Other dialysis

619

418

30.67

307.65

13.7

6.8

2.29

1.45

mg/l

43.91

610

385

Implicit bacterial Sepsis

1786

4556

3.56

307.65

5.7

2.9

2.15

1.48

mg/l

116.60

1655

4067

Preparatory care for dialysis

812

494

30.83

307.65

7.1

3.6

2.42

1.55

mg/l

52.54

792

443

ILD medications

4276

8568

2.79

307.65

7.7

2.6

1.65

1.35

mg/l

73.34

4013

7823

Caries of dentine

1393

2756

5.37

307.65

7.9

2.6

1.82

1.47

mg/l

27.02

1357

2499

Insulin medication

2216

7467

2.56

307.65

4.8

4.1

2.04

1.41

mg/l

143.43

2024

6895

Liquid cancers, including Hilmo

1402

3841

3.39

307.65

6.0

3.6

1.46

1.66

mg/l

14.10

1324

3407

Septicaemia

1958

5185

3.66

307.65

8.8

3.6

2.02

1.47

mg/l

87.94

1837

4689

Dental caries

1609

3056

5.48

307.65

8.9

2.7

1.79

1.47

mg/l

27.50

1568

2783

Antihypertensive medication - note that there are other indications

2062

3476

3.21

307.65

8.8

4.0

1.41

1.04

mg/l

85.11

1965

3261

ILD medications: prednisolone, methylprednisolone, prednisone

4099

8382

2.82

307.65

7.4

2.5

1.69

1.36

mg/l

84.65

3844

7645

Heart failure and antihypertensive medication

1035

1284

5.60

307.65

5.4

2.7

2.14

1.12

mg/l

137.30

965

1181

Fever of other and unknown origin

2326

6602

3.19

307.65

7.0

3.0

1.72

1.43

mg/l

36.29

2198

6024

Cardiovascular diseases

2041

3873

2.89

307.65

8.3

4.4

1.40

1.05

mg/l

78.42

1952

3630

ILD medications: azathioprine

882

1689

5.80

307.65

12.8

3.0

1.68

1.27

mg/l

30.64

846

1556

Diabetic nephropathy

1216

2377

5.95

307.65

5.8

2.9

2.37

1.70

mg/l

76.34

1156

2130

ILD medications: immunosuppressive drugs

3437

7860

4.25

307.65

9.7

2.6

1.73

1.34

mg/l

105.33

3290

7190

Other disorders of kidney and ureter

963

1639

6.85

307.65

9.1

3.7

2.18

1.58

mg/l

46.78

915

1488

Explicit Sepsis, including avohilmo

2038

5410

3.62

307.65

8.6

3.4

2.01

1.42

mg/l

104.15

1911

4879

Implicit Sepsis

2935

7737

2.92

307.65

5.3

3.1

1.94

1.37

mg/l

159.16

2733

7029

Hypertensive diseases (excluding secondary)

2162

3283

4.04

307.65

7.7

3.2

1.65

1.06

mg/l

159.37

2059

3052

IgA nephropathy (IgA glomerulonephritis)

379

296

21.04

307.65

6.7

3.0

1.89

1.50

mg/l

7.27

373

271

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

4255

9267

3.25

307.65

5.9

3.6

1.76

1.37

mg/l

115.15

3972

8490

Other disorders involving the immune mechanism, not elsewhere classified

455

446

15.40

307.65

11.2

7.3

1.80

1.42

mg/l

10.00

443

418

Glomerulonephritis

1052

1240

10.95

307.65

10.5

5.2

1.92

1.48

mg/l

27.61

1022

1139

Viral Sepsis

1050

2556

4.44

307.65

7.9

3.3

2.02

1.43

mg/l

57.60

995

2271

Insulin, fast-acting

1499

5371

2.94

303.24

5.3

4.6

2.06

1.41

mg/l

99.59

1371

4934

Influenza and pneumonia

3367

10167

2.10

301.68

5.8

3.8

1.70

1.37

mg/l

73.12

3161

9370

Disorders of other endocrine glands

1718

6509

2.72

300.37

7.6

4.6

1.72

1.41

mg/l

29.00

1609

5980

Diseases of arteries, arterioles and capillaries (FINNGEN)

893

1484

4.38

297.37

5.0

2.1

1.99

1.12

mg/l

102.05

842

1356

Insulin, intermediate and long-acting

2001

8021

2.50

296.18

4.5

3.9

2.05

1.46

mg/l

112.42

1821

7361

Gout, idiopatic and unspecified

1086

3311

3.51

292.46

4.8

2.6

2.29

1.65

mg/l

67.45

1008

2952

Infections, IBD-co-morbidities

719

1036

5.21

291.94

8.2

3.9

1.96

1.20

mg/l

61.37

692

968

Inflammatory bowel disease treatment related agents

3567

9937

2.04

289.95

6.3

3.5

1.59

1.44

mg/l

19.54

3294

9158

Hypertensive heart and/or renal disease

923

1729

4.10

289.19

4.8

2.2

2.25

1.34

mg/l

98.82

840

1543

Pneumonias (Asthma/COPD co-morbidities)

3217

10325

2.09

289.08

5.6

3.9

1.73

1.36

mg/l

84.60

3013

9516

Any reimbursement code in KELA

1670

2908

2.96

288.96

6.2

2.1

1.41

1.07

mg/l

55.63

1573

2713

Diabetes mellitus

3140

8748

2.12

287.09

4.0

1.75

1.32

mg/l

113.53

2882

8099

Liquid cancers

1123

3305

3.39

286.91

6.8

3.6

1.51

1.69

mg/l

8.43

1061

2927

Pneumonia, organism unspecified

2957

9736

2.14

285.97

5.6

3.8

1.76

1.38

mg/l

80.38

2759

8964

Autoimmune diseases

3436

8604

2.07

285.94

4.3

1.60

1.40

mg/l

30.55

3195

7915

Type 2 diabetes

2919

7950

2.18

284.45

3.6

2.8

1.76

1.35

mg/l

94.61

2673

7318

Diabetes, varying definitions

3123

8759

2.12

283.84

4.0

1.75

1.32

mg/l

113.77

2868

8106

2762

7444

2.23

283.76

5.1

3.1

1.73

1.39

mg/l

60.48

2586

6827

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

2762

7444

2.23

283.76

5.1

3.1

1.73

1.39

mg/l

60.48

2586

6827

Gout, strict definition

865

2330

4.03

282.46

4.8

2.5

2.33

1.66

mg/l

58.88

806

2061

Insulin, fast-acting or short human

1505

5626

2.81

280.62

5.3

4.6

2.06

1.45

mg/l

89.64

1377

5169

All pneumoniae

3219

10432

2.06

277.46

5.6

4.0

1.73

1.37

mg/l

81.04

3019

9624

Gout, unspecified

919

2613

3.79

276.39

5.0

2.6

2.30

1.63

mg/l

62.06

854

2318

Endocrine, nutritional and metabolic diseases

2334

5068

2.38

269.09

5.9

4.2

1.52

1.18

mg/l

64.70

2185

4722

Hyperkalaemia

397

576

7.94

266.78

5.9

3.0

2.33

1.65

mg/l

23.00

370

501

Malignant neoplasm, wide definition

2681

7307

2.19

265.38

6.0

3.7

1.39

1.50

mg/l

8.05

2542

6671

Used for control exclusion in common control thyroid runs

3202

7991

2.07

263.70

4.6

4.3

1.59

1.39

mg/l

26.79

2976

7366

Presence of other functional implants

1800

4946

2.57

263.53

3.8

2.2

1.82

1.50

mg/l

32.08

1576

4453

Malignant neoplasm, including Hilmo

2664

7294

2.18

261.10

6.0

3.7

1.39

1.50

mg/l

8.15

2525

6659

Certain disorders involving the immune mechanism

882

2551

3.73

258.89

8.3

4.4

1.74

1.48

mg/l

11.60

841

2356

Malignant neoplasm

2601

7128

2.20

258.37

6.1

3.7

1.39

1.50

mg/l

8.66

2464

6503

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

3107

10511

2.02

256.04

5.6

4.0

1.74

1.38

mg/l

76.36

2902

9698

General symptoms and signs

3104

7685

2.07

255.90

4.7

3.0

1.55

1.39

mg/l

18.13

2904

7041

Malignant neoplasm

2584

7111

2.19

253.98

6.0

3.7

1.40

1.50

mg/l

8.38

2447

6487

Certain infectious and parasitic diseases

2780

6614

2.15

253.76

5.5

2.8

1.61

1.31

mg/l

50.04

2581

6045

Type 1 diabetes

1058

3509

3.18

245.80

5.8

2.01

1.28

mg/l

89.27

989

3283

Diarrhoea and gastroenteritis of presumed infectious origin

2315

9856

2.16

241.21

7.6

3.6

1.68

1.43

mg/l

31.14

2162

9072

Other medical care

1531

5116

2.60

239.88

3.9

3.0

1.72

1.43

mg/l

26.30

1422

4569

Diseases of liver

1313

4963

2.78

239.68

4.8

3.3

1.70

1.53

mg/l

9.13

1234

4527

Polyarthropathies

2248

6665

2.23

236.89

4.5

3.9

1.88

1.40

mg/l

86.11

2052

6154

Intestinal infectious diseases

2925

11269

1.98

233.18

6.8

3.5

1.68

1.44

mg/l

34.13

2721

10357

Isolated proteinuria

279

328

11.02

228.74

5.8

3.9

1.75

1.48

mg/l

3.64

272

298

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

2768

8251

2.04

228.73

4.1

3.9

1.82

1.33

mg/l

123.55

2514

7622

Tramadol

2313

6534

2.18

228.57

4.0

2.8

1.70

1.44

mg/l

30.45

2142

5974

Diabetic maculopathy, excluding more controls

515

1109

5.06

225.91

5.6

2.7

2.14

1.40

mg/l

43.92

479

1015

Disorders of parathyroid gland

805

2374

3.56

222.94

5.8

2.8

2.08

1.60

mg/l

27.24

766

2114

Acute peritonitis

412

759

6.23

218.98

10.2

3.8

2.22

1.58

mg/l

23.01

400

679

Solid cancers, including Hilmo

2472

7073

2.09

216.55

5.2

3.5

1.41

1.51

mg/l

6.56

2344

6448

Any event in cancer register

2654

7864

2.02

212.73

5.9

3.7

1.40

1.49

mg/l

5.59

2513

7208

Covid-19 confirmed case

1326

5354

2.58

210.16

6.0

3.5

1.83

1.56

mg/l

19.08

1232

4840

Persons encountering health services in other circumstances, wide

3335

9334

1.87

209.98

5.0

3.7

1.61

1.44

mg/l

21.89

3094

8559

Oral corticosteroids

3021

9524

1.90

204.22

3.7

3.2

1.63

1.45

mg/l

19.45

2764

8761

Other diseases of blood and blood-forming organs, wide

884

2957

3.17

203.62

6.4

4.0

1.51

1.54

mg/l

0.46

823

2708

Type 1 diabetes, wide definition, subgroup 1

865

2851

3.21

203.59

5.6

6.1

2.02

1.24

mg/l

83.39

804

2686

Hernia of abdominal wall, postoperative

606

1578

3.99

202.36

6.2

2.2

1.84

1.37

mg/l

25.54

559

1380

Fibrosis and cirrhosis of liver

443

931

5.35

202.14

5.3

3.5

1.82

1.60

mg/l

4.85

422

847

Ulcer of lower limb, not elsewhere classified

645

1787

3.89

201.80

5.1

2.8

2.32

1.66

mg/l

36.97

597

1581

Solid cancers

2360

6871

2.06

200.90

5.1

3.5

1.41

1.52

mg/l

7.62

2232

6253

Abnormal findings on examination of urine, without diagnosis

325

521

7.40

200.49

5.8

4.8

1.73

1.54

mg/l

2.58

313

473

Hyperlipidaemia, other/unspecified

1233

4380

2.63

199.81

4.2

2.7

1.90

1.55

mg/l

27.71

1124

3910

Other heart diseases, wide

2663

8399

1.96

199.41

5.3

4.3

1.65

1.29

mg/l

66.09

2477

7820

Heart failure and coronary heart disease

1404

4030

2.54

199.29

4.4

2.9

2.23

1.59

mg/l

83.78

1263

3618

Hyperparathyroidism

704

2059

3.59

197.87

6.0

2.7

2.15

1.61

mg/l

28.06

673

1826

Diabetes, insulin treatment (Kela reimbursement)

2919

9350

1.90

197.73

4.1

3.8

1.83

1.38

mg/l

113.14

2648

8642

Diseases of arteries, arterioles and capillaries

1983

6990

2.14

194.84

4.3

2.9

2.01

1.56

mg/l

63.48

1846

6295

Erysipelas, including avohilmo

2076

7538

2.09

193.47

3.8

2.7

1.95

1.39

mg/l

101.86

1885

6850

Chronic tubulo-interstitial nephritis

228

250

10.49

192.96

6.3

2.2

2.12

1.16

mg/l

29.45

217

224

Disorders of lipoprotein metabolism and other lipidaemias

2286

6984

2.04

190.09

3.8

2.9

1.73

1.43

mg/l

44.53

2122

6356

Type 1 diabetes, wide definition

882

3057

3.04

189.68

5.8

6.1

2.02

1.26

mg/l

80.71

821

2869

Neoplasms

2257

5847

2.07

189.25

7.6

4.1

1.38

1.37

mg/l

0.29

2155

5379

Malaise and fatigue

1556

5433

2.32

189.00

4.2

3.1

1.75

1.47

mg/l

24.28

1397

4930

Nausea and vomiting

1022

3729

2.79

188.84

9.2

4.7

1.70

1.47

mg/l

10.81

945

3393

Hydronephrosis

428

922

4.96

186.56

5.9

2.7

1.92

1.21

mg/l

35.82

400

818

Codes for special purposes

1703

7984

2.18

185.57

5.8

3.7

1.72

1.49

mg/l

18.57

1584

7302

Provisional assignment of new diseases of uncertain etiology

1701

7974

2.18

185.44

5.8

3.7

1.72

1.49

mg/l

18.37

1582

7293

Malignant neoplasm of oral cavity, including Hilmo

281

417

7.78

185.18

2.7

1.21

1.65

mg/l

14.39

276

368

Persons encountering health services for other counselling and medical advice, not elsewhere classified

3138

9312

1.82

183.82

5.3

3.7

1.64

1.44

mg/l

27.18

2931

8540

Dipeptidyl peptidase 4 (DPP-4) inhibitors

1663

6034

2.23

182.99

3.7

2.8

2.04

1.55

mg/l

68.15

1486

5491

Care involving use of rehabilitation procedures

1802

7812

2.13

182.46

5.7

3.5

1.61

1.33

mg/l

33.37

1681

7108

Volume depletion

452

1044

4.69

181.61

5.7

4.4

2.07

1.54

mg/l

18.16

420

919

Malignant neoplasm of oral cavity

242

313

9.16

180.81

2.7

2.6

1.20

1.69

mg/l

13.53

237

271

Complications of surgical and medical care, not elsewhere classified

2829

10442

1.84

180.21

4.8

3.4

1.75

1.46

mg/l

44.82

2613

9570

Erysipelas

1617

6489

2.21

178.12

3.9

2.6

1.99

1.44

mg/l

74.05

1462

5878

Hypothyroidism (congenital or acquired)

689

1057

3.76

178.02

5.0

2.7

1.36

1.03

mg/l

24.64

641

999

Atrial fibrillation and flutter

886

1920

3.08

177.75

3.7

2.1

1.77

1.10

mg/l

70.61

827

1762

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

1156

2818

2.66

177.68

5.0

2.5

1.63

1.07

mg/l

72.22

1090

2612

Donors of organs and tissues

163

127

17.11

177.00

2.5

1.16

1.30

mg/l

1.76

158

111

Disorders of mineral metabolism

412

917

4.91

174.00

5.3

4.0

1.91

1.45

mg/l

13.75

388

834

Iron deficiency anaemia

1361

5924

2.33

173.60

5.2

3.8

1.90

1.54

mg/l

30.65

1243

5354

Diseases of peritoneum

473

1175

4.38

173.33

9.1

3.5

2.14

1.57

mg/l

23.81

453

1071

Hypo-osmolality and hyponatraemia

648

1963

3.46

172.96

4.9

3.0

1.80

1.55

mg/l

8.30

591

1733

Sub-endpoint used in defining T1D endpoints

1087

4317

2.58

172.60

5.7

5.4

2.02

1.41

mg/l

65.18

1015

3992

Oxycodone

1213

4334

2.47

172.39

3.5

2.8

1.71

1.57

mg/l

5.15

1123

3904

Nutritional anaemias

1518

6716

2.22

172.24

5.0

3.7

1.88

1.55

mg/l

30.39

1386

6066

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

643

1973

3.50

172.21

5.5

3.3

1.83

1.63

mg/l

5.94

614

1804

Diabetic retinopathy, excluding more controls

1014

2065

2.91

171.77

5.1

2.9

2.06

1.52

mg/l

48.37

926

1868

Second line medication for Crohn's disease

1795

8918

2.07

171.11

9.0

3.6

1.53

1.46

mg/l

3.06

1679

8215

Oedema, not elsewhere classified

1025

3941

2.63

170.36

4.4

2.8

1.84

1.51

mg/l

20.53

936

3547

Hypothyroidism and >3 levothyroxin purchases

671

1046

3.70

169.95

4.8

2.6

1.35

1.03

mg/l

23.02

625

988

Hypothyroidism, levothyroxine purchases

671

1046

3.70

169.95

4.8

2.6

1.35

1.03

mg/l

23.02

625

988

Diabetes medication

2892

9501

1.81

169.35

4.0

3.9

1.78

1.36

mg/l

97.92

2630

8805

Other disorders of skin and subcutaneous tissue

2111

9331

1.96

167.64

4.9

3.4

1.84

1.51

mg/l

41.69

1955

8490

Type 2 diabetes, definitions combined

2440

7657

1.89

163.09

3.2

2.7

1.70

1.35

mg/l

63.56

2223

7044

Insulin, fast-acting (human)

576

1701

3.60

163.00

6.2

3.5

2.02

1.31

mg/l

51.13

545

1580

L04AX Other immunosuppressants

1734

8672

2.06

162.57

9.2

3.6

1.54

1.47

mg/l

3.40

1619

7983

Persons with potential health hazards related to communicable diseases

1266

5569

2.33

162.01

8.2

5.2

1.43

1.33

mg/l

4.16

1200

5247

Heart failure and bmi 25plus

1089

2904

2.60

160.76

3.7

2.8

2.28

1.56

mg/l

76.40

977

2587

Type 2 diabetes, strict (exclude DM1)

2448

7729

1.88

160.61

3.2

2.7

1.70

1.36

mg/l

63.02

2230

7114

Disorders of lens

1886

5873

2.04

158.53

5.3

3.0

1.90

1.48

mg/l

56.87

1722

5434

Opioids

2548

7201

1.86

157.90

3.7

2.9

1.55

1.41

mg/l

11.88

2382

6606

Type 2 diabetes, definitions combined, including avohilmo

2435

7667

1.87

157.71

3.2

2.7

1.69

1.35

mg/l

58.55

2217

7065

Symptoms and signs involving the urinary system

2195

8912

1.90

156.86

4.7

3.7

1.72

1.51

mg/l

19.45

2002

8146

Oesophageal varices

278

489

6.64

155.95

7.1

5.1

1.81

1.57

mg/l

3.65

268

440

Other disorders of urethra and urinary system

1927

6894

1.99

155.01

4.6

3.5

1.69

1.49

mg/l

15.19

1760

6275

Other and unspecified iron deficiency

1097

4686

2.42

153.10

4.9

3.9

1.88

1.53

mg/l

25.05

1003

4242

Statin medication

1802

5032

2.06

152.24

5.4

2.9

1.59

1.27

mg/l

43.12

1692

4646

Unspecified haematuria

1321

4911

2.26

151.74

4.9

3.3

1.77

1.61

mg/l

6.63

1211

4460

Cirrhosis of liver, NAS

321

658

5.54

151.43

5.5

3.5

1.87

1.63

mg/l

4.43

307

592

Autoimmune diseases related-to ILD

2389

11204

1.82

151.39

3.9

3.7

1.55

1.48

mg/l

3.48

2213

10286

Persons encountering health services in other circumstances

1272

5753

2.25

151.03

4.5

3.8

1.59

1.43

mg/l

8.31

1161

5261

Congenital malformations, deformations and chromosomal abnormalities

1754

8541

2.00

150.76

6.9

4.0

1.56

1.39

mg/l

13.57

1669

7930

Non-ischemic cardiomyopathy

962

3037

2.61

149.70

4.3

3.1

2.05

1.50

mg/l

48.59

864

2723

Other retinal disorders

1822

7188

1.97

145.60

4.6

3.1

1.92

1.57

mg/l

41.45

1649

6516

Primary_lymphoid and hematopoietic malignant neoplasms

845

3308

2.68

144.15

7.8

3.8

1.56

1.64

mg/l

1.93

793

2968

Bleeding

2339

9212

1.82

143.67

5.6

3.7

1.84

1.47

mg/l

56.59

2164

8403

Diarrhoea and gastroenteritis of presumed infectious origin, including avohilmo

2805

10587

1.73

143.35

5.8

3.5

1.60

1.45

mg/l

14.64

2609

9716

Peripheral artery disease

1264

4572

2.25

143.14

4.3

2.6

2.19

1.66

mg/l

56.45

1165

4049

Monoclonal gammopathy of undetermined significance (MGUS), including Hilmo

250

428

6.55

142.72

3.9

2.5

1.87

1.78

mg/l

0.58

231

368

Adjustment and management of implanted device

591

1923

3.22

142.06

3.5

2.9

1.98

1.56

mg/l

19.29

517

1684

Disorders of choroid and retina

2225

8678

1.83

140.31

4.3

3.2

1.86

1.53

mg/l

45.78

2018

7924

Diabetic retinopathy, strict definition

750

2479

2.89

139.88

5.7

3.2

2.14

1.73

mg/l

22.89

695

2261

Intestinal infectious diseases, including avohilmo, including avohilmo

3112

10499

1.68

138.44

5.3

3.5

1.64

1.45

mg/l

23.01

2886

9631

Osteopathies and chondropathies

1649

7799

1.98

138.04

5.1

3.8

1.70

1.51

mg/l

13.85

1529

7112

COPD/asthma related infections

2595

7444

1.78

137.73

4.4

3.1

1.59

1.39

mg/l

21.87

2407

6827

COPD/asthma/ILD related infections

2595

7444

1.78

137.73

4.4

3.1

1.59

1.39

mg/l

21.87

2407

6827

Cerebrovascular diseases (FINNGEN)

795

2060

2.78

137.65

4.8

2.5

1.68

1.09

mg/l

58.47

750

1892

Valvular heart disease excluding rheumatic fever

1316

4401

2.19

137.52

4.9

4.3

1.85

1.39

mg/l

45.65

1198

4023

Coagulation defects, purpura and other haemorrhagic conditions

717

2649

2.85

137.39

6.2

4.7

1.62

1.50

mg/l

2.64

679

2425

Congenital malformations, deformations and chromosomal abnormalities, including avohilmo

1855

9114

1.90

136.51

6.5

3.9

1.55

1.40

mg/l

10.13

1764

8437

Complications of procedures, not elsewhere classified

2194

9981

1.81

135.66

4.2

3.2

1.72

1.47

mg/l

25.92

2034

9122

Ischemic heart diseases

2259

7572

1.81

133.02

4.9

4.1

1.75

1.41

mg/l

49.84

2099

6963

Non-rheumatic valve diseases

1280

4316

2.17

130.71

4.8

3.9

1.87

1.40

mg/l

46.37

1163

3940

Atrial fibrillation and flutter with reimbursement

674

1453

3.02

130.26

3.4

2.1

1.82

1.12

mg/l

59.12

616

1321

Amputation

414

1146

3.87

129.67

5.2

2.5

2.42

1.72

mg/l

25.55

390

999

Other viral diseases

1010

4474

2.34

129.45

11.2

5.5

1.64

1.33

mg/l

21.25

973

4201

Other cataract

1241

4347

2.18

128.87

5.8

2.9

1.87

1.52

mg/l

30.27

1128

3989

Gingival hyperplasia

272

562

5.71

128.67

25.0

8.9

1.72

1.36

mg/l

7.92

266

522

Disorders of calcium metabolism

301

670

4.91

127.29

5.5

4.0

2.06

1.48

mg/l

15.06

282

605

Cardiac arrhythmias

1531

4967

2.02

126.45

4.1

4.2

1.57

1.19

mg/l

49.04

1418

4646

Gout due to impairment of renal function

124

109

15.92

126.02

7.7

2.5

2.61

1.57

mg/l

15.70

112

101

Hypertensive Heart Disease

619

1609

3.01

125.94

4.4

2.2

2.18

1.36

mg/l

55.30

548

1430

Atherosclerosis, excluding cerebral and coronary sclerosis

1158

4234

2.21

125.83

4.1

2.5

2.19

1.68

mg/l

48.09

1065

3735

Depression medications

676

1135

3.06

125.14

4.3

2.7

1.32

1.02

mg/l

21.63

639

1073

Cholangitis (primary sclerosing, PSC)

322

770

4.60

124.76

8.1

5.0

1.60

1.50

mg/l

1.18

311

700

Disorders of gallbladder, biliary tract and pancreas

2579

9581

1.70

124.41

4.6

3.2

1.69

1.50

mg/l

19.26

2383

8750

Other CVD (FINNGEN)

353

639

4.42

124.36

4.2

1.9

1.89

1.18

mg/l

32.87

314

572

Hard cardiovascular diseases

2251

7630

1.78

124.22

5.1

4.1

1.72

1.40

mg/l

47.27

2115

7033

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

235

437

6.15

123.82

6.9

2.9

2.03

1.26

mg/l

26.14

226

419

Vitreous haemorrhage

429

1257

3.67

123.72

5.5

3.2

2.08

1.61

mg/l

15.23

405

1144

Complications of medical and surgical care

1977

10081

1.80

122.73

4.8

3.2

1.80

1.50

mg/l

30.68

1836

9194

Codeine

2271

7046

1.77

121.76

3.1

2.8

1.55

1.42

mg/l

9.34

2070

6465

Percutaneous Coronary Intervention

2123

7346

1.79

121.36

5.0

4.1

1.78

1.42

mg/l

52.66

1965

6750

Purpura and other haemorrhagic conditions

525

1768

3.15

119.85

6.2

5.1

1.64

1.52

mg/l

1.77

496

1634

Abnormalities of breathing

2375

7970

1.73

119.81

4.3

4.0

1.60

1.40

mg/l

21.01

2158

7389

Coronary revascularization (ANGIO or CABG)

2119

7348

1.79

119.72

5.0

4.1

1.77

1.42

mg/l

50.79

1959

6752

Unspecified nephritic syndrome

163

226

8.67

115.34

8.4

2.6

1.92

1.45

mg/l

5.37

157

202

Charcot foot

140

163

10.48

114.58

6.1

2.6

2.29

1.33

mg/l

15.71

130

147

Primary biliary cholangitis, wide definition

161

221

8.63

114.55

7.0

4.9

1.64

1.43

mg/l

2.28

155

202

Hepatic failure, not elsewhere classified

228

447

5.83

113.47

6.0

3.1

1.79

1.57

mg/l

2.80

219

403

Infections of the skin and subcutaneous tissue

1743

9657

1.82

113.17

6.5

4.2

1.71

1.43

mg/l

27.05

1650

8919

Ascites

330

863

4.13

112.68

5.8

2.9

1.99

1.61

mg/l

9.63

318

780

Gastrointestinal diseases

1489

3815

1.99

112.22

6.9

2.6

1.42

1.26

mg/l

9.84

1401

3490

Bronchitis

2827

10629

1.62

111.66

4.9

3.2

1.60

1.47

mg/l

11.10

2603

9753

Exposure to unspecified factor

2735

11650

1.62

111.31

4.3

1.57

1.47

mg/l

6.69

2496

10767

Osteoporosis

779

3017

2.46

110.92

5.1

3.1

1.71

1.65

mg/l

0.97

710

2677

Emergency coronary revascularization (for ACS)

2256

8091

1.71

110.50

4.8

4.0

1.79

1.46

mg/l

47.26

2085

7422

Major coronary heart disease event

2220

7857

1.72

110.20

4.9

4.0

1.78

1.44

mg/l

49.04

2060

7217

Senile cataract

1578

5130

1.91

110.15

4.2

2.7

1.92

1.52

mg/l

41.72

1430

4729

Viral infections characterized by skin and mucous membrane lesions

1295

6721

1.98

109.42

8.8

4.3

1.66

1.46

mg/l

12.78

1212

6209

All influenza

839

3703

2.35

109.32

8.4

4.4

1.76

1.43

mg/l

17.25

783

3377

Other diseases of urinary system

2546

8763

1.66

108.48

4.7

4.0

1.64

1.47

mg/l

17.48

2336

8056

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

495

1704

3.05

108.12

4.0

3.1

1.38

1.69

mg/l

15.04

474

1494

Other viral diseases, including avohilmo

1186

5944

2.03

107.85

9.8

5.0

1.57

1.33

mg/l

16.28

1140

5570

Peripheral artery operations in Hilmo

442

1435

3.24

106.98

5.1

2.4

2.35

1.69

mg/l

25.54

413

1253

Certain infectious and parasitic diseases, including avohilmo

1740

4792

1.85

105.69

5.0

2.8

1.59

1.32

mg/l

28.81

1611

4369

Diabetic retinopathy

1194

3689

2.09

104.87

4.8

3.3

2.07

1.77

mg/l

18.93

1088

3351

Dyspnoea

2342

10376

1.66

104.64

3.6

3.9

1.76

1.47

mg/l

37.66

2121

9546

Diseases of the digestive system

1308

6870

1.94

104.10

5.5

4.0

1.85

1.55

mg/l

20.24

1210

6240

Diseases of the skin and subcutaneous tissue

2519

7759

1.65

104.01

4.6

3.6

1.57

1.41

mg/l

15.75

2326

7132

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1601

8845

1.81

103.48

4.9

3.1

1.80

1.52

mg/l

22.22

1492

8031

Implicit fungal Sepsis, including avohilmo

285

716

4.28

102.64

5.4

2.9

1.91

1.43

mg/l

11.03

268

629

Pure hypercholesterolaemia

1808

6567

1.78

102.14

3.5

2.9

1.72

1.45

mg/l

29.92

1676

5965

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

891

1933

2.36

101.55

4.7

2.7

1.44

1.23

mg/l

10.67

830

1769

Arthropathies in other diseases classified elsewhere

196

375

5.87

99.73

5.3

2.7

2.16

1.45

mg/l

13.48

182

344

Hypokalaemia

399

1274

3.29

99.35

5.5

3.3

1.77

1.51

mg/l

6.19

367

1136

Other diseases of liver

597

2374

2.63

98.65

4.4

3.4

1.69

1.49

mg/l

5.07

549

2176

Explicit bacterial Sepsis, including avohilmo

382

1201

3.35

97.73

7.2

3.5

1.99

1.43

mg/l

18.36

354

1068

Malignant neoplasm of urinary organs, including Hilmo

379

1188

3.36

97.49

4.6

3.2

1.90

1.78

mg/l

1.58

349

1028

Fungal Sepsis

210

435

5.34

97.31

6.1

3.2

1.96

1.43

mg/l

9.72

201

391

Acute upper respiratory infections of multiple and unspecified sites

2017

8867

1.69

97.06

6.0

3.3

1.54

1.47

mg/l

2.75

1883

8140

2821

9197

1.58

96.36

4.5

3.1

1.59

1.48

mg/l

8.63

2587

8417

Other necrotizing vasculopathies

297

806

3.98

96.35

5.9

3.1

1.85

1.63

mg/l

3.46

280

714

Diseases of oesophagus, stomach and duodenum

2714

10296

1.58

96.34

3.9

3.8

1.64

1.46

mg/l

19.96

2511

9466

Other nutritional deficiencies

1772

9564

1.72

95.62

3.8

1.78

1.43

mg/l

41.53

1624

8848

Viral hepatitis, IBD co-morbidity

216

465

4.95

94.49

3.8

2.4

1.42

1.14

mg/l

6.35

208

433

Other diseases of pleura

1224

5660

1.93

93.72

4.3

3.4

1.88

1.66

mg/l

12.20

1125

5094

Malignant neoplasm of kidney, except renal pelvis, including Hilmo

338

1016

3.52

93.16

4.8

3.2

1.90

1.77

mg/l

1.64

311

882

Other (not insulin) diabetes medications

2321

8502

1.62

92.98

3.1

2.8

1.74

1.40

mg/l

54.83

2091

7838

Other diseases of blood and blood-forming organs

293

808

3.92

92.92

3.4

3.1

1.39

1.59

mg/l

4.12

272

735

Explicit bacterial Sepsis

370

1178

3.31

92.72

7.3

3.5

1.98

1.43

mg/l

17.85

342

1047

Pacemaker

982

4563

2.06

91.49

3.7

3.2

2.00

1.71

mg/l

16.11

869

4066

Symptoms and signs involving the digestive system and abdomen

2569

8200

1.59

91.40

5.7

3.8

1.54

1.45

mg/l

6.13

2374

7538

Factors influencing health status and contact with health services

729

1522

2.45

90.46

3.9

2.0

1.53

1.28

mg/l

11.45

671

1386

Other special examinations and investigations of persons without complaint or reported diagnosis

1668

4829

1.78

89.74

5.1

2.8

1.53

1.46

mg/l

2.34

1541

4405

Sleep apnoea

2383

9557

1.60

89.66

3.0

3.4

1.64

1.50

mg/l

10.59

2148

8833

Amputation of toe

295

837

3.80

89.63

5.4

2.8

2.36

1.73

mg/l

16.58

276

743

Implicit fungal Sepsis

192

396

5.36

89.45

6.0

3.1

1.99

1.44

mg/l

9.13

183

355

Malignant neoplasm of urinary organs

328

996

3.48

88.96

4.5

3.1

1.91

1.77

mg/l

1.79

303

865

COPD differential diagnosis

1876

5566

1.71

88.79

4.1

3.0

1.55

1.36

mg/l

16.31

1754

5111

Venous thromboembolism

1363

7377

1.82

88.77

3.8

2.9

1.83

1.60

mg/l

12.76

1248

6663

ILD differential diagnosis

1875

5563

1.71

88.72

4.1

3.0

1.55

1.36

mg/l

16.36

1754

5108

Hypothyroidism, strict autoimmune

1666

6374

1.74

88.61

3.6

3.2

1.58

1.45

mg/l

7.24

1521

5816

Other necrotizing vasculopathies (FG)

239

589

4.38

88.53

6.0

2.9

1.80

1.48

mg/l

6.21

225

521

Parasetamol

1850

5527

1.72

88.39

4.5

3.8

1.52

1.34

mg/l

15.04

1720

5171

Streptococcal septicaemia, including avohilmo

329

1007

3.46

88.21

7.6

3.9

2.00

1.49

mg/l

12.83

302

905

Excluding asthma or asthma-COPD overlap

1877

5580

1.71

88.18

4.1

3.0

1.55

1.36

mg/l

16.72

1754

5126

Malignant neoplasm of liver and intrahepatic bile ducts, including Hilmo

206

455

4.91

87.90

6.8

3.0

1.67

1.78

mg/l

0.90

193

386

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, including Hilmo

240

601

4.27

86.72

6.3

2.9

1.65

1.78

mg/l

1.21

221

519

Osteomyelitis

283

800

3.83

86.63

5.8

4.6

2.21

1.56

mg/l

17.96

268

729

Other pulmonary diagnosis

1868

5580

1.70

86.23

4.1

3.0

1.56

1.36

mg/l

16.80

1743

5126

Drug-induced cataract

157

283

6.51

86.20

15.3

3.7

1.95

1.43

mg/l

6.78

152

255

Idiopathic gout

341

1085

3.34

86.06

4.3

2.7

2.34

1.66

mg/l

21.42

320

974

Medical observation and evaluation for suspected diseases and conditions

1639

4828

1.76

85.90

4.7

2.8

1.50

1.46

mg/l

1.40

1496

4404

Other diseases of intestines

2706

9913

1.54

85.62

4.6

4.4

1.56

1.41

mg/l

15.20

2521

9155

Systemic connective tissue disorders

927

4672

2.04

85.56

4.1

3.3

1.69

1.57

mg/l

4.03

851

4207

437

1601

2.84

84.92

4.9

3.2

1.59

1.35

mg/l

5.81

413

1472

Noninfective enteritis and colitis

1317

7450

1.81

84.35

4.8

1.51

1.45

mg/l

1.96

1228

6874

Streptococcal septicaemia

318

981

3.43

84.20

7.7

4.0

1.99

1.49

mg/l

12.61

291

882

Other diseases of biliary tract

326

1023

3.39

84.13

6.7

4.0

1.66

1.58

mg/l

0.82

309

916

Viral warts

378

1297

3.09

83.69

12.8

4.9

1.81

1.39

mg/l

11.48

359

1214

Hepatocellular carcinoma, including Hilmo

150

264

6.35

83.39

6.0

3.3

1.71

1.78

mg/l

0.32

141

228

Coronary atherosclerosis

1559

5721

1.75

83.32

4.0

2.7

1.90

1.49

mg/l

47.69

1437

5197

Malignant neoplasm of kidney, except renal pelvis

300

899

3.53

83.18

4.7

3.2

1.91

1.76

mg/l

1.77

277

782

Codeine or tramadol medication

2705

9726

1.53

82.50

3.1

3.0

1.58

1.49

mg/l

5.46

2460

8967

GI-bleeding

899

4551

2.03

81.97

5.7

3.7

1.94

1.63

mg/l

14.82

828

4072

Other bacterial intestinal infections

548

2286

2.49

81.55

6.0

3.3

2.04

1.54

mg/l

20.55

512

2053

Artificial opening status

231

594

4.22

81.02

7.7

3.6

1.68

1.39

mg/l

4.27

217

537

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

1678

8870

1.67

81.01

3.6

3.5

1.67

1.58

mg/l

3.72

1564

8044

Finngen Rheumatological endpoints

2365

8686

1.57

80.82

4.1

3.8

1.62

1.38

mg/l

31.24

2185

8041

Viral infections characterized by skin and mucous membrane lesions, including avohilmo

2332

11875

1.55

80.64

6.1

3.9

1.57

1.46

mg/l

7.15

2174

10924

Diseases of the eye and adnexa

2003

6207

1.64

80.52

5.7

4.2

1.50

1.31

mg/l

18.91

1869

5827

Diabetic maculopathy

501

1915

2.63

80.16

5.6

3.2

2.13

1.72

mg/l

15.90

466

1739

Other diseases of the digestive system

895

4561

2.02

80.13

5.8

3.7

1.94

1.62

mg/l

15.01

826

4085

Tubulo-interstitial nephritis, not specified as acute or chronic

207

491

4.44

79.99

6.6

2.8

2.04

1.18

mg/l

22.53

196

435

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1436

8467

1.72

78.72

4.7

3.2

1.82

1.54

mg/l

19.46

1338

7702

Other acute lower respiratory infections

1467

8309

1.71

78.07

5.9

4.4

1.66

1.48

mg/l

10.30

1345

7645

Viral pneumonia

426

1612

2.76

78.01

6.3

4.4

1.91

1.45

mg/l

15.79

397

1464

Symptoms and signs involving the circulatory and respiratory systems

2443

7994

1.55

77.98

4.8

4.0

1.52

1.40

mg/l

8.89

2259

7413

Haemolytic anaemias

187

426

4.91

77.72

9.9

7.0

1.65

1.50

mg/l

1.49

181

386

Cardiomyopathy

495

2013

2.55

77.71

5.5

3.7

1.87

1.42

mg/l

20.59

460

1825

Hypothyroidism, drug reimbursement

297

600

3.55

77.22

4.4

2.7

1.59

1.05

mg/l

19.96

277

560

Pain in throat and chest

2064

7760

1.60

77.18

4.1

3.8

1.52

1.41

mg/l

7.54

1902

7184

Malignant neoplasm of liver and intrahepatic bile ducts

149

280

5.88

77.07

8.3

3.6

1.67

1.77

mg/l

0.64

138

238

Reimbursement for rheumatic diseases

1427

8421

1.72

76.89

4.9

3.7

1.53

1.51

mg/l

0.47

1317

7697

Obesity due to excess calories

1248

7151

1.78

76.79

3.7

3.9

1.87

1.41

mg/l

45.69

1136

6650

Asthma, unspecified (mode), excluding more controls

1182

4676

1.84

76.78

3.9

2.9

1.60

1.31

mg/l

23.73

1086

4291

Sleep apnoea, including avohilmo

2436

9742

1.53

76.47

3.0

3.4

1.62

1.49

mg/l

9.38

2200

9008

Dermatitis

1609

9654

1.66

76.12

4.9

3.7

1.63

1.50

mg/l

6.19

1482

8850

Bacterial intestinal infections, IBD co-morbidities

548

2359

2.41

76.05

5.9

3.7

2.04

1.57

mg/l

18.27

514

2117

Ischaemic heart disease, wide definition

1838

7038

1.63

75.83

3.9

2.8

1.84

1.50

mg/l

39.41

1694

6413

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

300

624

3.50

75.62

3.6

2.8

1.79

1.29

mg/l

16.04

281

574

Paroxysmal tachycardia

522

1796

2.48

75.27

4.5

3.8

1.64

1.09

mg/l

33.16

482

1652

Enterocolitis due to Clostridium difficile

356

1251

2.99

75.21

6.1

3.4

2.23

1.61

mg/l

18.25

330

1103

Invasive ventilation

302

976

3.32

74.71

8.4

5.8

1.78

1.51

mg/l

4.14

279

901

Constipation

2241

9962

1.55

74.68

4.0

4.4

1.59

1.51

mg/l

3.90

2022

9184

Cellulitis

687

3271

2.17

74.53

6.4

4.4

1.82

1.47

mg/l

14.82

652

3002

Urinary track infection

1269

3542

1.82

74.09

5.2

4.0

1.48

1.28

mg/l

12.94

1178

3251

Continuous positive airway pressure

529

1856

2.45

74.02

7.0

5.3

1.75

1.24

mg/l

27.47

491

1726

Abdominal and pelvic pain

2464

8196

1.53

73.77

5.3

3.8

1.52

1.45

mg/l

3.32

2267

7534

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder

189

448

4.52

73.57

7.3

3.1

1.65

1.80

mg/l

1.38

173

381

Syncope and collapse

1067

4888

1.85

73.33

3.8

2.9

1.68

1.49

mg/l

9.01

965

4428

Polyneuropathies and other disorders of the peripheral nervous system

637

2981

2.21

72.34

6.7

3.5

1.88

1.63

mg/l

7.40

593

2670

Thrombocytopenia, unspecified

282

892

3.38

72.16

7.0

4.8

1.66

1.57

mg/l

0.85

263

808

Other reaction to severe stress, and adjustment disorders

966

5220

1.89

72.06

6.9

3.7

1.51

1.36

mg/l

6.22

905

4877

Other obstructive and reflux uropathy

154

316

5.22

71.53

5.1

4.0

2.06

1.13

mg/l

15.33

147

284

Obesity and other hyperalimentation

1584

9258

1.63

70.59

3.6

3.7

1.82

1.43

mg/l

44.67

1451

8564

Exclusions for E4_PCOS_BROAD

582

2655

2.28

70.58

8.4

7.2

1.48

1.37

mg/l

2.45

539

2500

Hypoplasia of dental enamel , including avohilmo

264

792

3.66

70.54

37.4

13.4

1.31

1.02

mg/l

11.96

257

772

Hepatocellular carcinoma

118

194

6.83

70.40

6.3

2.9

1.70

1.76

mg/l

0.27

110

166

Other problems related to primary support group, including family circumstances

419

1610

2.66

70.30

27.4

6.4

1.23

1.21

mg/l

0.35

407

1531

Molar incisor enamel hypoplasia

276

847

3.54

70.23

37.7

12.8

1.30

1.03

mg/l

12.12

269

826

Obesity

1576

9230

1.63

70.09

3.6

3.7

1.82

1.43

mg/l

44.41

1443

8537

Primary biliary cholangitis (PBC)

115

186

6.98

69.79

4.9

2.3

1.71

1.50

mg/l

1.51

110

166

Pain in limb

2121

8846

1.54

69.79

5.0

4.3

1.63

1.45

mg/l

16.74

1947

8189

Colitis, primary sclerosing, strict definition

129

9.25

69.13

5.3

4.3

1.50

1.28

mg/l

1.67

119

Other bacterial intestinal infections, including avohilmo

641

3055

2.16

69.12

5.5

3.2

1.93

1.51

mg/l

18.91

599

2773

Enlarged lymph nodes

452

1869

2.50

68.54

4.7

3.2

1.40

1.43

mg/l

0.28

436

1698

Neurological diseases, wide definition

738

1757

2.15

68.28

7.2

5.3

1.35

1.13

mg/l

12.87

702

1666

Presence of cardiac and vascular implants and grafts

971

3880

1.88

67.42

3.2

2.2

2.04

1.56

mg/l

38.19

872

3475

Cystitis

1935

7438

1.57

67.25

4.4

3.9

1.58

1.48

mg/l

5.11

1783

6791

General examination and investigation of persons without complaint and reported diagnosis

1531

4821

1.67

67.12

5.9

2.8

1.54

1.46

mg/l

3.17

1455

4400

Acute upper respiratory infections

2480

10131

1.48

67.07

4.9

3.2

1.52

1.51

mg/l

0.22

2297

9259

Benign neoplasms

2428

8939

1.50

66.94

4.5

3.9

1.55

1.43

mg/l

8.29

2272

8228

Non-Hodgkin lymphoma, all, including Hilmo

364

1375

2.75

66.83

5.5

3.1

1.55

1.74

mg/l

3.70

341

1191

Contact with and exposure to communicable diseases

842

4448

1.93

66.79

6.9

5.6

1.30

1.28

mg/l

0.30

787

4219

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

2287

9725

1.50

66.77

4.2

3.1

1.71

1.50

mg/l

19.75

2108

8911

Periodontitis

2375

10268

1.49

66.69

3.9

2.9

1.68

1.49

mg/l

19.59

2191

9391

Peripheral arterial reconstruction

478

2056

2.41

66.56

4.3

2.6

2.31

1.77

mg/l

21.53

437

1797

Other and unspecified polyneuropathies, also in other diseases

556

2550

2.26

66.53

4.9

2.9

1.97

1.66

mg/l

8.76

519

2287

Malignant neoplasm of skin, including Hilmo

1148

4388

1.78

66.45

3.8

2.9

1.74

1.66

mg/l

1.75

1050

3900

Other diseases of arteries and capillaries

295

1002

3.10

66.40

5.5

3.2

2.13

1.56

mg/l

11.66

276

897

Other viral diseases, not elsewhere classified

593

2783

2.20

66.38

13.5

6.5

1.53

1.34

mg/l

6.24

562

2624

Chronic periodontitis, including avohilmo

2369

10268

1.49

66.08

3.9

2.9

1.69

1.49

mg/l

20.05

2185

9393

STROKE

1223

4799

1.74

65.80

4.2

2.9

1.71

1.33

mg/l

37.54

1136

4403

Asthma, unspecified (mode)

1221

5152

1.74

65.75

3.9

3.0

1.60

1.38

mg/l

15.49

1119

4711

Other and unspecified dermatitis

1324

8058

1.67

65.09

5.0

3.8

1.63

1.50

mg/l

6.41

1224

7378

Headache

1484

7105

1.63

64.71

5.5

3.0

1.41

1.38

mg/l

0.53

1372

6510

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

585

2674

2.18

64.43

3.2

2.8

1.42

1.74

mg/l

19.86

554

2357

Haemorrhage from respiratory passages

882

4224

1.89

64.40

5.0

3.7

1.81

1.56

mg/l

11.79

809

3839

Chronic hepatitis, not elsewhere classified

161

377

4.70

64.38

4.9

3.2

1.57

1.44

mg/l

1.20

153

342

Other soft tissue disorders, not elsewhere classified

2351

9080

1.49

64.32

4.9

4.4

1.59

1.44

mg/l

12.07

2153

8412

Acute bronchitis

1092

6211

1.76

64.27

5.6

4.5

1.72

1.51

mg/l

10.40

993

5682

Malignant neoplasm of skin

1084

4167

1.79

63.95

3.6

2.8

1.75

1.68

mg/l

1.62

983

3688

Chronic apical periodontitis

2636

10267

1.46

63.87

3.5

3.4

1.59

1.48

mg/l

8.49

2410

9444

Asthma, excluding more controls

1578

5017

1.63

63.44

3.7

2.9

1.50

1.30

mg/l

16.89

1453

4623

Conduction disorders

716

2893

2.03

63.31

3.6

3.9

1.91

1.43

mg/l

30.38

640

2623

Pulmonary heart disease, diseases of pulmonary circulation

808

4310

1.92

63.16

3.6

3.0

1.85

1.65

mg/l

6.72

746

3859

Myeloproliferative diseases

277

937

3.13

63.04

3.6

2.8

1.38

1.66

mg/l

8.15

266

837

Viral and other specified intestinal infections

628

2997

2.10

63.00

12.9

5.2

1.48

1.26

mg/l

10.58

595

2797

Hypercalcemia

181

471

4.17

62.65

5.9

3.7

1.98

1.62

mg/l

4.34

171

423

Agranulocytosis

352

1355

2.72

62.60

8.6

4.3

1.52

1.53

mg/l

0.07

329

1247

DVT of lower extremities and pulmonary embolism

1016

5800

1.78

62.44

3.6

2.8

1.81

1.64

mg/l

6.56

936

5209

Squamous cell neoplasms and carcinomas of the skin, including Hilmo

336

1247

2.76

62.28

4.3

2.4

1.91

1.92

mg/l

0.07

307

1046

Alcoholic liver disease

337

1276

2.78

62.09

4.9

2.8

1.90

1.61

mg/l

6.24

319

1163

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

1021

3883

1.80

61.81

3.7

2.8

1.77

1.70

mg/l

1.48

928

3426

Chronic periodontitis, complicated

1380

8387

1.63

61.33

3.9

2.9

1.77

1.56

mg/l

13.63

1280

7658

Viral and other specified intestinal infections, including avohilmo

779

3983

1.92

61.20

11.1

4.6

1.48

1.27

mg/l

11.13

733

3717

Other malignant neoplasms of skin (=non-melanoma skin cancer)

979

3713

1.82

61.08

3.5

2.8

1.79

1.72

mg/l

1.45

881

3265

Multiple myeloma, including Hilmo

162

395

4.40

60.95

4.1

2.9

1.87

1.75

mg/l

0.77

151

344

Examination and observation for other reasons

1391

4795

1.66

60.50

4.8

2.8

1.53

1.45

mg/l

2.63

1310

4376

Inflammatory bowel disease

851

4695

1.86

59.90

4.1

1.45

mg/l

0.02

799

4332

Autoimmune hepatitis, wide definition

176

462

4.08

59.88

5.6

4.0

1.51

1.42

mg/l

0.68

167

430

Iron deficiency anaemia secondary to blood loss (chronic)

442

1924

2.38

59.86

5.6

3.2

1.99

1.61

mg/l

10.65

402

1735

Congenital malformations of gallbladder, bile ducts and liver

103

182

7.47

59.49

18.1

12.3

1.57

1.21

mg/l

3.12

103

171

Malignant neoplasm of larynx, including Hilmo

162

6.82

59.30

3.1

2.4

1.32

1.80

mg/l

5.41

137

960

4923

1.79

59.24

4.2

2.6

1.82

1.74

mg/l

1.77

866

4369

Pleural effusion

433

1881

2.38

59.02

3.9

2.8

2.04

1.72

mg/l

8.09

402

1663

Rare circulating lymphoid malignancy, including Hilmo

146

340

4.76

58.95

20.7

9.1

1.15

1.47

mg/l

6.25

137

303

Abnormal findings on examination of blood, without diagnosis

1217

6714

1.67

58.78

4.9

3.7

1.68

1.61

mg/l

2.08

1134

6121

Myeloproliferative diseases (CML excluded)

254

852

3.16

58.75

3.3

2.8

1.38

1.66

mg/l

7.50

245

763

Squamous cell neoplasms and carcinomas of the skin

278

977

2.96

58.51

4.2

2.4

1.91

1.92

mg/l

0.07

255

819

Malignant neoplasm of larynx

124

7.86

58.20

3.3

2.5

1.36

1.89

mg/l

4.79

109

Amputation of foot

132

287

5.14

58.17

4.9

2.7

2.49

1.70

mg/l

12.44

126

253

Actinic keratosis

887

4525

1.82

58.04

4.2

2.6

1.84

1.77

mg/l

1.38

796

4003

Skin changes due to chronic exposure to nonionizing radiation

908

4643

1.81

57.94

4.2

2.6

1.84

1.76

mg/l

1.51

816

4110

Pre-eclampsia

457

2047

2.29

57.61

3.8

2.8

1.47

1.32

mg/l

4.40

435

1897

Other functional intestinal disorders

1160

6375

1.68

57.58

5.0

5.1

1.60

1.47

mg/l

4.92

1059

5830

Myocardial infarction

1127

4674

1.72

57.53

3.9

2.7

2.06

1.53

mg/l

52.14

1032

4231

Carcinoma in situ of skin of other and unspecified parts of face

266

927

3.02

57.28

5.1

2.4

1.93

1.84

mg/l

0.89

246

794

Amputation of ankle bones

116

229

5.69

57.23

6.3

2.7

2.75

1.68

mg/l

13.46

109

206

5-aminosalicylic acid

571

2799

2.10

57.23

4.0

3.3

1.36

1.38

mg/l

0.30

528

2581

Acute pancreatitis

533

2550

2.15

57.15

5.0

3.1

1.80

1.58

mg/l

6.18

483

2302

IBD patients in KELA-register

638

3276

2.00

56.21

3.8

4.1

1.39

1.41

mg/l

0.25

599

3052

Other renal tubulo-interstitial diseases

103

184

6.13

56.19

7.1

2.9

1.98

1.12

mg/l

9.62

167

Budesonide

392

1665

2.43

56.17

3.4

3.0

1.41

1.42

mg/l

0.02

362

1529

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

903

4441

1.79

56.13

3.6

2.9

1.46

1.36

mg/l

3.67

849

4100

Essential (haemorrhagic) thrombocythaemia

143

339

4.56

55.98

3.4

2.7

1.30

1.67

mg/l

5.99

138

296

AV-block

440

1661

2.32

55.48

4.0

3.5

2.01

1.51

mg/l

18.94

393

1475

Pre-eclampsia or eclampsia

479

2226

2.21

55.14

3.9

2.8

1.49

1.34

mg/l

4.50

455

2056

Other inflammatory liver diseases

232

767

3.21

55.10

5.2

3.6

1.57

1.52

mg/l

0.37

221

700

Any death

1499

6762

1.58

54.80

4.2

3.2

1.96

1.55

mg/l

39.99

1405

6107

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

248

853

3.06

54.73

3.4

2.9

1.87

1.68

mg/l

2.22

226

749

Cardiomyopathies, Primary/intrinsic

339

1371

2.57

54.24

5.7

3.7

1.94

1.43

mg/l

17.58

318

1236

Glucagon-like peptide-1 (GLP-1) analogues

775

4298

1.84

53.67

3.0

1.82

1.43

mg/l

24.03

703

4018

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

775

4298

1.84

53.67

3.0

1.82

1.43

mg/l

24.03

703

4018

Ulcerative colitis

660

3484

1.94

53.54

4.2

4.0

1.46

1.45

mg/l

0.11

618

3219

Dermatitis and eczema

2680

11440

1.40

53.33

4.4

4.0

1.56

1.48

mg/l

4.91

2464

10540

Amyloidosis

106

205

5.72

53.30

4.0

2.4

2.13

1.60

mg/l

4.66

101

181

Pulmonary embolism

722

3926

1.88

53.24

3.4

2.7

1.82

1.64

mg/l

5.06

666

3516

Other specified disorders of kidney and ureter

139

338

4.49

52.89

9.2

3.6

1.91

1.56

mg/l

3.13

133

302

Other arrhythmias

1377

6568

1.59

52.74

3.4

1.59

1.34

mg/l

21.47

1243

6069

Inflammatory bowel disease, strict (require KELA)

638

3349

1.96

52.71

3.8

4.2

1.39

1.42

mg/l

0.47

599

3119

Use of hypnotics and sedatives

2488

10133

1.42

52.71

3.5

3.6

1.58

1.50

mg/l

4.52

2296

9329

Basal cell carcinoma, including Hilmo

951

3735

1.75

52.31

3.6

2.8

1.77

1.71

mg/l

1.16

858

3286

Pneumonia due to other infectious organisms, not elsewhere classified

135

323

4.53

52.31

6.0

3.3

1.84

1.49

mg/l

3.92

130

287

Pulmonary heart disease

722

3949

1.87

52.26

3.4

2.8

1.82

1.65

mg/l

4.62

666

3538

Cardiomyopathy (excluding other)

344

1425

2.50

52.26

5.6

3.8

1.94

1.42

mg/l

18.32

323

1281

Convulsions, not elsewhere classified

603

3069

1.98

52.24

7.0

3.5

1.53

1.39

mg/l

3.69

562

2798

Hypocalcemia

121

268

5.06

52.23

5.0

4.7

2.18

1.51

mg/l

8.83

113

241

Hypothyroidism, other/unspecified

1997

9045

1.47

52.23

3.7

3.6

1.56

1.51

mg/l

1.99

1825

8309

Other noninfective gastroenteritis and colitis

679

3645

1.91

52.20

5.8

1.61

1.45

mg/l

4.96

637

3354

In situ neoplasms

906

5295

1.74

52.13

4.0

2.7

1.76

1.62

mg/l

4.41

830

4748

Retention of urine

821

3736

1.81

52.07

3.6

3.0

1.91

1.67

mg/l

10.35

737

3354

Pregnancy hypertension

815

4107

1.80

52.03

3.6

2.9

1.45

1.34

mg/l

4.03

767

3799

Chronic pancreatitis

369

1585

2.42

51.89

4.7

3.0

1.82

1.59

mg/l

4.39

342

1450

Other viral diseases, not elsewhere classified, including avohilmo

752

4152

1.84

51.79

11.2

5.7

1.45

1.32

mg/l

4.30

713

3903

Asthma (only as main-diagnosis), excluding more controls

1423

5017

1.59

51.70

3.7

2.9

1.49

1.30

mg/l

14.76

1319

4623

Asthma

1630

5523

1.54

51.14

3.7

3.0

1.51

1.36

mg/l

10.34

1499

5071

Acute pancreatitis (for exclusion)

533

2664

2.06

50.85

5.0

3.0

1.80

1.58

mg/l

6.04

483

2416

Hypothyreosis and Thyroxine purchase for inclusion criteria

2054

9368

1.45

50.75

3.7

3.6

1.57

1.51

mg/l

1.89

1878

8597

Gingivitis and periodontal diseases

2322

8478

1.43

50.46

4.7

3.8

1.57

1.47

mg/l

5.34

2146

7762

Other disorders of bladder

331

1381

2.49

49.58

3.0

2.8

1.67

1.65

mg/l

0.16

278

1251

Sleep disorders (combined)

2553

9617

1.40

49.57

3.1

4.0

1.57

1.49

mg/l

4.44

2323

8889

Crohn disease

379

1680

2.34

49.44

4.4

4.5

1.47

1.41

mg/l

0.71

365

1576

SLE (Finngen)

128

307

4.48

49.32

4.5

4.6

1.69

1.37

mg/l

3.47

121

282

Cutaneous abscess, furuncle and carbuncle

699

3860

1.85

49.21

6.0

3.9

1.78

1.43

mg/l

16.57

666

3557

L01XX Other antineoplastic agents

199

644

3.29

49.14

3.5

2.8

1.38

1.71

mg/l

7.43

189

573

Disorders of the thyroid gland

2133

9764

1.43

48.90

3.6

1.57

1.51

mg/l

2.49

1962

8976

Pain, not elsewhere classified

657

3560

1.88

48.89

4.9

3.0

1.53

1.42

mg/l

2.46

601

3228

Symptoms and signs concerning food and fluid intake

309

1260

2.54

48.38

10.7

3.8

1.47

mg/l

0.00

290

1145

Adrenocortical insufficiency

149

407

3.96

48.22

7.7

5.3

1.66

1.43

mg/l

1.82

143

370

Other symptoms and signs involving the urinary system

309

1269

2.53

48.04

5.0

3.8

1.70

1.57

mg/l

1.58

291

1153

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

695

3816

1.84

47.75

17.9

4.5

1.29

1.30

mg/l

0.12

667

3592

Major coronary heart disease event excluding revascularizations

1329

5669

1.57

47.53

3.7

2.7

1.98

1.52

mg/l

47.67

1203

5128

Other CVD

517

2619

2.03

47.43

4.0

3.0

1.87

1.74

mg/l

2.50

460

2321

Abnormalities of heart beat

830

4706

1.74

47.39

3.0

3.3

1.52

1.48

mg/l

0.69

728

4286

Vocal cord dysfunction

311

1115

2.51

47.34

3.4

4.0

1.43

1.15

mg/l

7.49

295

1053

Other arthritis (FG)

738

4188

1.80

47.25

4.7

3.6

1.70

1.42

mg/l

12.65

675

3840

Symptoms and signs involving the skin and subcutaneous tissue

1684

10948

1.47

46.96

4.8

3.8

1.52

1.51

mg/l

0.05

1576

10007

Other diseases of pericardium

157

451

3.70

46.86

8.0

4.3

1.88

1.41

mg/l

6.91

147

410

Other viral hepatitis

220

774

3.00

46.85

4.3

3.5

1.41

1.34

mg/l

0.71

212

725

Abnormal results of function studies

284

1137

2.61

46.75

4.0

5.1

1.60

1.47

mg/l

1.59

263

1047

Diseases of the respiratory system

1401

4550

1.56

46.58

4.2

3.1

1.54

1.38

mg/l

8.08

1305

4189

Malignant neoplasm of digestive organs, including Hilmo

882

3829

1.72

46.33

4.4

2.9

1.71

1.70

mg/l

0.07

812

3378

Other diseases of pancreas

258

991

2.73

46.27

4.2

3.1

1.86

1.61

mg/l

3.55

236

896

ILD, hospital admission 2, with pulmonary infections

270

1058

2.65

46.26

3.7

2.6

1.83

1.63

mg/l

3.20

251

942

Cardiomyopathy, other and unspecified

224

799

2.93

46.23

4.8

3.6

1.83

1.43

mg/l

8.46

207

729

Episodal and paroxysmal disorders

2550

9434

1.38

46.01

4.1

4.6

1.50

1.45

mg/l

1.99

2347

8748

Fall on same level

2706

10643

1.37

45.89

4.2

4.4

1.56

1.44

mg/l

10.09

2481

9879

Acute sinusitis

1215

7140

1.57

45.79

5.3

3.2

1.51

1.43

mg/l

2.32

1129

6597

Cholelithiasis, broad definition with cholecystitis

1858

8622

1.45

45.78

3.6

2.9

1.69

1.53

mg/l

10.96

1701

7837

Biguanides

2094

8985

1.42

45.58

2.8

3.0

1.71

1.45

mg/l

31.75

1871

8284

Other metabolic disorders

329

1419

2.39

45.57

6.2

4.0

1.45

1.34

mg/l

1.49

311

1297

All influenza (not pneumonia)

417

1984

2.17

45.53

9.2

4.6

1.70

1.38

mg/l

8.49

392

1835

Respiratory insufficiency

222

791

2.91

45.46

5.0

2.8

1.96

1.61

mg/l

5.04

195

700

Basal cell carcinoma

891

3602

1.71

45.42

3.5

2.8

1.79

1.72

mg/l

1.16

795

3166

Diverticular disease of intestine

1579

6643

1.50

45.29

3.5

2.8

1.76

1.55

mg/l

14.97

1457

6029

Secondary and unspecified malignant neoplasm of lymph nodes

232

853

2.83

45.17

5.1

3.4

1.52

1.68

mg/l

2.02

223

754

Mycoses

700

3974

1.80

44.93

5.5

3.7

1.68

1.52

mg/l

4.23

650

3632

Other disorders of adrenal gland

178

571

3.34

44.81

7.8

6.7

1.63

1.37

mg/l

2.91

172

525

Mucosal proctocolitis

365

1660

2.28

44.80

3.5

3.8

1.44

1.42

mg/l

0.28

343

1555

Melanocytic naevi

755

4382

1.76

44.77

7.1

3.6

1.59

1.47

mg/l

3.44

721

4032

Other disorders of glucose regulation and pancreatic internal secretion

276

1118

2.58

44.39

6.8

6.4

1.87

1.44

mg/l

10.35

253

1026

Persons encountering health services for specific procedures, not carried out

243

923

2.73

44.34

4.4

3.5

1.69

1.28

mg/l

7.68

226

858

Hypotension

447

2206

2.08

44.19

3.7

2.6

1.89

1.77

mg/l

1.97

394

1928

Cholelithiasis

1778

8461

1.45

44.04

3.6

2.9

1.69

1.53

mg/l

10.83

1624

7681

Congenital malformations of the circulatory system

464

2261

2.07

44.00

10.4

9.5

1.28

1.34

mg/l

0.98

451

2146

COPD (mode)

658

2841

1.84

43.78

2.7

2.6

1.88

1.54

mg/l

13.12

575

2526

Other viral hepatitis, including avohilmo

224

826

2.85

43.66

4.3

3.5

1.40

1.33

mg/l

0.73

215

776

Pre-eclampsia or poor fetal growth

592

3204

1.87

43.57

3.8

2.9

1.46

1.30

mg/l

5.70

559

2980

ILD, hospital admissions 3, with pneumonia sepsis

241

923

2.72

43.36

3.8

2.7

1.86

1.66

mg/l

2.69

223

804

Secondary uncertain malignant neoplasm

326

1433

2.34

43.26

4.4

3.1

1.48

1.73

mg/l

6.31

311

1245

Missing teeth due to accident, extraction or parodontitis

1407

8483

1.50

43.24

3.5

3.1

1.64

1.60

mg/l

1.09

1274

7712

Other embolism and thrombosis

339

1521

2.30

42.97

4.8

3.0

1.85

1.54

mg/l

5.15

311

1376

Asthma (mode)

1565

5563

1.49

42.95

3.6

3.0

1.50

1.36

mg/l

8.64

1450

5108

Ulcerative colitis, NAS

387

1833

2.18

42.87

4.6

4.7

1.48

1.42

mg/l

0.73

364

1714

Multiple myeloma and malignant plasma cell neoplasms

167

529

3.37

42.86

4.1

3.3

1.86

1.74

mg/l

0.82

154

470

Zoster [herpes zoster]

469

2382

2.02

42.82

5.7

3.2

1.79

1.61

mg/l

4.24

430

2145

Congenital malformations of heart and great arteries

428

2046

2.11

42.77

10.1

10.4

1.28

1.33

mg/l

0.75

416

1945

Disorders of thyroid, IBD co-morbidities

361

1098

2.29

42.65

3.0

2.9

1.57

1.18

mg/l

13.87

335

1027

Other diseases of hard tissues of teeth

1240

4141

1.57

42.64

5.5

2.6

1.57

1.55

mg/l

0.37

1144

3737

Lung transplant status

103

8.08

42.59

12.8

9.1

1.89

1.39

mg/l

4.02

Lung transplantation

103

8.06

42.57

12.8

9.1

1.89

1.39

mg/l

4.02

Viral hepatitis

235

900

2.74

42.50

4.2

3.5

1.41

1.37

mg/l

0.35

226

842

Neuromuscular dysfunction of bladder

259

1038

2.60

42.47

3.7

3.2

1.53

1.55

mg/l

0.16

236

940

Pain (limb, back, neck, head abdominally)

1721

5956

1.46

42.30

5.5

4.1

1.51

1.45

mg/l

2.07

1603

5487

Other disorders of skin and subcutaneous tissue, not elsewhere classified

374

1758

2.19

42.20

3.6

3.3

1.93

1.55

mg/l

9.78

349

1583

Other antidepressants

2340

8723

1.38

42.04

3.1

3.5

1.49

1.53

mg/l

1.59

2134

8066

Chronic viral hepatitis

188

645

3.09

42.01

3.8

3.1

1.41

1.32

mg/l

0.85

180

603

Myocardial infarction, without ST-elevation

908

5056

1.65

41.91

3.6

2.7

2.15

1.70

mg/l

30.37

829

4501

Hypothyroidism, strict autoimmune, 3 medication purchases required

1799

8541

1.43

41.35

3.5

3.3

1.58

1.51

mg/l

2.44

1634

7828

Osteoporosis with pathological fracture (FG)

202

726

2.90

41.15

3.8

2.8

1.65

1.55

mg/l

0.97

184

634

Other specified/unspecified arthritis

649

3698

1.79

41.10

4.8

3.8

1.70

1.44

mg/l

9.85

596

3387

Other respiratory diseases principally affecting the interstitium

451

2298

2.02

40.87

3.7

2.8

1.88

1.72

mg/l

3.24

418

2029

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

479

2493

1.97

40.81

3.8

4.0

1.36

1.43

mg/l

1.36

448

2332

Other Crohn's disease

223

851

2.75

40.61

3.8

4.5

1.46

1.36

mg/l

1.02

214

794

Disorders of sclera, cornea, iris and ciliary body

1285

8664

1.50

40.50

4.4

3.5

1.60

1.50

mg/l

4.49

1197

7946

Viral warts, including avohilmo

586

3261

1.84

40.40

9.5

5.0

1.61

1.36

mg/l

8.37

560

3047

Protozoal diseases

125

343

3.97

40.40

6.0

3.6

1.89

1.54

mg/l

3.53

118

311

Myocardial infarction, strict

994

4434

1.61

40.36

3.7

2.6

2.02

1.54

mg/l

40.73

905

4007

Calcific aortic valvular stenosis

677

3772

1.76

40.33

3.6

3.0

2.10

1.77

mg/l

11.61

603

3323

Calcific aortic valvular stenosis, operated

677

3772

1.76

40.33

3.6

3.0

2.10

1.77

mg/l

11.61

603

3323

Late syphilis, including avohilmo

190

5.28

40.33

4.8

3.0

2.06

1.49

mg/l

5.45

170

Asthma (only as main-diagnosis)

1458

5523

1.49

40.32

3.7

3.0

1.50

1.36

mg/l

8.06

1350

5071

Other diseases of the respiratory system

510

2719

1.92

40.32

5.0

3.9

1.88

1.67

mg/l

4.93

458

2429

Other respiratory disorders and diseases

510

2719

1.92

40.32

5.0

3.9

1.88

1.67

mg/l

4.93

458

2429

Elevated blood glucose level

259

1070

2.53

39.95

6.9

5.2

1.74

1.51

mg/l

3.60

233

977

Systemic lupus erythematosus

128

358

3.83

39.94

4.5

3.8

1.69

1.44

mg/l

2.30

121

324

Protozoal diseases, including avohilmo

127

355

3.88

39.91

6.0

3.5

1.87

1.54

mg/l

3.20

120

321

Acute suppurative otitis media

677

3661

1.76

39.80

10.7

5.0

1.36

1.27

mg/l

2.22

643

3462

Persons encountering health services for examination and investigation

1427

4829

1.50

39.46

4.4

2.8

1.50

1.46

mg/l

1.24

1330

4405

Ulcerative colitis (strict definition, require KELA)

446

2293

2.00

39.43

3.9

4.0

1.35

1.43

mg/l

1.54

417

2142

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

436

2225

2.02

39.40

3.9

4.1

1.35

1.42

mg/l

1.26

407

2077

Cystic disease of liver

9.12

39.37

8.6

3.1

1.91

1.48

mg/l

1.79

Viral hepatitis, including avohilmo

239

959

2.61

39.28

4.2

3.5

1.40

1.37

mg/l

0.29

229

898

Calcific aortic valvular stenosis, including rheumatic fever

671

3754

1.75

39.23

3.4

2.8

2.11

1.77

mg/l

12.09

598

3305

Clear cell adenocarcinoma of kidney

146

449

3.44

39.22

2.9

2.7

1.93

1.72

mg/l

2.01

134

393

Calcific aortic valvular stenosis, diagnosis (helper)

669

3747

1.75

39.12

3.4

2.8

2.11

1.77

mg/l

12.08

596

3298

Operations 2 for CAVS

669

3747

1.75

39.12

3.4

2.8

2.11

1.77

mg/l

12.08

596

3298

Syphilis, including avohilmo

119

324

4.02

38.99

4.4

2.9

1.92

1.46

mg/l

3.69

110

301

Syphilis

119

324

4.02

38.99

4.4

2.9

1.92

1.46

mg/l

3.69

110

301

Zoster [herpes zoster], including avohilmo

1146

7337

1.53

38.83

4.3

3.0

1.68

1.57

mg/l

4.63

1046

6637

Decubitus ulcer and pressure area

187

667

2.94

38.74

4.9

3.0

2.26

1.68

mg/l

7.33

175

587

Need for other prophylactic measures

206

779

2.80

38.47

15.7

5.8

1.58

1.43

mg/l

1.69

201

718

Nonischemic cardiomyopathy

276

1192

2.40

38.35

5.0

3.6

1.93

1.51

mg/l

10.05

260

1073

Lymphoid leukaemia

195

720

2.87

38.17

16.4

6.4

1.28

1.59

mg/l

6.99

181

648

Diseases of oral cavity, salivary glands and jaws

1226

4168

1.53

37.99

4.3

2.6

1.62

1.55

mg/l

1.77

1120

3758

Other gastritis (incl. Duodenitis)

531

2922

1.86

37.94

4.1

3.0

1.86

1.59

mg/l

8.22

490

2635

Attention to artificial openings

133

394

3.57

37.90

9.2

4.5

1.60

1.49

mg/l

0.72

128

347

Carcinoma in situ of skin of upper limb, including shoulder

105

269

4.26

37.40

5.8

2.8

2.03

1.81

mg/l

1.42

235

Alcohol use disorder, Swedish definition

1287

7998

1.48

37.29

3.8

3.2

1.67

1.53

mg/l

6.16

1196

7364

1418

8585

1.45

37.12

3.8

3.4

1.65

1.51

mg/l

6.82

1314

7916

Other infectious diseases

219

867

2.63

36.98

5.3

3.8

2.14

1.60

mg/l

7.90

200

774

Cardiodefibrillation

807

5003

1.64

36.91

3.2

2.9

1.87

1.70

mg/l

5.60

728

4496

Diseases of the musculoskeletal system and connective tissue

1292

4346

1.51

36.89

6.7

5.3

1.42

1.30

mg/l

5.38

1213

4068

Chronic ulcer of skin, not elsewhere classified

199

755

2.75

36.63

3.8

2.6

2.15

1.61

mg/l

9.30

185

666

Abnormal findings on diagnostic imaging of lung

1056

6609

1.53

36.47

3.4

3.0

1.76

1.66

mg/l

2.77

985

5937

Benzodiazepine use

2236

11290

1.35

36.27

3.1

3.5

1.55

1.51

mg/l

1.42

2020

10404

1352

8375

1.46

36.22

3.8

3.4

1.65

1.52

mg/l

5.82

1251

7723

Dental caries, including avohilmo

1621

5859

1.43

35.70

4.7

3.3

1.60

1.51

mg/l

3.38

1491

5350

Presbycusis

331

1562

2.15

35.65

3.1

2.4

1.83

1.88

mg/l

0.41

267

1349

Benign neoplasm of colon, rectum, anus and anal canal

1373

8088

1.45

35.60

3.4

2.9

1.81

1.61

mg/l

11.92

1270

7292

Other diseases of intestine

396

2027

2.01

35.49

5.8

3.1

1.77

1.56

mg/l

4.32

370

1824

Viral pneumonia (unknown virus, not influenza)

213

850

2.62

35.48

6.9

4.7

1.85

1.49

mg/l

6.24

203

781

Ulcerative ileocolitis

143

463

3.29

35.46

4.1

2.9

1.43

mg/l

0.00

134

426

Cough

927

5588

1.57

35.42

6.6

4.4

1.50

1.45

mg/l

1.28

851

5122

Mood disorders, excluding more controls

2086

9083

1.36

35.27

3.7

3.3

1.50

1.49

mg/l

0.26

1930

8373

Acquired absence of organs, not elsewhere classified

122

6.11

35.16

5.1

3.0

1.86

1.44

mg/l

2.55

111

Diseases of pulp and periapical tissues and dental caries

1445

5145

1.46

34.86

4.8

3.3

1.61

1.51

mg/l

3.86

1325

4694

Hernia of abdominal wall

1053

7049

1.52

34.58

5.1

3.3

1.74

1.56

mg/l

8.88

969

6440

Paralytic ileus and intestinal obstruction

592

3451

1.75

34.56

4.8

3.2

1.75

1.60

mg/l

3.29

552

3082

Malnutrition

114

330

3.83

34.41

13.1

13.6

1.39

1.38

mg/l

0.03

104

302

Other disorders of white blood cells

176

651

2.85

34.29

6.2

3.9

1.59

1.56

mg/l

0.22

165

594

Gastroduodenal ulcer

584

3392

1.75

34.25

4.4

2.9

1.98

1.69

mg/l

8.88

544

3031

Acidosis

220

4.46

34.17

5.4

5.2

2.14

1.44

mg/l

9.07

195

Other infectious diseases, including avohilmo

247

1071

2.39

34.16

5.4

3.8

2.08

1.57

mg/l

8.40

226

967

Neurological diseases

1958

7217

1.37

34.12

5.4

4.7

1.45

1.40

mg/l

1.99

1823

6736

Intestinal stricture

712

4380

1.66

34.03

5.2

3.3

1.75

1.63

mg/l

2.66

665

3925

Sulfonylureas

690

3312

1.68

34.00

3.2

2.7

2.26

1.69

mg/l

34.75

606

2969

Noninfectious colitis NAS

358

1797

2.05

34.00

4.8

5.3

1.67

1.46

mg/l

4.34

339

1656

Dysphagia

573

3329

1.75

34.00

3.9

3.0

1.61

1.59

mg/l

0.20

519

2988

Crohn's disease NAS

202

803

2.63

33.96

4.5

5.7

1.48

1.40

mg/l

0.68

196

745

SLE, strict definition

119

354

3.59

33.91

4.6

3.5

1.72

1.43

mg/l

2.71

112

321

SLE, ICD10

119

354

3.59

33.91

4.6

3.5

1.72

1.43

mg/l

2.71

112

321

Angina pectoris

1144

5119

1.50

33.77

3.4

2.7

1.84

1.52

mg/l

22.78

1031

4621

Vasculitis limited to skin, not elsewhere classified

102

275

4.00

33.76

3.8

3.7

1.73

1.53

mg/l

1.06

242

Cardiac arrest

153

436

3.07

33.76

4.9

2.6

2.12

1.18

mg/l

17.58

136

390

Melanocytic naevi of trunk

322

1561

2.13

33.70

8.0

3.7

1.71

1.48

mg/l

4.48

310

1445

Falls/tendency to fall

2433

9262

1.33

33.61

4.1

4.4

1.54

1.43

mg/l

6.46

2230

8602

Phlebitis and thrombophlebitis (not including DVT)

515

2916

1.80

33.52

4.7

2.9

1.82

1.53

mg/l

7.68

476

2661

Postprocedural endocrine and metabolic disorders, not elsewhere classified

277

1267

2.24

33.48

4.6

3.2

1.42

1.35

mg/l

0.89

261

1152

Other and unspecified vasculitis limited to skin

250

4.17

33.42

3.9

3.8

1.75

1.52

mg/l

1.15

218

Misadventures to patients during surgical and medical care

350

1753

2.05

33.41

4.4

3.0

1.82

1.54

mg/l

5.48

322

1594

Fentanyl

247

1076

2.35

33.41

3.8

2.8

1.66

mg/l

0.01

229

945

6-mercaptopurine

129

407

3.36

33.36

16.2

5.6

1.09

1.27

mg/l

2.93

122

380

Injuries to the head

2544

11605

1.31

33.31

4.2

4.3

1.56

1.47

mg/l

5.93

2321

10729

Seborrhoeic keratosis

567

3308

1.75

33.22

5.6

2.6

1.72

1.61

mg/l

2.01

527

2973

Malignant neoplasm of digestive organs

759

3608

1.63

33.13

4.5

2.9

1.69

1.72

mg/l

0.28

694

3176

Cerebrovascular diseases

1583

7903

1.40

33.09

4.1

3.2

1.80

1.59

mg/l

14.58

1433

7191

Arthropathies

2060

7754

1.35

32.73

4.3

4.6

1.52

1.36

mg/l

13.02

1910

7205

Hypoparathyroidism

122

377

3.45

32.71

4.2

3.7

1.70

1.47

mg/l

1.74

113

339

Candidiasis

350

1768

2.03

32.63

6.0

3.6

1.72

1.48

mg/l

4.33

329

1622

Non-Hodgkin lymphoma, all

124

386

3.37

32.61

2.2

2.8

1.57

1.85

mg/l

2.75

117

325

Dental operations

1292

4578

1.47

32.52

3.7

2.8

1.63

1.54

mg/l

2.57

1180

4157

Osteonecrosis

183

711

2.69

32.26

5.8

2.9

1.70

1.59

mg/l

0.78

174

648

Other interstitial pulmonary diseases

366

1894

1.98

31.87

3.4

2.9

1.81

1.74

mg/l

0.80

340

1675

Testicular dysfunction

155

560

2.95

31.78

3.1

3.2

1.38

1.37

mg/l

0.05

142

530

Drug-induced neutropenia

200

819

2.55

31.59

4.2

3.3

1.54

1.60

mg/l

0.51

187

748

Endocrine disorders, other/unspecified

190

4.59

31.55

4.9

3.3

1.70

1.39

mg/l

1.91

170

Cyst of kidney

199

814

2.55

31.49

4.1

2.6

1.97

1.65

mg/l

4.18

185

728

Any operation in hilmo

5.49

31.46

3.6

1.2

1.31

0.95

mg/l

4.80

Speech and linguistic disorders, excluding more controls

259

1108

2.27

31.44

19.0

9.5

1.24

1.21

mg/l

0.32

248

1053

Procreative management

854

4573

1.56

31.36

7.1

6.0

1.26

1.34

mg/l

3.17

811

4306

Gastro-oesophageal reflux disease

1487

9063

1.40

31.34

3.7

1.61

1.49

mg/l

5.42

1364

8290

Interstitial lung disease endpoints

366

1906

1.97

31.29

3.4

2.9

1.81

1.74

mg/l

0.72

340

1684

Interstitial lung disease

366

1906

1.97

31.29

3.4

2.9

1.81

1.74

mg/l

0.72

340

1684

Other hearing loss

620

3640

1.68

31.24

3.8

3.0

1.79

1.71

mg/l

1.12

538

3276

Anxiety disorders, excluding more controls

1819

8615

1.36

31.22

5.3

3.4

1.46

mg/l

0.09

1682

7950

Thiazolidinediones

269

1255

2.21

31.15

3.0

2.8

2.04

1.60

mg/l

9.13

234

1148

Sequelae with surgical and medical care as external cause

478

2709

1.80

31.14

4.5

3.3

1.88

1.60

mg/l

6.67

441

2458

Diabetic neuropathy

377

1989

1.97

31.04

4.9

3.3

2.11

1.83

mg/l

5.56

344

1787

Crohn's disease of large intestine

164

616

2.80

31.02

4.0

4.4

1.53

1.39

mg/l

1.26

155

571

ILD, hospital admissions

361

1878

1.97

30.98

3.4

2.9

1.81

1.74

mg/l

0.79

336

1662

Collagenous colitis

247

1118

2.29

30.92

5.1

4.1

1.61

1.51

mg/l

1.14

226

1020

Sequelae of external causes of morbidity and mortality

592

3569

1.69

30.75

4.5

3.5

1.81

1.57

mg/l

6.76

549

3249

Other systemic involvement of connective tissue (FG)

523

2987

1.75

30.75

3.1

2.9

1.65

1.46

mg/l

5.39

469

2689

Mood [affective] disorders

2262

11108

1.31

30.73

3.8

3.6

1.48

1.49

mg/l

0.01

2091

10222

Any mental disorder

2428

9358

1.31

30.69

4.6

3.7

1.53

1.49

mg/l

1.25

2241

8632

Diseases of the ear and mastoid process

2549

9895

1.30

30.65

4.6

3.6

1.50

1.47

mg/l

0.89

2348

9166

Mood disorders

2265

11114

1.31

30.55

3.8

3.6

1.49

mg/l

0.02

2094

10225

Haemorrhage, not elsewhere classified

119

380

3.29

30.10

5.8

3.0

2.26

1.57

mg/l

6.42

109

333

Non-follicular lymphoma

250

1151

2.25

30.06

6.8

3.4

1.57

1.69

mg/l

1.35

234

1033

Left ventricular outflow tract obstruction (LVOTO), broad definition

309

1545

2.08

30.04

7.6

6.8

1.61

1.40

mg/l

3.25

291

1451

Bacterial pneumoniae

864

4999

1.54

29.96

5.7

3.4

1.80

1.49

mg/l

17.16

786

4533

Depression

2114

10798

1.32

29.73

3.8

3.6

1.48

mg/l

0.04

1946

9958

ILD, hospital admissions 1, main diag only

328

1677

2.01

29.67

3.5

2.9

1.83

1.75

mg/l

0.89

304

1494

Soft tissue disorders

2328

9180

1.31

29.48

5.0

4.4

1.52

1.44

mg/l

3.84

2151

8504

Abnormal findings on diagnostic imaging of other body structures

344

1791

1.97

29.45

3.7

3.4

1.62

1.56

mg/l

0.58

318

1623

Asthma, hospital admission 2, infections

1362

9591

1.40

29.45

4.7

4.6

1.56

1.49

mg/l

2.50

1257

8812

Asthma-related infections

1362

9591

1.40

29.45

4.7

4.6

1.56

1.49

mg/l

2.50

1257

8812

Suppurative and unspecified otitis media

832

4841

1.54

29.38

9.1

4.4

1.41

1.34

mg/l

1.67

785

4533

Other disorders starting during childhood or adolecense, excluding more controls

180

692

2.60

29.27

21.3

12.3

1.23

1.06

mg/l

2.85

175

667

Valvular operations

325

1662

2.00

29.26

5.2

4.9

1.82

1.44

mg/l

8.61

293

1504

Extreme obesity with alveolar hypoventilation

130

446

3.08

29.20

2.7

2.8

2.14

1.52

mg/l

6.81

110

402

Primary hyperparathyroidism

264

1255

2.17

29.19

3.5

2.8

1.84

1.60

mg/l

3.68

245

1126

Disorders of ocular muscles, binocular movement, accommodation and refraction

1111

7702

1.45

29.07

7.5

4.7

1.42

1.41

mg/l

0.02

1025

7154

Intestinal malabsorption

150

558

2.83

28.97

7.0

3.8

1.78

1.44

mg/l

3.34

137

512

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

385

2088

1.88

28.96

2.9

2.7

1.52

1.74

mg/l

5.82

356

1827

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

554

2891

1.70

28.95

11.0

7.4

1.19

1.18

mg/l

0.27

531

2756

COPD-related respiratory insufficiency

281

1373

2.11

28.85

3.3

2.7

2.11

1.77

mg/l

5.84

245

1224

Hypoglycaemia, other or unspecified

210

919

2.38

28.66

6.7

6.9

1.83

1.45

mg/l

6.65

192

846

Other or unspecified ileus, impaction or obstruction

426

2393

1.82

28.54

4.6

3.2

1.76

1.61

mg/l

2.55

393

2120

Other and unspecified local infections of skin and subcutaneous tissue

264

1267

2.15

28.53

8.9

4.9

1.83

1.47

mg/l

5.56

245

1171

Benign neoplasm: Colon

1138

7528

1.43

28.28

3.5

2.8

1.83

1.64

mg/l

10.14

1057

6769

Other and unspecified coagulation defects

150

567

2.77

28.02

5.0

4.5

1.53

1.41

mg/l

0.82

145

527

Other endocrine disorders

230

1016

2.30

27.95

21.9

13.8

1.40

1.14

mg/l

5.77

216

972

Pericarditis

110

351

3.30

27.92

8.5

3.6

1.95

1.41

mg/l

5.35

103

325

Early onset COPD, excluding more controls

415

2329

1.81

27.77

2.8

1.76

1.49

mg/l

5.93

370

2105

Disorders of psychological development

369

1854

1.90

27.76

15.9

9.6

1.19

mg/l

0.05

354

1765

Other coagulation defects

197

849

2.40

27.74

5.0

4.2

1.58

1.50

mg/l

0.58

187

784

Myocarditis

120

404

3.08

27.58

3.7

2.5

1.70

1.08

mg/l

9.75

110

370

Congenital malformations of cardiac septa

254

1185

2.18

27.48

10.3

14.4

1.22

1.24

mg/l

0.21

248

1131

Emotional disorders starting during childhood or adolecense, excluding more controls

152

564

2.73

27.46

15.9

12.1

1.13

1.04

mg/l

1.20

147

545

Depression or dysthymia

1464

5826

1.38

27.35

3.6

1.52

mg/l

0.09

1339

5385

malignant neoplasm of female genital organs, including Hilmo

309

1509

1.99

27.31

3.5

2.6

1.51

1.65

mg/l

2.13

282

1320

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

249

1190

2.16

27.22

6.1

3.3

1.76

1.57

mg/l

2.44

231

1086

Diffuse large B-cell lymphoma, including Hilmo

129

458

2.94

27.12

7.3

3.0

1.62

1.75

mg/l

0.91

124

400

Diffuse large B-cell lymphoma

129

458

2.94

27.12

7.3

3.0

1.62

1.75

mg/l

0.91

124

400

Diffuse large B-cell lymphoma, helper endpoint

129

458

2.94

27.12

7.3

3.0

1.62

1.75

mg/l

0.91

124

400

Complications of cardiac and vascular prosthetic devices, implants and grafts

222

3.99

27.09

5.2

3.9

2.12

1.62

mg/l

3.97

196

Other skin changes

460

2685

1.75

27.08

5.0

3.5

1.76

1.62

mg/l

2.50

435

2406

Nonsuppurative otitis media

551

2907

1.67

27.08

9.5

5.4

1.39

1.30

mg/l

1.71

527

2723

Malignant neoplasm of respiratory system and intrathoracic organs, including Hilmo

461

2192

1.76

27.05

3.3

2.8

1.48

1.80

mg/l

14.10

437

1907

Infections with a predominantly sexual mode of transmission

643

4076

1.60

26.92

4.0

3.3

1.48

1.34

mg/l

3.71

601

3812

Caries of dentine, including avohilmo

1729

6614

1.35

26.88

4.5

4.2

1.59

1.48

mg/l

5.22

1593

6073

Asthma-related pneumonia

828

5544

1.51

26.83

5.4

4.6

1.74

1.57

mg/l

5.72

758

5025

Open wound of lower leg

390

2179

1.83

26.81

5.1

4.6

1.81

1.50

mg/l

7.77

370

2004

Asthma, hospital admissions 3, pneumonia

829

5554

1.51

26.77

5.4

4.6

1.74

1.57

mg/l

5.63

759

5034

Asthma-related pneumonia or sepsis

829

5554

1.51

26.77

5.4

4.6

1.74

1.57

mg/l

5.63

759

5034

Acute and subacute iridocyclitis

437

2524

1.77

26.73

4.0

3.5

1.62

1.51

mg/l

1.95

402

2318

Other local infections of skin and subcutaneous tissue

272

1353

2.07

26.70

8.8

4.8

1.80

1.47

mg/l

5.25

253

1253

Other symptoms and signs involving the digestive system and abdomen

381

2115

1.84

26.63

5.7

3.7

1.57

1.47

mg/l

1.68

344

1919

Psychiatric diseases

2163

8373

1.30

26.61

4.7

3.8

1.51

1.49

mg/l

0.48

1990

7738

Immunodeficiencies

159

637

2.63

26.58

10.8

7.2

1.64

1.40

mg/l

2.65

153

588

Pre-existing hypertension complicating pregnancy, childbirth and the puerperium

166

674

2.54

26.57

4.1

2.9

1.44

1.23

mg/l

3.37

159

632

Other diseases of anus and rectum

656

4185

1.58

26.55

4.4

3.4

1.71

1.55

mg/l

4.22

597

3761

Otitis media, unspecified

314

1508

1.97

26.49

15.3

7.5

1.30

1.22

mg/l

1.21

302

1432

Vitamin deficiency

143

543

2.75

26.49

5.9

4.2

1.59

1.51

mg/l

0.55

132

493

Vitamin deficiency, wide

143

543

2.75

26.49

5.9

4.2

1.59

1.51

mg/l

0.55

132

493

Bacterial pneumonia (organism specified)

974

6117

1.46

26.38

5.8

3.7

1.83

1.58

mg/l

12.37

892

5545

Candidiasis, including avohilmo

650

4164

1.58

26.32

4.6

3.6

1.60

1.47

mg/l

3.04

605

3815

Diagnoses used for exclusion with ILD

561

3482

1.64

26.04

3.7

3.1

1.72

1.62

mg/l

1.65

502

3146

Substance abuse, excluding more controls

1221

7374

1.40

25.84

3.5

3.2

1.57

1.50

mg/l

1.91

1124

6816

Stroke, excluding SAH

1242

6480

1.40

25.70

3.8

3.1

1.86

1.64

mg/l

11.64

1117

5854

Disorders of eyelid, lacrimal system and orbit

1862

10478

1.31

25.67

4.0

3.7

1.55

1.53

mg/l

0.43

1709

9599

Iridocyclitis

511

3112

1.67

25.64

4.1

3.6

1.63

1.51

mg/l

2.60

474

2849

Hernia

2021

10407

1.30

25.63

4.5

3.6

1.60

1.49

mg/l

7.32

1859

9563

Other general symptoms and signs

152

598

2.62

25.59

7.3

5.5

1.33

1.27

mg/l

0.41

140

559

Later onset COPD, excluding more controls

404

1736

1.80

25.56

2.5

2.01

1.69

mg/l

7.70

351

1509

Personal history of other diseases and conditions

274

1380

2.03

25.51

11.0

5.1

1.29

1.13

mg/l

3.23

266

1300

Gastric ulcer

391

2217

1.80

25.48

4.1

2.7

1.93

1.68

mg/l

5.03

365

1966

Viral pneumonia (known virus, not influenza)

110

373

3.16

25.47

7.6

8.1

1.82

1.53

mg/l

2.16

105

337

Malignant neoplasm of gum, including Hilmo

6.27

25.44

2.5

2.0

1.11

1.68

mg/l

4.81

Nonalcoholic fatty liver disease

259

1289

2.07

25.43

3.4

3.8

1.57

1.44

mg/l

1.53

233

1205

Herpesviral [herpes simplex] infections

277

1410

2.02

25.42

6.1

3.7

1.63

1.45

mg/l

2.39

260

1306

Hyperaldosteronism

300

3.41

25.42

3.3

3.4

1.64

1.54

mg/l

0.34

269

Other external causes of accidental injury

1735

6561

1.33

25.34

4.2

4.5

1.54

1.44

mg/l

4.42

1590

6103

Intracranial trauma

1265

6198

1.39

25.29

4.1

4.6

1.54

1.37

mg/l

9.36

1158

5798

Hypopituitarism

237

1150

2.14

25.13

9.9

8.2

1.31

1.27

mg/l

0.32

214

1083

Sarcoidosis

306

1618

1.94

25.13

3.3

3.0

1.70

1.51

mg/l

2.91

283

1492

Retinal detachments and breaks

739

4923

1.52

25.04

3.8

2.8

1.82

1.62

mg/l

6.44

672

4447

1036

7298

1.42

25.02

5.1

1.49

1.43

mg/l

1.49

961

6747

Other ulcerative colitis

166

696

2.48

25.01

5.1

3.7

1.49

1.43

mg/l

0.40

156

643

Testicular hypofunction

129

482

2.83

24.89

3.3

3.1

1.40

1.37

mg/l

0.13

120

457

Ventral hernia

527

3263

1.64

24.75

4.9

3.0

1.81

1.59

mg/l

6.51

479

2960

Cholecystectomy

1419

8992

1.35

24.54

3.4

2.9

1.67

1.56

mg/l

4.81

1311

8160

Disorders of vitreous body

1043

7072

1.42

24.49

4.0

2.9

1.77

1.61

mg/l

6.33

956

6404

Urolithiasis

703

4659

1.53

24.48

4.0

3.2

1.65

1.64

mg/l

0.10

648

4231

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

745

4998

1.51

24.44

5.2

4.7

1.48

1.46

mg/l

0.24

685

4615

Diseases of middle ear and mastoid

1269

7603

1.38

24.44

6.7

3.8

1.43

1.42

mg/l

0.24

1192

7047

Stroke, including SAH

1300

6856

1.37

24.31

3.8

3.1

1.84

1.62

mg/l

12.34

1171

6209

malignant neoplasm of female genital organs

272

1363

1.99

24.26

3.6

2.7

1.49

1.66

mg/l

2.55

246

1194

Diseases of pulp and periapical tissues, including avohilmo

2282

9301

1.28

24.26

3.7

4.4

1.56

1.46

mg/l

6.03

2085

8584

Disorders of vitreous body and globe

1065

7217

1.41

24.22

4.0

2.9

1.77

1.61

mg/l

6.34

978

6532

External causes of morbidity and mortality

1393

5134

1.37

24.21

4.5

4.6

1.49

1.40

mg/l

3.50

1294

4781

Anxiety disorders

1956

10442

1.29

24.18

5.4

3.7

1.45

mg/l

0.06

1810

9663

Disorders of refraction and accommodation

676

4438

1.54

24.16

9.6

5.9

1.38

1.36

mg/l

0.31

634

4165

Accidents

1724

6561

1.33

24.12

4.2

4.5

1.53

1.44

mg/l

4.14

1582

6103

Other symptoms and signs involving the circulatory and respiratory systems

178

781

2.36

24.09

4.8

4.2

1.68

1.44

mg/l

2.66

173

721

Other and unspecified tonsillitis

758

4233

1.51

23.94

6.7

3.9

1.35

1.30

mg/l

1.11

732

3994

Infections with a predominantly sexual mode of transmission, including avohilmo

822

5148

1.48

23.91

4.1

3.5

1.42

1.33

mg/l

2.62

767

4827

Anterior Iridocyclitis

450

2705

1.70

23.82

4.1

3.6

1.62

1.51

mg/l

1.71

415

2487

Other pleural conditions

238

1176

2.08

23.80

4.2

3.1

2.09

1.73

mg/l

5.64

218

1031

Unknown and unspecified causes of morbidity

163

691

2.43

23.80

4.8

3.0

1.73

1.45

mg/l

3.10

153

626

Neurotic, stress-related and somatoform disorders

1934

10384

1.29

23.64

5.4

3.7

1.44

1.45

mg/l

0.12

1788

9614

Injuries to the abdomen, lower back, lumbar spine and pelvis

897

6183

1.45

23.61

3.8

1.67

1.54

mg/l

3.50

814

5619

Carcinoma in situ of skin

203

949

2.21

23.58

4.6

2.6

1.87

1.73

mg/l

1.06

184

837

Calculus of kidney and ureter

655

4313

1.54

23.56

4.1

3.2

1.66

1.62

mg/l

0.57

605

3915

Hypoplasia of dental enamel, prenatal

118

11.88

23.50

68.9

19.1

1.39

1.01

mg/l

4.69

118

Bacterial pneumonia, not elsewhere classified

788

4718

1.48

23.29

5.6

3.4

1.81

1.50

mg/l

15.74

719

4270

Malignant neoplasm of breast, ER-positive, including Hilmo

533

2472

1.62

23.04

2.6

2.7

1.35

1.54

mg/l

7.30

478

2210

Malignant neoplasm of breast, HER-positive

531

2466

1.62

22.96

2.7

1.35

1.54

mg/l

7.59

476

2205

Hyperkinetic disorders, excluding more controls

307

1555

1.88

22.87

10.5

6.9

1.13

1.12

mg/l

0.17

295

1498

Other and unspecified disorders of white blood cells

121

457

2.78

22.81

7.1

4.1

1.53

1.57

mg/l

0.15

114

412

Dilated cardiomyopathy

291

1566

1.91

22.79

4.5

3.5

1.99

1.66

mg/l

6.42

272

1425

Crohn's disease of small intestine

183

834

2.27

22.70

3.7

4.5

1.50

1.39

mg/l

0.98

174

777

Disorders of skin appendages

1081

7821

1.39

22.68

5.2

4.0

1.52

1.43

mg/l

3.11

1022

7230

Systemic lupus erythematosus, unspecified

316

3.19

22.67

4.1

3.6

1.68

1.42

mg/l

1.97

287

Single ventricle heart

13.86

22.64

12.5

29.6

1.05

mg/l

0.03

Mixed hyperlipidaemia

114

419

2.85

22.58

3.8

2.6

2.01

1.56

mg/l

3.84

108

376

Other congenital malformations

258

1340

1.99

22.56

8.9

10.7

1.32

1.26

mg/l

0.62

246

1278

Other disorders of lacrimal gland

747

5098

1.48

22.49

4.5

3.2

1.52

1.54

mg/l

0.32

681

4642

Malignant neoplasm of gum

8.40

22.39

2.3

2.2

1.08

1.68

mg/l

3.72

Malignant neoplasm of breast, HER2-negative, including Hilmo

678

2863

1.53

22.38

2.6

2.7

1.35

1.50

mg/l

5.93

617

2573

Malignant neoplasm of breast, including Hilmo

678

2863

1.53

22.37

2.6

2.7

1.35

1.50

mg/l

5.93

617

2573

Malignant neoplasm of respiratory system and intrathoracic organs

402

1960

1.73

22.36

3.4

2.8

1.46

1.82

mg/l

15.49

381

1702

DVT of lower extremities

398

2356

1.72

22.33

4.0

2.7

1.80

1.59

mg/l

3.92

368

2120

Neovascular glaucoma

119

450

2.77

22.33

5.4

3.8

1.87

1.64

mg/l

2.00

113

405

Certain conditions originating in the perinatal period

279

1318

1.94

22.28

16.4

11.8

1.21

1.10

mg/l

3.07

272

1267

Benign neoplasm of mouth and pharynx

252

1304

1.98

22.17

3.8

3.1

1.36

1.58

mg/l

4.79

238

1190

Carcinoma in situ of skin of scalp and neck

305

3.21

22.13

6.6

2.6

2.09

1.86

mg/l

1.40

266

Obesity related asthma

757

5204

1.47

22.01

3.2

3.6

1.70

1.50

mg/l

6.89

690

4791

Arterial embolism and thrombosis

142

587

2.50

22.00

4.9

3.0

2.19

1.67

mg/l

5.22

129

510

Pain in joint

1259

5723

1.36

21.97

3.5

3.7

1.49

1.45

mg/l

0.91

1165

5267

Concussion

1088

6136

1.39

21.96

4.0

4.5

1.50

1.38

mg/l

4.95

993

5741

Ulcerative colitis (strict definition, all Crohn cases excluded)

337

1917

1.80

21.90

3.8

4.1

1.34

1.42

mg/l

1.26

313

1791

Malignant neoplasm of endocrine gland, including Hilmo

178

814

2.25

21.80

6.1

4.0

1.56

1.53

mg/l

0.14

168

727

Total colectomy operation

126

498

2.65

21.70

5.4

4.1

1.70

1.44

mg/l

2.18

119

458

Total colectomy

126

498

2.65

21.70

5.4

4.1

1.70

1.44

mg/l

2.18

119

458

Melanocytic naevi, other sites/unspecified

204

988

2.13

21.64

8.1

3.7

1.64

1.46

mg/l

2.08

195

914

Ischaemic Stroke, excluding all haemorrhages

1132

6111

1.38

21.60

3.5

3.0

1.87

1.66

mg/l

10.39

1015

5518

Myelodysplastic syndrome, including Hilmo

242

3.42

21.48

3.5

3.1

1.50

1.83

mg/l

3.08

206

Other systemic involvement of connective tissue

541

3494

1.57

21.26

3.2

3.1

1.65

1.58

mg/l

1.17

487

3166

Unspecified fall

1141

8322

1.36

20.89

4.8

4.7

1.61

1.50

mg/l

3.65

1026

7651

Degeneration of macula and posterior pole

921

5074

1.41

20.87

3.3

2.8

1.87

1.69

mg/l

5.82

808

4518

Protein-energy malnutrition of moderate and mild degree

156

4.34

20.70

9.9

15.3

1.39

1.41

mg/l

0.11

140

Caries of enamel

2078

10857

1.26

20.70

5.9

3.4

1.41

1.48

mg/l

4.06

1946

10013

Personal history of malignant neoplasm

180

845

2.19

20.66

11.3

2.9

1.17

1.34

mg/l

3.37

172

776

Acute pharyngitis

369

2166

1.72

20.62

9.4

4.7

1.27

1.28

mg/l

0.08

352

2038

Diseases of the myoneural junction and muscle

282

1551

1.86

20.58

3.7

4.2

1.80

1.59

mg/l

2.33

256

1414

Speech and linguistic disorders

293

1565

1.85

20.53

19.2

11.4

1.21

1.17

mg/l

0.67

281

1497

Other complications of surgical and medical care, not elsewhere classified

222

1132

2.01

20.40

4.5

3.6

1.58

1.44

mg/l

1.68

208

1041

Other abnormal findings of blood chemistry

133

556

2.49

20.29

4.5

3.4

1.54

1.57

mg/l

0.10

125

501

Keratitis

775

5444

1.44

20.11

4.7

3.5

1.60

1.49

mg/l

3.38

720

5006

Umbilical hernia

607

4072

1.51

20.09

5.4

3.4

1.70

1.54

mg/l

4.14

561

3747

Glaucoma secondary to other eye disorders

119

475

2.62

20.07

5.4

3.9

1.87

1.66

mg/l

1.74

113

422

Problems related to lifestyle

237

1242

1.95

20.06

3.5

3.0

1.58

1.37

mg/l

2.87

212

1146

Erosion of teeth , including avohilmo

596

3983

1.52

20.06

10.5

4.3

1.47

1.38

mg/l

1.97

559

3728

Diseases of male genital organs

1261

4749

1.35

19.98

4.6

4.9

1.58

1.47

mg/l

3.57

1177

4455

Low back pain

1654

8719

1.29

19.98

3.2

3.5

1.57

1.48

mg/l

3.50

1497

8055

Excessive attrition of teeth

1294

9759

1.32

19.92

7.3

3.8

1.43

1.45

mg/l

0.34

1217

9049

Eosinophilic disease (BM)

131

4.33

19.86

2.8

4.7

1.76

1.34

mg/l

2.08

118

Secondary polycythaemia

266

3.24

19.84

2.7

3.1

1.50

1.59

mg/l

0.44

243

Other specific joint derangements/joint disorders

1542

7432

1.30

19.82

3.6

4.2

1.48

1.37

mg/l

6.09

1433

6901

Acute posthaemorrhagic anaemia

318

2.98

19.80

4.9

2.5

2.04

1.63

mg/l

3.00

279

Malignant neoplasm of breast

652

2825

1.50

19.76

2.6

2.7

1.35

1.50

mg/l

5.58

590

2536

Malignant neoplasm of breast, HER2-negative

651

2823

1.50

19.67

2.6

2.7

1.35

1.50

mg/l

5.64

589

2534

Other disorders of ear

1956

10091

1.26

19.54

4.8

4.1

1.59

1.51

mg/l

4.03

1747

9335

Special screening examination for infectious and parasitic diseases

494

2298

1.59

19.47

2.7

2.6

1.23

1.28

mg/l

0.83

468

2156

Nerve, nerve root and plexus disorders

2204

10701

1.24

19.40

3.3

3.2

1.65

1.50

mg/l

11.17

2007

9823

Visual disturbances and blindness

1107

8280

1.35

19.39

4.7

4.1

1.56

1.53

mg/l

0.56

1008

7574

Impotence

158

727

2.26

19.30

4.6

2.7

1.78

1.63

mg/l

1.13

146

662

Other specified congenital malformation syndromes affecting multiple systems

357

2.98

19.30

10.7

18.8

1.36

1.13

mg/l

1.44

349

Exclusions for E4_PCOS_CONSORTIUM

1431

6872

1.31

19.18

5.1

4.7

1.43

1.39

mg/l

1.04

1303

6366

Chorioretinal inflammation

303

3.02

19.18

4.3

3.0

1.55

1.48

mg/l

0.36

277

Multiple myeloma

229

3.34

19.16

2.8

2.6

1.98

1.83

mg/l

0.57

194

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS)

229

3.34

19.16

2.8

2.6

1.98

1.83

mg/l

0.57

194

KRA_PSY_EATING, excluding more controls

167

778

2.17

19.00

6.1

5.4

1.24

1.12

mg/l

1.17

151

739

Other diseases of stomach and duodenum

154

705

2.25

18.95

4.9

3.0

1.97

1.63

mg/l

3.07

136

632

Pruritus

248

1347

1.88

18.83

5.4

3.8

1.80

1.49

mg/l

4.43

220

1228

Lichen simplex chronicus and prurigo

159

740

2.22

18.82

4.2

3.1

1.80

1.55

mg/l

2.37

150

676

Abnormal spermatozoa

294

1689

1.79

18.66

3.1

2.8

1.78

1.76

mg/l

0.12

258

1521

Glaucoma

1097

6989

1.34

18.53

3.3

3.0

1.71

1.67

mg/l

0.83

979

6292

Polyuria

453

2907

1.58

18.45

3.0

2.9

1.68

1.62

mg/l

0.72

397

2627

Fracture of lumbar spine and pelvis

467

3010

1.57

18.43

3.6

3.2

1.85

1.67

mg/l

3.16

419

2673

Weight loss

246

1346

1.88

18.37

5.8

1.51

1.55

mg/l

0.31

227

1227

Malignant neoplasm of bladder, including Hilmo

220

1143

1.94

18.32

2.6

2.9

1.92

1.91

mg/l

0.08

190

975

Spondylopathies

1635

7607

1.28

18.26

2.9

3.2

1.60

1.54

mg/l

2.01

1476

6987

Chronic lower respiratory diseases

2602

11318

1.22

18.22

3.8

4.4

1.55

1.46

mg/l

5.58

2388

10463

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

178

876

2.09

18.18

3.9

3.2

1.90

1.56

mg/l

3.57

166

797

Discitis, unspecified

188

3.60

18.12

4.0

3.0

2.15

1.72

mg/l

2.06

172

Other arterial embolism and thrombosis

269

3.08

18.10

4.7

2.6

2.17

1.65

mg/l

3.04

232

Mental and behavioural disorders due to psychoactive substance use

1279

9024

1.31

18.07

3.5

3.4

1.57

1.51

mg/l

1.85

1179

8337

Malignant neoplasm of nasal cavity and sinuses, including Hilmo

5.41

17.99

2.2

2.3

1.10

1.79

mg/l

5.17

Disorders of lacrimal system

873

6272

1.38

17.96

4.4

3.3

1.52

1.54

mg/l

0.31

796

5683

Vascular disorders of the intestines

154

720

2.20

17.95

3.8

2.6

2.12

1.74

mg/l

3.54

142

620

Other blood glucose lowering drugs, excl. Insulins

310

1824

1.73

17.93

3.0

2.8

2.06

1.61

mg/l

11.31

280

1654

Other joint disorders

1844

7671

1.26

17.92

3.6

4.4

1.42

1.37

mg/l

1.74

1698

7122

Hypertrophic cardiomyopathy

123

527

2.44

17.91

5.0

4.0

1.73

1.65

mg/l

0.45

113

475

Nonsuppurative otitis media, including avohilmo

680

4107

1.45

17.86

7.4

4.6

1.40

1.34

mg/l

1.08

649

3825

COPD

899

5345

1.38

17.79

2.6

3.1

1.89

1.68

mg/l

7.83

793

4816

Convalescence

112

459

2.51

17.76

3.5

2.8

1.62

1.38

mg/l

1.96

105

417

Malignant neoplasm of endocrine gland

150

700

2.20

17.58

6.3

3.8

1.58

1.54

mg/l

0.22

140

630

Dorsalgia

2100

9029

1.24

17.56

3.3

3.8

1.52

1.47

mg/l

1.48

1910

8352

Gestational [pregnancy-induced] hypertension

411

2601

1.60

17.53

3.1

2.8

1.40

1.29

mg/l

2.37

383

2421

Injuries to the thorax

972

7248

1.35

17.49

3.5

3.3

1.72

1.57

mg/l

4.54

883

6611

Undetermined asthma, excluding more controls

243

1340

1.84

17.47

5.0

3.1

1.50

1.34

mg/l

2.70

228

1215

Malignant neoplasm of nasal cavity and sinuses

6.52

17.40

2.4

2.5

1.08

1.65

mg/l

4.09

Injury, poisoning and certain other consequences of external causes

1119

4205

1.34

17.38

5.1

4.6

1.47

1.39

mg/l

2.54

1036

3905

Disease of hard tissues of teeth, NOS

1031

4003

1.36

17.34

3.5

2.5

1.52

1.54

mg/l

0.39

944

3616

Hepatomegaly and splenomegaly, not elsewhere classified

115

4.41

17.21

9.8

3.2

1.53

1.43

mg/l

0.38

105

Rash and other nonspecific skin eruption

221

1194

1.90

17.19

6.8

5.2

1.56

1.53

mg/l

0.22

205

1089

Aortic valve malfunction, age under 60 years

244

1362

1.84

17.18

6.5

5.3

1.71

1.43

mg/l

4.04

228

1272

Type 1 diabetes, definitions combined

261

1480

1.80

17.18

6.3

10.2

1.78

1.11

mg/l

21.92

246

1419

Vitamin D deficiency

220

3.29

17.15

6.9

4.8

1.60

1.38

mg/l

1.62

197

Juvenile arthritis (FINNGEN)

134

606

2.30

17.14

6.1

10.8

1.43

1.15

mg/l

3.91

129

577

Exclusion endpoint for clefts

102

415

2.66

17.00

11.0

17.3

1.40

1.13

mg/l

1.84

404

Delirium, not induced by alcohol and other psychoactive substances

269

1545

1.77

16.88

3.1

2.6

1.91

1.80

mg/l

1.08

234

1365

Varicella [chickenpox]

149

710

2.19

16.83

12.5

6.5

1.51

1.32

mg/l

1.59

144

672

Other congenital malformations, including avohilmo

319

1927

1.69

16.82

7.7

8.6

1.33

1.29

mg/l

0.41

305

1825

Fitting and adjustment of other devices

611

3727

1.46

16.80

3.9

2.5

1.76

1.51

mg/l

9.15

537

3292

Chronic gastritis

522

3525

1.50

16.76

3.0

2.8

1.73

1.65

mg/l

1.30

479

3140

Other ill-defined and unspecified causes of mortality

204

1084

1.93

16.72

3.3

2.7

1.93

1.78

mg/l

1.17

183

954

Septal defects

224

1207

1.89

16.72

9.9

14.9

1.24

1.22

mg/l

0.17

218

1154

Aortic aneurysm

457

2944

1.54

16.71

3.5

2.6

1.88

1.67

mg/l

5.11

422

2617

Other diseases of lip and oral mucosa

858

6337

1.37

16.59

4.8

3.7

1.41

1.51

mg/l

3.23

810

5809

Type 1 diabetes, strict (exclude DM2)

259

1482

1.79

16.56

6.3

10.4

1.79

1.11

mg/l

21.47

244

1421

Unspecified acute lower respiratory infection

351

2180

1.64

16.55

5.0

4.5

1.63

1.47

mg/l

2.70

328

2016

Herpesviral [herpes simplex] infections, including avohilmo

501

3367

1.51

16.48

4.7

3.4

1.46

1.40

mg/l

0.79

469

3121

Injuries to the knee and lower leg

2527

11370

1.21

16.47

3.9

4.1

1.54

1.48

mg/l

2.87

2337

10461

Amputation of thigh

289

2.89

16.47

3.7

2.5

2.42

1.84

mg/l

4.39

248

Renal cell carcinoma of kidney

256

3.00

16.44

3.0

2.6

1.90

1.81

mg/l

0.35

219

Open wound of head

1212

8826

1.30

16.43

4.5

4.4

1.64

1.52

mg/l

4.74

1095

8134

Emotional disorders and disorders of social functioning with onset specific to childhood

171

846

2.05

16.37

15.1

14.0

1.12

1.06

mg/l

0.79

166

817

Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

199

1040

1.95

16.30

19.9

13.4

1.28

1.08

mg/l

3.64

193

1001

Disorders of tooth development and eruption

332

1645

1.67

16.30

9.4

2.8

1.37

1.34

mg/l

0.30

322

1509

Malignant neoplasm of bone and articular cartilage

102

4.51

16.29

18.1

9.2

1.23

1.46

mg/l

1.19

Other pulmonary heart/vessel disease

114

492

2.40

16.27

4.3

4.9

2.03

1.70

mg/l

2.65

105

437

Spondylosis

1110

6642

1.32

16.12

2.8

3.0

1.57

1.58

mg/l

0.06

985

6064

Mycoses, including avohilmo

1938

12057

1.23

16.11

3.8

3.9

1.52

1.49

mg/l

0.95

1791

11094

Malignant neoplasm of palate, including Hilmo

5.90

16.09

3.4

3.0

1.17

1.68

mg/l

3.80

Open wound of ankle and foot

247

1410

1.79

16.06

4.8

4.5

1.96

1.45

mg/l

10.00

234

1308

Acute laryngitis and tracheitis

282

1642

1.72

16.03

9.7

5.2

1.25

1.24

mg/l

0.06

273

1545

Abnormal weight loss

223

1238

1.85

15.97

3.8

5.5

1.52

1.57

mg/l

0.40

205

1124

Rheumatoid arthritis

591

3641

1.45

15.95

2.9

2.7

1.69

1.48

mg/l

6.24

528

3295

Injuries to the ankle and foot

1554

10624

1.26

15.94

4.8

4.3

1.49

1.43

mg/l

2.02

1453

9857

Benign neoplasm of other and ill-defined parts of digestive system

355

2237

1.61

15.77

3.9

2.9

1.80

1.63

mg/l

2.59

330

2020

Malignant melanoma, including Hilmo

309

1881

1.67

15.74

3.6

2.7

1.67

1.75

mg/l

0.81

289

1657

Prurigo nodularis

264

2.95

15.71

4.0

2.8

1.89

1.60

mg/l

1.50

239

Coxarthrosis [arthrosis of hip](FG)

1016

5293

1.33

15.68

3.1

2.7

1.71

1.51

mg/l

10.59

925

4799

Other chronic obstructive pulmonary disease

850

5161

1.36

15.54

2.6

3.1

1.89

1.68

mg/l

7.16

748

4648

Pulmonary oedema

181

3.39

15.50

6.3

2.3

2.54

1.84

mg/l

4.67

157

Postmenopausal osteoporosis with pathological fracture

137

650

2.17

15.49

2.7

2.4

1.63

1.65

mg/l

0.11

121

565

Covid-19 suspected case

431

2851

1.53

15.37

5.8

4.0

1.34

1.38

mg/l

0.42

397

2653

Absence of one kidney, including avohilmo

6.20

15.27

8.8

15.0

1.59

1.27

mg/l

1.36

Vascular diseases of the intestine

371

2.57

15.21

3.5

2.7

2.05

1.70

mg/l

1.95

323

Thyroiditis, ILD-related definition

234

1335

1.79

15.21

3.4

4.2

1.44

1.39

mg/l

0.46

212

1241

Crohn disease (strict definition, require KELA)

160

812

2.03

15.13

3.6

5.1

1.45

1.36

mg/l

0.67

153

757

Malignant melanoma

277

1657

1.70

15.12

3.6

2.7

1.64

1.75

mg/l

1.17

260

1451

Malignant neoplasm of nasal cavity and middle ear, including Hilmo

5.77

15.01

2.4

1.09

1.65

mg/l

3.96

Crohn disease (strict definition, require KELA, min 2 HDR)

158

802

2.03

14.94

3.6

5.2

1.46

1.36

mg/l

0.73

151

747

Substance abuse

1221

8917

1.28

14.86

3.5

3.4

1.57

1.51

mg/l

1.70

1124

8243

Hydrocele

264

1572

1.71

14.76

5.3

4.3

1.89

1.64

mg/l

3.60

245

1437

COPD related to multimorbidity

762

4742

1.37

14.75

2.6

2.9

1.97

1.72

mg/l

8.26

665

4259

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

167

869

1.98

14.69

3.6

5.0

1.48

1.37

mg/l

0.93

159

812

Osteosarcoma, including Hilmo

7.46

14.61

27.3

16.3

1.14

1.49

mg/l

1.83

Visual disturbances

996

7662

1.31

14.58

4.8

4.1

1.53

1.52

mg/l

0.14

904

7005

Amiodarone users

214

1207

1.82

14.57

3.4

3.0

2.01

1.73

mg/l

4.43

206

1082

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

521

3569

1.46

14.56

2.9

3.3

1.43

1.36

mg/l

1.12

484

3345

Symptoms and signs involving the nervous and musculoskeletal systems

1184

9311

1.28

14.51

4.6

4.3

1.49

1.54

mg/l

0.95

1082

8530

Anomalies of dental arch relationship, including avohilmo

439

2663

1.51

14.50

12.9

5.5

1.23

1.30

mg/l

1.65

408

2515

Non-invasive ventilation

409

2327

1.53

14.44

4.8

3.6

1.85

1.21

mg/l

28.08

375

2158

Malignant neoplasm of oropharynx, including Hilmo

6.60

14.43

3.7

2.7

1.12

1.59

mg/l

2.77

Supplementary factors related to causes of morbidity and mortality classified elsewhere

672

4890

1.39

14.40

5.7

4.0

1.63

1.48

mg/l

3.49

609

4494

Disorder of lipoprotein metabolism, unspecified

241

1409

1.74

14.37

3.6

2.6

1.98

1.59

mg/l

7.99

225

1237

Eosinophilia

170

3.39

14.32

4.3

6.2

1.75

1.53

mg/l

0.81

152

Colectomy operation

341

2185

1.59

14.18

3.8

3.0

1.79

1.65

mg/l

1.86

313

1957

Ill-defined and unknown causes of mortality

211

1197

1.80

14.07

3.6

2.8

1.92

1.77

mg/l

1.20

190

1056

Crowding of teeth, including avohilmo

257

1268

1.72

14.02

20.4

11.1

1.13

1.11

mg/l

0.27

249

1217

Alzheimer’s disease, strict definition

191

2715

0.56

13.97

2.0

2.4

1.66

1.90

mg/l

3.22

153

2352

Secondary right heart disease

424

2.39

13.97

4.0

3.7

2.10

1.71

mg/l

3.17

375

Duodenal ulcer

222

1280

1.77

13.96

4.8

2.9

2.02

1.70

mg/l

4.70

206

1142

Bipolar affective disorders

369

2413

1.55

13.95

2.7

3.3

1.41

1.36

mg/l

0.64

345

2259

Cerebral cysts

140

701

2.06

13.79

7.3

5.1

1.51

1.45

mg/l

0.34

131

642

Other and unspecified acquired haemolytic anaemias

111

4.04

13.79

7.9

3.7

1.94

1.53

mg/l

2.07

Sensorineural hearing loss

1479

7955

1.25

13.74

4.2

3.5

1.68

1.59

mg/l

3.32

1282

7299

Undetermined asthma

243

1441

1.71

13.70

5.0

3.1

1.50

1.42

mg/l

0.87

228

1303

Use of pramipexole

422

2851

1.50

13.69

3.9

2.9

1.85

1.62

mg/l

4.43

384

2560

Acute bronchiolitis

209

1076

1.81

13.69

17.7

15.0

1.24

1.10

mg/l

2.33

202

1038

Mixed specific developmental disorders

127

577

2.20

13.59

16.6

19.9

1.09

1.04

mg/l

0.58

127

569

Visual impairment including blindness (binocular or monocular)

160

843

1.95

13.58

4.2

5.0

1.81

1.56

mg/l

2.62

152

756

Lower back pain or/and sciatica

2190

11415

1.20

13.58

3.1

3.4

1.55

1.50

mg/l

1.71

1982

10515

All dysplastic lesions of the vulva

424

2.36

13.50

3.6

3.0

1.54

1.41

mg/l

0.87

392

Heart failure and hypertrophic cardiomyopathy

215

3.02

13.37

5.5

3.2

2.04

1.64

mg/l

2.55

188

Left ventricular outflow tract obstruction, narrow definition

162

867

1.94

13.34

11.6

10.2

1.26

1.32

mg/l

0.53

157

820

Fracture of rib(s), sternum and thoracic spine

632

4613

1.39

13.34

3.2

3.0

1.77

1.61

mg/l

3.31

568

4176

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

1050

6361

1.29

13.31

3.6

2.9

1.51

1.47

mg/l

0.64

977

5829

Other disorders of eyelid

829

5936

1.33

13.31

3.0

1.65

1.66

mg/l

0.22

753

5332

Bacterial, viral and other infectious agents

206

1182

1.79

13.30

8.1

4.8

1.68

1.42

mg/l

2.39

199

1108

Other neurological diseases

1408

8817

1.25

13.29

4.0

3.4

1.65

1.59

mg/l

1.71

1278

8027

Open wound of forearm

214

1240

1.76

13.29

4.3

3.5

1.69

1.48

mg/l

2.84

183

1136

Special screening examination for other diseases and disorders

246

1477

1.69

13.28

5.2

2.8

1.68

1.48

mg/l

3.10

234

1334

Coxarthrosis

940

4649

1.31

13.27

3.1

2.7

1.70

1.51

mg/l

8.92

858

4226

Type of accident

617

4496

1.39

13.17

5.9

4.0

1.63

1.48

mg/l

3.07

559

4129

Other chronic obstructive pulmonary disease, including avohilmo

1031

6608

1.29

13.17

2.6

3.1

1.84

1.66

mg/l

6.54

913

5970

Spondyloarthritis

340

2213

1.56

13.15

3.3

3.1

1.66

1.50

mg/l

2.46

309

2027

L01XE Protein kinase inhibitors

123

599

2.12

13.15

7.5

3.2

1.52

1.66

mg/l

1.33

117

538

Nonorganic sleeping disorders, excluding more controls

406

2744

1.50

13.12

3.7

1.44

1.37

mg/l

0.88

373

2550

Malignant neoplasm of palate

7.49

13.03

4.1

2.5

1.20

1.63

mg/l

1.80

Abnormal blood-pressure reading, without diagnosis

112

528

2.18

12.98

7.1

5.5

1.32

1.37

mg/l

0.42

104

487

Specific development disorders of scholastic skills

153

794

1.96

12.94

23.7

13.3

1.20

1.08

mg/l

1.82

147

770

Meniscus derangement

1058

5488

1.29

12.93

2.7

2.8

1.54

1.46

mg/l

2.41

966

5035

COPD, early/later onset

858

5504

1.32

12.92

2.6

3.0

1.90

1.70

mg/l

6.54

754

4954

Other diseases of oesophagus

194

1102

1.80

12.90

3.5

2.8

1.68

1.63

mg/l

0.32

180

989

Localized swelling, mass and lump of skin and subcutaneous tissue

642

4724

1.37

12.88

5.4

4.0

1.42

1.53

mg/l

2.56

610

4303

Obesity, other/unspecified

634

4654

1.38

12.88

3.2

3.4

1.70

1.39

mg/l

14.25

585

4323

Benign neoplasm: Skin of trunk

106

492

2.23

12.83

5.4

3.4

1.83

1.54

mg/l

1.73

451

Symptoms and signs involving cognition, perception, emotional state and behaviour

1968

11001

1.20

12.73

3.5

3.7

1.58

1.50

mg/l

3.41

1798

10138

Fracture of femur

514

3285

1.42

12.68

3.7

3.4

1.88

1.72

mg/l

3.03

455

2902

Benign neoplasm of other and unspecified endocrine glands

269

1676

1.63

12.68

2.9

3.4

1.54

1.56

mg/l

0.18

249

1539

Alcohol-induced chronic pancreatitis

155

829

1.93

12.67

3.9

2.9

1.83

1.57

mg/l

2.91

140

770

COPD, hospital admissions

846

5455

1.32

12.63

2.6

3.0

1.90

1.70

mg/l

6.62

742

4909

Recurrent or chronic depression

792

4151

1.33

12.59

3.1

3.3

1.36

1.43

mg/l

1.85

718

3876

Other disorders starting during childhood or adolescence

188

1062

1.82

12.56

21.3

14.9

1.24

1.06

mg/l

3.26

182

1030

Hypogonadotropic hypogonadism

440

2.30

12.54

2.2

3.5

1.16

1.39

mg/l

2.81

417

Hyperfunction of pituitary gland

109

516

2.17

12.51

7.2

4.9

1.46

1.29

mg/l

1.37

478

Seropositive rheumatoid arthritis

422

2888

1.47

12.44

2.8

2.6

1.72

1.49

mg/l

5.81

381

2591

Urticaria and erythema

729

5499

1.34

12.39

6.7

5.0

1.45

1.41

mg/l

0.72

682

5106

Amenorrhoea

131

665

2.01

12.36

6.0

4.3

1.39

1.21

mg/l

1.74

121

624

Astigmatism

177

994

1.83

12.35

13.5

9.8

1.33

1.30

mg/l

0.28

169

939

Bacterial, viral and other infectious agents, including avohilmo

215

1277

1.72

12.29

8.0

5.2

1.66

1.42

mg/l

2.32

208

1195

Conductive and sensorineural hearing loss

1550

8446

1.22

12.29

4.5

3.7

1.66

1.57

mg/l

3.49

1352

7767

Malignant neoplasm of bone and articular cartilage of limbs, including Hilmo

4.20

12.29

20.0

8.2

1.25

1.48

mg/l

1.19

Other or ill-defined heart diseases

117

574

2.09

12.19

7.4

3.9

1.80

1.35

mg/l

4.30

108

533

Other aneurysm

117

575

2.09

12.17

5.8

3.1

1.96

1.66

mg/l

2.10

111

503

Use of antiglaucoma preparations and miotics

159

868

1.87

12.12

4.0

2.5

1.81

1.73

mg/l

0.47

146

751

Polyarthrosis

365

2204

1.51

12.11

2.8

2.6

1.69

1.55

mg/l

2.17

314

1981

Inflammatory diseases of female pelvic organs

1031

5549

1.28

12.05

3.3

3.2

1.40

1.42

mg/l

0.48

949

5070

Mental and behavioural disorders due to opioids

440

2.25

12.01

3.3

3.2

1.54

1.28

mg/l

1.91

407

Varicella [chickenpox], including avohilmo

166

925

1.85

12.00

13.8

8.4

1.47

1.26

mg/l

2.00

159

877

Myopia

274

1738

1.60

11.99

6.8

5.2

1.38

1.31

mg/l

0.55

256

1637

Asthma (diagnoses ohter than nonallergic)

1788

12078

1.20

11.96

3.8

4.3

1.53

1.49

mg/l

1.44

1645

11117

COPD, hospital admission 2, with asthma infections

609

3863

1.37

11.90

2.7

3.0

1.96

1.73

mg/l

5.98

533

3459

Selective serotonin reuptake inhibitors

2038

8919

1.19

11.86

3.4

3.9

1.47

1.52

mg/l

1.74

1871

8261

Other disorders of veins

737

5513

1.33

11.83

2.9

2.8

1.65

1.52

mg/l

3.33

673

4997

Clefts and syndromes for tooth agenesis exclusion, including avohilmo

123

626

2.06

11.81

10.2

15.5

1.34

1.14

mg/l

1.61

116

603

Dermatophytosis

285

1832

1.58

11.80

4.9

3.6

1.71

1.56

mg/l

1.85

261

1686

Anxiety (asthma-related co-morbidities)

1223

7495

1.25

11.77

4.7

4.0

1.36

1.38

mg/l

0.42

1126

6994

Mental and behavioural disorders due to alcohol

1052

7972

1.27

11.77

3.4

1.58

1.53

mg/l

1.19

971

7356

Disturbance of activity and attention

306

1950

1.56

11.75

11.1

8.4

1.13

mg/l

0.10

294

1857

Other anxiety disorders

921

6127

1.29

11.71

4.3

3.8

1.36

1.35

mg/l

0.13

849

5732

Seborrhoeic dermatitis

211

1264

1.70

11.67

5.9

4.1

1.64

1.54

mg/l

0.86

196

1164

Other dorsopathies, not elsewhere classified

2068

9067

1.19

11.66

3.3

3.9

1.50

1.47

mg/l

0.92

1884

8390

Combinations of oral blood glucose lowering drugs

528

3830

1.39

11.66

2.6

2.9

1.78

1.54

mg/l

7.25

464

3525

Malignant neoplasm of mesothelium and soft tissue, including Hilmo

125

639

2.00

11.64

7.5

4.0

1.50

1.69

mg/l

2.03

119

558

Chronic lymphocytic leukaemia

266

2.61

11.58

3.1

2.6

1.49

1.77

mg/l

2.26

227

Chronic lymphocytic leukaemia and small lyphocytis leukaemia, including Hilmo

266

2.61

11.58

3.1

2.6

1.49

1.77

mg/l

2.26

227

Chronic lymphocytic leukaemia, helper endpoint

266

2.61

11.58

3.1

2.6

1.49

1.77

mg/l

2.26

227

Medicines for HER+ breast cancer

593

4078

1.37

11.55

2.6

2.8

1.36

1.54

mg/l

8.12

533

3676

Crossbite

230

1303

1.67

11.49

23.1

12.4

1.17

1.16

mg/l

0.12

220

1252

Other and unspecified types of non-Hodgkin lymphoma, hilmo

442

2.22

11.48

3.6

3.1

1.73

1.71

mg/l

0.10

394

Other predominantly sexually transmitted diseases, not elsewhere classified

318

2105

1.53

11.47

4.2

3.3

1.44

1.31

mg/l

2.41

302

1985

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

118

598

2.05

11.46

17.0

11.7

1.39

1.12

mg/l

3.15

111

570

Hyperkinetic disorders

334

2180

1.52

11.43

10.7

9.4

1.13

mg/l

0.08

321

2082

Other and unspecified myopathies

182

1054

1.76

11.41

3.7

3.6

1.95

1.63

mg/l

2.88

162

951

Malignant neoplasm of other and unspecified parts of biliary tract, including Hilmo

172

3.03

11.37

3.0

2.7

1.49

1.84

mg/l

2.06

148

Injuries to the hip and thigh

959

6791

1.27

11.34

3.8

3.6

1.71

1.60

mg/l

3.16

869

6150

Methotrexate

248

1557

1.62

11.33

2.8

2.9

1.61

1.47

mg/l

1.70

227

1419

L02BG Aromatase inhibitors

487

3457

1.40

11.31

2.6

2.8

1.38

1.57

mg/l

7.07

436

3108

Follow-up examination after treatment for conditions other than malignant neoplasms

790

4031

1.31

11.31

3.9

2.7

1.52

1.47

mg/l

0.76

742

3657

Malignant neoplasm of thyroid gland, including Hilmo

132

694

1.94

11.31

3.0

1.63

1.56

mg/l

0.33

125

618

Emotional disorders starting during childhood or adolescence

158

876

1.85

11.27

15.5

14.8

1.12

1.08

mg/l

0.46

153

855

All anxiety disorders

1254

7910

1.24

11.24

4.7

3.8

1.35

1.38

mg/l

0.63

1157

7389

Alzheimer’s disease (Late onset)

180

2494

0.59

11.22

2.0

2.4

1.67

1.93

mg/l

3.52

145

2148

Substance use, excluding alcohol

407

2845

1.45

11.17

3.1

3.6

1.48

1.42

mg/l

0.81

378

2657

Coronary artery bypass grafting

453

2373

1.43

11.17

3.4

2.5

2.17

1.64

mg/l

21.78

409

2110

Alzheimer disease, including avohilmo

354

3569

0.68

11.16

2.1

2.6

1.70

1.87

mg/l

3.05

283

3124

Thoracic aortic aneurysm

287

1874

1.56

11.11

3.5

2.7

1.77

1.61

mg/l

2.41

272

1689

Conjunctivitis (acute, non atopic)

600

4460

1.35

11.05

7.2

5.9

1.47

1.40

mg/l

1.20

567

4152

Mental retardation, excluding more controls

125

631

1.99

11.04

12.7

13.2

1.13

1.19

mg/l

0.65

119

608

Excessive, frequent and irregular menstruation

622

2453

1.36

11.03

5.0

3.5

1.44

1.42

mg/l

0.23

585

2253

Other obstetric conditions, not elsewhere classified

480

2155

1.42

11.00

3.1

3.2

1.21

1.20

mg/l

0.18

453

2030

Acne

239

1492

1.62

10.98

7.4

6.8

1.43

1.17

mg/l

4.95

231

1407

COPD, hospital admissions 3, with asthma pneumonia sepsis

507

3152

1.39

10.96

2.7

2.9

2.04

1.77

mg/l

6.48

438

2807

Unspecified privation

218

1344

1.65

10.81

4.4

3.9

1.70

1.51

mg/l

2.32

209

1236

Hyperplasia of prostate

733

3143

1.33

10.80

3.2

3.0

1.73

1.64

mg/l

1.65

669

2900

Infective dermatitis

226

1408

1.63

10.74

3.8

3.2

1.64

1.54

mg/l

1.04

201

1296

Cerebral palsy and other paralytic syndromes

233

1463

1.62

10.73

7.5

5.3

1.51

1.47

mg/l

0.28

212

1352

Alcohol-induced acute pancreatitis

462

2.16

10.72

3.6

3.0

1.89

1.53

mg/l

2.86

427

Vitamin B12 deficiency anaemia

186

1104

1.71

10.65

2.8

2.7

1.75

1.68

mg/l

0.45

169

971

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

467

2097

1.41

10.60

3.1

3.2

1.22

1.20

mg/l

0.43

440

1978

378

2451

1.45

10.60

2.8

2.5

1.95

1.82

mg/l

1.74

322

2133

Malignant neoplasm of nasal cavity and middle ear

5.67

10.60

2.1

2.5

1.07

1.71

mg/l

3.54

Dorsopathies

2135

9229

1.18

10.55

3.7

4.2

1.47

1.46

mg/l

0.09

1952

8550

N06DA Anticholinesterases

326

3670

0.68

10.54

2.0

2.6

1.63

1.87

mg/l

5.74

265

3210

Use of anticholinesterases

326

3670

0.68

10.54

2.0

2.6

1.63

1.87

mg/l

5.74

265

3210

Atrial septal defect

134

727

1.91

10.52

11.0

15.1

1.24

1.21

mg/l

0.19

129

693

Retinal vascular disorders

229

1439

1.62

10.50

4.3

2.5

2.06

1.76

mg/l

4.12

211

1267

Lung cancer and mesothelioma

319

1819

1.50

10.45

3.1

2.6

1.58

1.62

mg/l

0.40

300

1608

513

3229

1.38

10.45

3.0

2.5

1.96

1.81

mg/l

2.63

441

2830

Congenital malformations and deformations of the musculoskeletal system

233

1468

1.61

10.42

10.4

11.7

1.23

1.20

mg/l

0.24

224

1404

Alzheimer disease

301

3184

0.67

10.39

2.2

2.5

1.74

1.88

mg/l

1.78

237

2771

Other shoulder lesions

196

1189

1.68

10.37

3.1

3.3

1.54

1.44

mg/l

0.78

185

1099

Papulosquamous disorders

757

5892

1.30

10.34

3.5

3.4

1.59

1.53

mg/l

1.00

689

5398

Glaucoma suspect

660

5042

1.32

10.33

3.4

2.9

1.62

1.66

mg/l

0.60

593

4526

Fracture of foot, except ankle

504

3705

1.37

10.32

5.3

4.4

1.55

1.40

mg/l

2.91

467

3442

Other and unspecified glaucoma

138

760

1.85

10.31

2.9

2.8

1.81

1.73

mg/l

0.48

111

660

Other specified/unspecified systemic involvement of connective tissue

112

577

1.99

10.28

3.5

3.7

1.60

1.49

mg/l

0.77

107

527

Other disorders of optic [2nd] nerve and visual pathways

145

813

1.83

10.27

7.9

6.7

1.58

1.47

mg/l

0.69

134

750

Retinal vascular occlusion

225

1418

1.61

10.21

4.3

2.5

2.05

1.75

mg/l

4.09

208

1249

Degenerative diseases of the nervous system

354

3643

0.69

10.20

2.4

2.6

1.72

1.85

mg/l

1.93

288

3197

Abnormalities of gait and mobility

254

1648

1.57

10.19

4.8

5.3

1.65

mg/l

0.02

229

1498

Malignant neoplasm of thyroid gland

118

620

1.94

10.18

2.9

3.1

1.63

1.55

mg/l

0.41

111

554

Other sleep disorders

230

1458

1.60

10.18

3.3

3.8

1.57

1.47

mg/l

0.93

213

1349

Poisoning by drugs, medicaments and biological substances

460

3340

1.39

10.17

3.4

4.0

1.46

1.37

mg/l

1.72

425

3125

Corneal ulcer

368

2572

1.45

10.17

4.7

3.7

1.63

1.46

mg/l

3.19

346

2388

Personality disorders, excluding more controls

457

3307

1.39

10.13

3.0

3.1

1.42

1.35

mg/l

0.97

418

3112

Use of other anti-dementia drugs

237

2938

0.64

10.11

1.9

2.5

1.57

1.90

mg/l

10.62

176

2549

Use of memantine

237

2938

0.64

10.11

1.9

2.5

1.57

1.90

mg/l

10.62

176

2549

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified, including avohilmo

204

1240

1.66

10.09

12.0

11.0

1.28

1.15

mg/l

1.87

197

1188

ILD-related respiratory insufficiency

355

2.27

10.02

2.5

3.0

2.02

1.78

mg/l

1.47

314

Other predominantly sexually transmitted diseases, not elsewhere classified, including avohilmo

373

2619

1.44

10.02

4.2

3.5

1.42

1.29

mg/l

2.60

353

2473

Other postsurgical states

131

717

1.87

9.99

12.4

3.9

1.46

1.35

mg/l

0.68

124

650

Polycystic ovarian syndrome, consortium definition

1163

5427

1.24

9.93

3.9

3.2

1.46

1.40

mg/l

1.90

1076

4957

Deep bite

293

1726

1.52

9.93

16.9

9.9

1.23

1.24

mg/l

0.13

280

1643

Pyogenic arthritis

132

726

1.86

9.91

4.7

3.3

2.07

1.48

mg/l

6.22

121

661

Toxic liver disease

187

2.83

9.90

8.0

3.3

1.59

1.44

mg/l

0.73

167

Intestinal adhesions without obstruction

167

984

1.73

9.89

3.8

3.4

1.74

1.60

mg/l

1.14

157

871

Benign neoplasm: Transverse colon

213

1337

1.62

9.88

3.5

2.9

1.76

1.69

mg/l

0.61

197

1206

Ulcerative rectosigmoiditis

167

985

1.73

9.87

3.4

1.39

1.48

mg/l

0.80

153

918

Irregular menses

783

4600

1.29

9.84

4.7

3.3

1.38

1.34

mg/l

0.67

733

4252

Mental and behavioural disorders due to alcohol, excluding acute intoxication

891

7055

1.26

9.81

3.3

3.2

1.60

1.55

mg/l

0.95

823

6507

Specific development disorders of speech and language

177

1026

1.71

9.79

18.0

12.9

1.21

1.20

mg/l

0.11

170

976

Arthrosis

1323

5982

1.22

9.76

3.0

2.8

1.61

1.44

mg/l

9.30

1206

5496

Dermatitis due to substances taken internally

120

646

1.90

9.69

5.6

1.58

1.44

mg/l

0.93

112

599

Gestational [pregnancy-induced] oedema and proteinuria without hypertension

148

848

1.78

9.69

3.6

2.9

1.53

1.40

mg/l

1.08

136

785

Myalgia

449

3274

1.38

9.69

3.1

3.3

1.41

1.44

mg/l

0.39

408

3013

Intracranial injury

1179

9053

1.22

9.57

4.1

4.4

1.59

1.50

mg/l

2.96

1060

8339

Benign neoplasm: Colon, unspecified

471

3470

1.37

9.57

3.6

2.7

1.91

1.67

mg/l

6.03

439

3104

Oesophagitis

118

635

1.90

9.56

4.9

3.4

1.84

1.59

mg/l

2.05

105

568

Congenital malformations of aortic and mitral valves

125

688

1.88

9.55

11.4

9.5

1.27

1.34

mg/l

0.55

120

645

Faecal incontinence

165

979

1.71

9.53

2.8

2.5

1.59

mg/l

0.01

144

878

Injuries to the shoulder and upper arm

1746

11476

1.18

9.50

3.8

3.9

1.56

1.51

mg/l

1.80

1592

10554

Leisure time condition

360

2541

1.43

9.47

5.8

4.4

1.63

1.48

mg/l

2.20

319

2343

Retinal detachment with retinal break

245

1604

1.55

9.45

3.7

2.9

1.83

1.63

mg/l

2.38

221

1456

Unspecific neurodegenerative disorder

439

4099

0.73

9.45

2.1

2.7

1.67

1.85

mg/l

4.68

352

3625

Sicca syndrome [Sjögren]

153

892

1.75

9.45

2.9

3.0

1.54

1.50

mg/l

0.29

140

806

Eating disorder

169

1012

1.69

9.36

6.2

6.9

1.23

1.16

mg/l

0.60

153

953

Other congenital malformations of kidney

4.19

9.35

10.3

18.6

1.41

1.20

mg/l

0.72

Rosacea

237

1544

1.56

9.34

5.5

3.4

1.49

mg/l

0.03

223

1417

Orchitis and epididymitis

201

1263

1.62

9.31

4.2

3.7

1.61

1.59

mg/l

0.15

180

1161

Post-traumatic stress disorder

160

948

1.71

9.29

6.1

4.5

1.21

mg/l

0.07

151

898

Fracture of shoulder and upper arm

722

5662

1.28

9.24

4.7

4.3

1.64

1.52

mg/l

2.67

660

5172

Childhood asthma (age<16), excluding more controls

242

1229

1.55

9.22

7.3

4.1

1.17

1.10

mg/l

1.11

235

1172

Other benign neoplasms of skin

682

5322

1.29

9.19

4.4

3.1

1.65

1.59

mg/l

1.12

635

4799

Other and unspecified disorders of skin and subcutaneous tissue

122

672

1.85

9.17

2.8

3.2

1.77

1.53

mg/l

1.62

114

608

Diseases of salivary glands

606

4659

1.31

9.16

3.5

1.50

1.49

mg/l

0.05

570

4262

Congenital malformations and deformations of the musculoskeletal system, including avohilmo

272

1824

1.51

9.16

9.5

10.5

1.24

1.23

mg/l

0.06

262

1743

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

173

1053

1.67

9.11

6.4

4.2

1.75

1.46

mg/l

3.01

158

963

Other abnormal uterine and vaginal bleeding

368

1869

1.43

9.09

2.7

3.1

1.51

1.50

mg/l

0.09

327

1699

Other diseases of spinal cord

357

2.20

9.09

6.3

3.9

1.49

1.55

mg/l

0.24

318

Oral leukoplakia and other epithelial disorders of tongue and oral cavity , including avohilmo

180

1109

1.65

9.06

2.9

3.1

1.47

1.58

mg/l

0.90

167

1021

Waldenstrom macroglobulinemia, lymphoplasmacytic lymphoma

5.10

9.06

4.5

2.0

2.12

1.68

mg/l

0.60

Paraplegia, diplegia of upper limbs

244

2.48

9.01

4.2

4.4

1.62

1.56

mg/l

0.19

220

Acne vulgaris

185

1147

1.64

8.99

6.4

6.7

1.38

1.16

mg/l

4.09

178

1082

Exposure to other specified factors

1646

12057

1.18

8.95

3.9

4.3

1.47

mg/l

0.03

1517

11150

Conjunctivitis (acute, non atopic), including avohilmo

2079

10864

1.16

8.94

4.4

4.1

1.47

1.50

mg/l

0.83

1948

9982

Psoriatic and enteropathic arthropathies

213

1369

1.58

8.94

2.7

2.8

1.48

1.36

mg/l

1.40

192

1275

Malignant neoplasm of bone and articular cartilage of limbs

4.87

8.91

29.6

12.9

1.16

1.57

mg/l

2.02

Presence of other devices

368

2591

1.41

8.88

3.6

2.2

1.72

1.60

mg/l

2.00

336

2300

Injuries to unspecified part of trunk, limb or body region

212

1365

1.58

8.87

4.4

5.3

1.84

1.48

mg/l

4.05

190

1253

Hypermetropia

184

1147

1.64

8.86

15.9

9.7

1.46

1.32

mg/l

1.43

169

1077

Reactive arthropathies

166

1007

1.68

8.86

3.9

3.7

1.60

1.40

mg/l

2.09

155

934

Psoriasis

545

4154

1.32

8.82

3.6

3.3

1.59

1.51

mg/l

1.30

499

3822

Unstable angina pectoris

624

3786

1.30

8.81

3.2

2.5

1.92

1.60

mg/l

13.37

550

3393

Complications of internal orthopaedic prosthetic devices, implants and grafts

395

2869

1.39

8.80

3.5

2.7

1.89

1.63

mg/l

5.81

356

2544

Alcohol use disorder, ICD-based

819

6569

1.26

8.80

3.3

3.2

1.59

1.54

mg/l

1.11

758

6055

Eating disorders

199

1263

1.60

8.76

5.9

6.2

1.32

1.24

mg/l

0.68

183

1186

Ovarian cyst

534

2293

1.34

8.75

3.9

3.1

1.44

1.45

mg/l

0.15

493

2099

Childhood asthma (age<16)

243

1251

1.53

8.73

7.8

4.2

1.17

1.12

mg/l

0.82

236

1195

Pneumonia due to Streptococcus pneumoniae

436

2.05

8.72

7.3

4.0

1.64

1.44

mg/l

1.22

393

Malignant neoplasm of eye, brain and central nervous system, including Hilmo

127

719

1.80

8.71

10.9

4.2

1.38

1.56

mg/l

1.67

116

649

Stomatitis and related lesions

390

2833

1.39

8.71

10.6

4.4

1.41

1.46

mg/l

0.56

364

2614

Functional dyspepsia

480

3599

1.35

8.70

3.3

3.1

1.56

1.49

mg/l

0.90

434

3271

Irritable bowel syndrome

480

3600

1.34

8.67

2.6

3.3

1.38

1.43

mg/l

0.64

426

3288

Pure hyperglyceridaemia

242

2.44

8.67

4.5

1.87

1.50

mg/l

1.71

220

Papillary adenocarcinoma of thyroid gland

464

2.00

8.66

2.9

3.1

1.58

1.56

mg/l

0.07

418

Fracture of lower leg, including ankle

1077

8735

1.22

8.64

4.3

3.7

1.60

1.50

mg/l

3.53

983

8007

L02BA Anti-estrogens

266

1806

1.49

8.62

3.0

2.8

1.24

1.51

mg/l

12.61

249

1642

Myositis

287

2.31

8.59

4.4

3.3

1.77

1.53

mg/l

1.05

264

Cholecystitis

249

1670

1.51

8.58

3.6

2.6

1.72

1.66

mg/l

0.50

232

1472

Biological medication for rheuma

357

2564

1.41

8.56

3.3

5.0

1.34

1.35

mg/l

0.08

337

2410

Other disorders of nervous system

138

806

1.75

8.55

3.9

3.0

1.69

1.58

mg/l

0.61

122

733

L04AC Interleukin inhibitors

142

836

1.73

8.55

3.1

4.3

1.39

1.37

mg/l

0.13

135

786

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

1033

8203

1.22

8.55

3.2

3.7

1.42

1.53

mg/l

3.94

949

7573

Malignant neoplasm of other and unspecified major salivary glands, including Hilmo

3.99

8.54

2.1

2.5

1.27

1.63

mg/l

1.48

Fissure and fistula of anal and rectal regions

442

3284

1.36

8.53

3.3

3.0

1.52

1.48

mg/l

0.52

399

2999

Injuries to the elbow and forearm

1427

10364

1.19

8.49

4.8

4.2

1.53

1.46

mg/l

2.27

1297

9554

Early onset COPD

415

3062

1.37

8.43

2.8

3.2

1.76

1.61

mg/l

2.14

370

2795

Poisoning by medicine

407

2993

1.37

8.42

3.3

3.9

1.47

1.37

mg/l

1.82

377

2802

Abscess of anal and rectal regions

175

1091

1.63

8.42

4.2

4.3

1.67

1.43

mg/l

2.70

165

1012

Spirochaetal infections, other/unspecified, including avohilmo

369

5035

0.73

8.30

2.8

3.5

1.28

1.52

mg/l

11.76

343

4611

Sulfasalazine

482

3646

1.33

8.24

2.7

2.8

1.54

1.46

mg/l

1.36

439

3327

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

305

2146

1.44

8.23

3.0

4.0

1.43

1.36

mg/l

0.91

284

2017

Disturbances of skin sensation

496

3769

1.33

8.23

3.4

3.1

1.42

1.44

mg/l

0.27

456

3465

Other/unspecified dorsalgia

703

5516

1.27

8.19

3.7

3.4

1.56

1.51

mg/l

0.79

632

5065

Other and unspecified follicular disorders

503

1.94

8.18

4.6

3.5

1.71

1.47

mg/l

1.44

462

Deficiency of other B group vitamins

206

2.51

8.13

3.1

2.5

1.57

1.66

mg/l

0.32

182

Disorders of conjunctiva

1683

11224

1.17

8.13

4.8

4.3

1.44

1.46

mg/l

0.38

1563

10346

Acne, including avohilmo

430

2584

1.36

8.11

5.8

6.1

1.32

1.21

mg/l

2.27

406

2448

Calcinosis cutis

9.84

8.11

4.8

8.7

2.76

1.69

mg/l

1.94

Lyme disease

367

4992

0.73

8.10

2.8

3.5

1.27

1.53

mg/l

11.97

341

4574

Lyme disease, including avohilmo

367

4992

0.73

8.10

2.8

3.5

1.27

1.53

mg/l

11.97

341

4574

Olecranon bursitis

137

812

1.72

8.09

3.5

2.8

1.81

1.59

mg/l

2.20

128

745

Unspecified misadventure during surgical and medical care

117

664

1.80

8.05

3.9

3.2

1.80

1.59

mg/l

1.25

106

598

Strabismus

531

4076

1.31

8.05

7.9

6.2

1.42

1.40

mg/l

0.18

485

3795

Other and unspecified rosacea

168

1049

1.63

8.05

3.7

3.2

1.54

1.50

mg/l

0.22

157

965

Bronchiectasis

147

888

1.69

8.05

5.0

3.7

1.69

1.68

mg/l

0.02

131

805

Cardiac murmurs and other cardiac sounds

207

1341

1.55

8.02

10.5

8.8

1.41

1.28

mg/l

1.97

195

1264

Rheumatoid arthritis, including avohilmo

655

5179

1.27

8.00

2.8

3.0

1.65

1.58

mg/l

1.25

585

4682

Digestive system disorders of fetus and newborn

6.04

7.98

15.6

30.3

1.13

1.10

mg/l

0.09

Other disorders of conjunctiva

266

1838

1.47

7.96

4.1

3.3

1.74

1.64

mg/l

1.07

248

1662

Other noninflammatory disorders of vulva and perineum

167

1047

1.62

7.85

3.5

3.1

1.38

1.41

mg/l

0.26

156

968

Dizziness and giddiness

1426

9453

1.18

7.84

3.3

3.5

1.60

1.54

mg/l

1.58

1290

8667

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

521

4014

1.31

7.83

2.9

3.7

1.43

1.37

mg/l

0.93

484

3757

Disorders of continuity of bone

192

1246

1.56

7.81

4.8

4.1

1.67

1.41

mg/l

3.16

178

1158

Benign neoplasm: Caecum

204

1343

1.54

7.79

2.9

2.8

1.93

1.71

mg/l

2.23

186

1204

Other spirochaetal diseases

375

5051

0.74

7.78

2.9

3.5

1.28

1.52

mg/l

10.23

348

4629

Menorrhagia

518

2198

1.32

7.77

3.6

3.3

1.42

1.46

mg/l

0.58

483

2016

Gonarthrosis [arthrosis of knee](FG)

1317

6399

1.19

7.75

2.8

2.7

1.64

1.46

mg/l

10.39

1195

5854

Degenerative macular diseases

212

1408

1.53

7.74

3.9

2.5

1.94

1.71

mg/l

2.25

186

1249

Other follicular disorders

147

898

1.67

7.72

5.1

3.8

1.76

1.40

mg/l

3.66

137

833

Diseases of external ear

699

5597

1.26

7.71

6.3

4.5

1.61

1.52

mg/l

1.73

639

5137

Type 1 diabetes, strict definition, subgroup 1

181

1162

1.58

7.69

5.4

11.0

1.78

1.06

mg/l

18.50

168

1126

Other spirochaetal diseases, including avohilmo

382

5122

0.74

7.69

2.9

3.6

1.29

1.52

mg/l

9.95

355

4692

Transport accidents

884

6023

1.23

7.68

4.0

1.46

1.44

mg/l

0.33

814

5605

Malignant neoplasm of bladder

108

606

1.81

7.65

2.6

2.5

1.97

1.91

mg/l

0.24

511

Endometriosis

505

2234

1.32

7.64

2.7

3.0

1.39

1.46

mg/l

1.23

456

2045

Use of donepezil

167

2473

0.64

7.64

2.1

2.4

1.63

1.88

mg/l

3.42

128

2136

Drug-induced polyneuropathy

143

2.88

7.63

40.9

13.1

1.07

1.32

mg/l

2.29

129

Other diseases of upper respiratory tract

2240

10258

1.14

7.61

4.1

4.3

1.48

1.52

mg/l

1.64

2061

9436

Type 1 diabetes, strict definition

189

1228

1.56

7.61

6.4

11.1

1.76

1.06

mg/l

18.81

176

1187

Sequelae of injuries of neck and trunk

350

2.09

7.55

2.7

3.0

1.43

1.50

mg/l

0.32

318

Nonorganic sleeping disorders

406

3041

1.35

7.51

3.7

4.4

1.44

1.40

mg/l

0.48

373

2834

Other strabismus

433

3265

1.33

7.46

8.7

6.5

1.37

1.36

mg/l

0.10

399

3058

Crohn disease (strict definition, all UC cases excluded)

107

606

1.80

7.45

2.8

5.0

1.42

1.41

mg/l

0.06

100

562

Complications following infusion, transfusion and therapeutic injection

161

2.66

7.43

6.9

3.6

1.65

1.38

mg/l

1.02

144

Marginal zone B-cell lymphoma, including Hilmo

132

2.84

7.42

3.5

2.8

1.83

1.75

mg/l

0.22

115

Tooth eruption problems

312

2171

1.40

7.37

16.0

8.0

1.30

1.17

mg/l

2.92

299

2058

Malignant melanoma of skin, including Hilmo

227

1544

1.49

7.37

3.6

2.7

1.65

1.74

mg/l

0.73

213

1342

Haemorrhoids and perianal venous thrombosis

593

4651

1.27

7.32

2.7

2.9

1.62

1.56

mg/l

0.78

524

4187

Subjective visual disturbances

460

3527

1.32

7.23

3.3

3.5

1.53

1.52

mg/l

0.13

429

3240

Deforming dorsopathies

528

4122

1.29

7.20

3.8

4.4

1.45

1.48

mg/l

0.34

483

3791

Other eating disorders

104

590

1.80

7.17

7.7

8.6

1.19

1.14

mg/l

0.24

558

Benign neoplasm: Pituitary gland, craniopharyngeal duct

104

594

1.79

7.06

3.0

3.9

1.39

1.48

mg/l

0.71

542

Disorders of optic nerve and visual pathways

183

1204

1.54

7.05

6.7

5.6

1.54

1.43

mg/l

0.82

166

1121

Other specified/unspecified bacterial intestinal infections

128

776

1.68

6.99

4.6

4.1

1.80

1.54

mg/l

2.05

121

702

Other and unspecified vascular occlusions

167

1080

1.57

6.95

4.5

2.5

2.02

1.73

mg/l

3.36

154

948

Malignant neoplasm of bone and articular cartilage of other and unspecified sites

3.91

6.95

6.7

7.7

1.31

1.54

mg/l

0.56

Familial hypercholesterolemia

238

1654

1.45

6.94

3.5

3.2

1.88

1.62

mg/l

4.43

215

1454

Melanoma in situ

488

1.87

6.94

4.8

2.9

1.79

1.72

mg/l

0.32

438

Unspecified chronic bronchitis

347

2.03

6.92

4.1

3.7

1.70

mg/l

0.02

313

Lung diseases due to external agents

247

1730

1.44

6.92

4.4

3.1

1.75

1.73

mg/l

0.10

211

1543

Pneumonia derived septicemia

441

1.91

6.83

13.0

7.2

1.67

1.50

mg/l

0.80

405

Suicide or other Intentional self-harm

442

3403

1.31

6.78

3.1

3.7

1.48

1.40

mg/l

1.26

413

3171

Symptoms and signs involving speech and voice

588

4691

1.26

6.76

3.6

3.3

1.51

1.57

mg/l

1.13

525

4258

Urticaria

555

4399

1.27

6.74

7.2

5.3

1.40

1.39

mg/l

0.21

518

4092

Arterial embolism and thrombosis of lower extremity artery

351

2.01

6.72

5.1

3.2

2.12

1.67

mg/l

2.44

302

Suppurative and necrotic conditions of lower respiratory tract

116

694

1.71

6.70

4.6

3.6

1.89

1.63

mg/l

1.86

111

620

Redundant prepuce, phimosis and paraphimosis

447

3399

1.31

6.69

4.4

4.1

1.64

1.45

mg/l

3.92

402

3187

Nail disorders

169

1107

1.55

6.68

5.4

4.8

1.68

1.45

mg/l

2.61

155

1025

Abnormality of white blood cells, not elsewhere classified

112

2.95

6.68

6.4

4.3

1.69

1.36

mg/l

1.23

100

Migraine

906

5867

1.21

6.66

5.0

4.6

1.29

1.36

mg/l

2.46

858

5461

Gonarthrosis

1133

5416

1.19

6.60

2.9

2.7

1.64

1.47

mg/l

7.95

1023

4957

Other and unspecified drugs and medicaments

159

1031

1.57

6.58

6.8

3.9

1.78

1.52

mg/l

2.24

144

945

Injury of unspecified body region

154

992

1.58

6.58

4.8

5.4

1.83

1.48

mg/l

3.01

137

906

Other inflammation of eyelid, including avohilmo

834

6921

1.21

6.57

3.9

4.2

1.35

1.43

mg/l

2.06

785

6398

Phobic anxiety disorders

248

1752

1.43

6.55

8.2

4.8

1.32

1.23

mg/l

1.14

237

1659

Disseminated intravascular coagulation [defibrination syndrome]

5.71

6.51

8.7

4.9

1.87

1.46

mg/l

1.78

Listeriosis, including avohilmo

4.35

6.51

4.5

1.9

2.17

1.55

mg/l

1.42

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

145

924

1.60

6.50

3.2

3.7

1.40

1.29

mg/l

0.91

136

869

Pneumonitis due to solids and liquids

152

979

1.58

6.48

4.8

3.4

1.74

1.71

mg/l

0.13

128

865

Excessive earwax

1231

9572

1.17

6.47

4.3

4.1

1.54

1.56

mg/l

0.52

1114

8759

Generalized skin eruption due to drugs and medicaments

456

1.86

6.46

6.1

1.52

1.46

mg/l

0.25

417

Benign neoplasm: Tongue

316

2.06

6.45

3.9

2.9

1.40

1.57

mg/l

0.85

285

Other and unspecified psoriasis

133

832

1.63

6.45

3.8

3.6

1.69

1.55

mg/l

1.12

127

764

Pediculosis, acariasis and other infestations

129

802

1.64

6.43

6.6

4.4

1.65

1.43

mg/l

1.61

118

747

Psoriasis vulgaris

343

2570

1.35

6.43

3.9

3.5

1.61

1.52

mg/l

0.98

319

2379

Liver disorders in diseases classified elsewhere

7.05

6.43

7.6

2.5

1.95

1.33

mg/l

1.52

Noninflammatory disorders of female genital tract

621

2486

1.26

6.41

6.0

3.9

1.36

1.41

mg/l

1.06

577

2286

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

407

1.91

6.41

4.1

3.1

1.65

1.55

mg/l

0.49

368

Ulcerative proctitis

119

725

1.67

6.41

2.9

3.8

1.31

1.43

mg/l

1.17

110

675

Non-small cell lung cancer, including Hilmo

226

1480

1.45

6.41

3.0

2.7

1.49

1.84

mg/l

9.74

213

1266

Corns and callosities

122

748

1.66

6.41

5.7

3.4

2.02

1.51

mg/l

5.73

111

673

Coeliac disease

230

1616

1.44

6.40

4.6

6.0

1.60

1.41

mg/l

2.64

214

1493

Otitis externa

432

3345

1.30

6.39

7.7

4.6

1.58

1.47

mg/l

1.65

404

3089

Cytomegaloviral hepatitis

6.00

6.38

6.4

3.0

1.99

1.41

mg/l

1.32

Other abnormal findings in urine

180

2.43

6.38

6.3

4.8

1.69

1.58

mg/l

0.42

156

Other and unspecified effects of external causes

521

4129

1.27

6.37

5.3

5.2

1.46

1.39

mg/l

1.32

482

3850

Alkalosis

8.68

6.37

6.3

1.4

1.80

1.43

mg/l

0.61

Complications of other internal prosthetic devices, implants and grafts

451

1.86

6.35

6.2

4.0

2.04

1.52

mg/l

2.78

401

Blindness or visual impairment, binocular

3.81

6.35

4.3

4.0

1.97

1.49

mg/l

1.24

Mental and behavioural disorders due to sedatives or hypnotics

136

859

1.61

6.34

2.7

3.5

1.47

1.38

mg/l

0.63

124

800

Allergic asthma (mode), excluding more controls

359

2646

1.33

6.29

3.2

1.26

1.24

mg/l

0.36

330

2449

Malignant neoplasm of bronchus and lung, including Hilmo

315

1941

1.36

6.28

3.1

2.7

1.59

1.83

mg/l

5.69

296

1678

Otitis externa, unspecified

222

1557

1.44

6.25

10.1

5.2

1.62

1.43

mg/l

2.27

207

1458

Other disorders of eye and adnexa

264

1908

1.40

6.25

6.3

5.0

1.45

1.43

mg/l

0.12

246

1770

Acute generalized exanthematous pustulosis

527

1.78

6.25

5.7

5.6

1.55

1.45

mg/l

0.52

480

Chronic laryngitis and laryngotracheitis

247

1767

1.41

6.21

2.8

1.45

1.58

mg/l

1.53

218

1626

Other headache syndromes

716

5873

1.22

6.16

3.6

1.37

1.45

mg/l

2.16

660

5406

Superficial injury of lower leg

495

3919

1.27

6.13

4.3

1.61

1.44

mg/l

3.95

450

3618

malignant neoplasm of male genital organs, including Hilmo

486

2285

1.29

6.12

2.9

1.69

1.76

mg/l

0.85

441

2032

Campylobacter enteritis

316

2.02

6.09

5.3

3.7

1.70

1.48

mg/l

1.19

286

Colonic or urogenital fistula

482

3809

1.28

6.08

3.6

3.1

1.57

1.53

mg/l

0.35

436

3492

Emphysema

134

852

1.60

6.08

2.2

3.1

1.88

1.73

mg/l

1.08

120

760

Non-allergic asthma (mode), excluding more controls

285

2073

1.37

6.07

6.0

3.4

1.49

1.32

mg/l

2.71

267

1878

Atopic dermatitis, strict definition with reimbursement

575

4452

1.25

6.05

6.8

5.8

1.33

1.29

mg/l

0.75

551

4198

Restrictive cardiomyopathy

4.21

6.04

23.8

6.2

2.09

1.58

mg/l

0.84

Thyrotoxicosis, other and/or unspecified

329

2473

1.34

6.04

2.9

3.2

1.60

1.47

mg/l

2.15

306

2263

Inflammatory diseases of the central nervous system

158

1045

1.54

6.02

5.8

4.3

1.58

1.48

mg/l

0.82

150

968

Asthma and allergy, excluding more controls

208

1431

1.45

6.02

3.6

3.8

1.20

1.16

mg/l

0.50

191

1339

Single spontaneous delivery

409

2790

0.77

6.00

2.5

3.5

1.40

1.53

mg/l

2.68

376

2526

Nummular dermatitis

157

1038

1.54

5.99

4.7

3.5

1.63

1.58

mg/l

0.26

144

953

Other specified and unspecified personality disorders

162

1078

1.52

5.99

3.0

3.3

1.47

1.37

mg/l

0.90

153

1014

Spondylopathies (FG)

230

1636

1.42

5.98

2.8

3.1

1.47

1.34

mg/l

1.53

212

1526

Malignant neoplasm of other and unspecified parts of biliary tract

124

2.67

5.97

3.6

2.5

1.50

1.80

mg/l

0.97

103

Type1 diabetes, definitions combined, early onset

175

1182

1.50

5.97

7.0

12.7

1.68

1.13

mg/l

15.09

162

1142

Adverse effects, not elsewhere classified

357

2721

1.32

5.97

6.1

5.7

1.48

1.40

mg/l

1.16

331

2527

Superficial injury of abdomen, lower back and pelvis

287

2120

1.37

5.94

4.0

4.6

1.47

1.45

mg/l

0.14

259

1955

Other (seronegative) rheumatoid arthritis, wide

310

2317

1.35

5.94

2.9

2.8

1.67

1.59

mg/l

0.78

280

2101

Urethral stricture

110

671

1.67

5.93

4.4

2.9

1.92

1.72

mg/l

1.32

595

Pyothorax

521

1.77

5.92

3.9

3.0

1.96

1.66

mg/l

1.83

467

Internal derangement of knee

661

5367

1.23

5.91

2.8

3.2

1.51

1.43

mg/l

1.33

597

4938

Chronic rhinitis, nasopharyngitis and pharyngitis

606

4928

1.24

5.91

3.9

4.4

1.43

1.47

mg/l

0.72

556

4567

Diaphragmatic hernia

613

4993

1.24

5.90

3.3

2.8

1.65

1.63

mg/l

0.12

566

4497

Early syphilis, including avohilmo

162

2.45

5.88

2.3

3.1

1.12

1.32

mg/l

2.20

151

Left bundle-branch block

116

718

1.64

5.87

2.5

2.6

1.80

1.51

mg/l

3.07

103

646

Non-neuropathic heredofamilial amyloidosis

12.30

5.86

4.9

1.4

1.67

1.08

mg/l

—

Listeriosis

4.18

5.85

4.8

2.0

2.10

1.57

mg/l

1.09

Recurrent aphthous stomatitis , including avohilmo

268

1965

1.38

5.84

13.9

4.7

1.34

1.45

mg/l

2.14

253

1819

Other peripheral vascular diseases

136

876

1.57

5.84

2.6

3.0

1.45

1.51

mg/l

0.43

127

793

Fracture of skull and facial bones

415

3240

1.29

5.81

5.3

4.0

1.50

1.48

mg/l

0.25

384

2995

Abdominal aortic aneurysm (AAA)

154

1012

1.53

5.78

3.2

2.4

2.18

1.84

mg/l

4.10

136

862

Benign neoplasm of middle ear and respiratory system

143

935

1.55

5.77

2.7

3.2

1.48

1.60

mg/l

1.11

132

849

Right bundle-branch block

357

1.91

5.75

2.9

3.2

1.72

1.44

mg/l

2.14

323

Asthma, hospital admissions , main diagnosis only

1587

12164

1.14

5.73

4.3

1.49

1.48

mg/l

0.18

1474

11202

Other disorders of bone

341

2599

1.32

5.72

5.5

3.9

1.32

1.41

mg/l

2.11

315

2405

Moderate visual impairment, binocular

316

1.98

5.72

4.8

4.1

1.89

1.66

mg/l

1.04

275

Ingrowing nail

112

694

1.64

5.71

5.7

5.2

1.65

1.38

mg/l

2.27

105

640

Other condition

270

1990

1.37

5.71

6.1

3.9

1.58

1.46

mg/l

1.18

252

1847

Cystic fibrosis with pulmonary manifestations

9.76

5.71

5.2

6.8

1.57

1.29

mg/l

0.33

Bulimia nervosa (incl. atypical)

295

2.00

5.70

3.4

4.1

1.21

1.17

mg/l

0.15

277

Bilateral cryptorchidism (undescended testicles)

3.54

5.68

25.3

28.3

1.20

1.12

mg/l

0.33

Paracetamol or NSAID medication

377

1449

1.32

5.68

6.5

8.7

1.42

1.40

mg/l

0.21

343

1379

Seronegative rheumatoid arthritis

186

1287

1.46

5.66

2.7

2.6

1.63

1.45

mg/l

1.81

164

1170

Perioral dermatitis

236

2.13

5.62

12.8

4.1

1.48

1.28

mg/l

0.89

209

Other disorders of cornea

177

1216

1.47

5.62

3.9

3.2

1.54

1.55

mg/l

0.10

163

1114

Idiopathic pulmonary fibrosis

134

869

1.57

5.62

2.5

2.7

1.82

mg/l

0.01

120

761

Respiratory conditions due to other external agents

197

2.25

5.61

2.8

1.64

mg/l

0.01

171

Malignant melanoma of skin

180

1241

1.47

5.58

3.5

2.7

1.58

1.72

mg/l

1.57

171

1085

Varicose veins

1010

6514

1.18

5.58

2.8

1.71

1.59

mg/l

4.24

899

5887

Muscular dystrophy

124

2.67

5.58

4.2

10.9

1.19

1.35

mg/l

0.74

116

Atrophic disorders of skin

255

1869

1.38

5.58

4.9

3.3

1.38

1.43

mg/l

0.57

235

1698

Anogenital herpesviral [herpes simplex] infection

109

675

1.64

5.55

3.8

3.5

1.33

1.30

mg/l

0.16

101

634

Other specified and unspecified retinal disorders

384

1.87

5.53

8.9

3.0

1.71

1.61

mg/l

0.45

349

Trigger finger

257

1893

1.37

5.46

4.5

2.9

1.80

1.48

mg/l

5.93

235

1738

Embedded teeth, including avohilmo

170

1166

1.48

5.45

6.8

6.3

1.44

1.23

mg/l

3.24

164

1098

Reactive arthropathies, FINNGEN

124

796

1.58

5.44

4.0

3.8

1.54

1.34

mg/l

2.05

115

738

Asthma and allergy

208

1460

1.42

5.42

3.6

3.8

1.20

1.18

mg/l

0.20

191

1365

Follicular lymphoma, hilmo

460

1.78

5.42

2.5

3.1

1.46

1.68

mg/l

1.31

414

Other melanin hyperpigmentation

213

2.17

5.42

4.0

2.9

1.78

1.59

mg/l

0.53

187

Conjunctivitis

1469

10405

1.14

5.41

4.9

4.5

1.39

1.43

mg/l

1.09

1366

9616

Any dementia

443

3851

0.79

5.41

2.2

2.7

1.77

1.84

mg/l

0.79

367

3385

Mental and behavioural disorders due to use of other stimulants, including caffeine

344

1.91

5.41

2.5

4.1

1.30

1.18

mg/l

0.66

321

Other symptoms and signs involving the nervous and musculoskeletal systems

769

6461

1.20

5.40

4.7

4.2

1.46

1.51

mg/l

0.85

708

5929

Disorders of adult personality and behaviour

494

3978

1.25

5.34

2.9

3.8

1.40

1.35

mg/l

0.53

452

3743

Soft tissue disorders related to use, overuse and pressure

491

3952

1.25

5.34

3.2

3.1

1.60

1.53

mg/l

1.09

450

3604

Somatoform disorder

272

2029

1.35

5.33

2.9

3.4

1.37

1.43

mg/l

0.71

240

1873

Ectropion of eyelid

403

1.82

5.32

3.2

2.9

1.93

1.84

mg/l

0.33

347

Benign neoplasm: Ascending colon

244

1792

1.38

5.32

3.6

2.8

1.86

1.70

mg/l

1.91

230

1608

Adhesive capsulitis of shoulder

288

2169

1.34

5.30

3.4

2.8

1.73

1.54

mg/l

2.75

261

1975

Ulcer of oesophagus

120

770

1.58

5.30

3.7

2.8

1.97

1.69

mg/l

1.72

106

688

Asthma mixed form (mode), excluding more controls

440

1.77

5.28

3.5

3.4

1.53

1.33

mg/l

1.35

400

Open bite

132

868

1.55

5.27

20.8

11.9

1.16

mg/l

0.06

126

832

Primary open-angle glaucoma, strict

428

3390

1.27

5.24

2.8

2.7

1.79

1.77

mg/l

0.19

380

2988

Marginal zone B-cell lymphoma

3.06

5.24

3.5

2.4

1.77

1.63

mg/l

0.29

Pneumococcal septicemia

421

1.80

5.23

12.4

7.7

1.60

1.51

mg/l

0.37

384

Malignant neoplasm of accessory sinuses, including Hilmo

5.54

5.20

2.5

3.1

1.14

1.96

mg/l

2.87

Other diseases of gallbladder

473

1.74

5.20

4.0

2.6

1.67

1.55

mg/l

0.58

427

Benign neoplasm: Adrenal gland

140

934

1.52

5.19

2.5

3.0

1.56

1.61

mg/l

0.25

129

854

Colorectal cancer, including Hilmo

384

2805

1.28

5.18

2.9

2.7

1.85

1.77

mg/l

0.81

344

2453

Other nutritional anaemias

2.76

5.17

2.5

2.7

2.14

1.58

mg/l

1.71

Benign neoplasm of eye and adnexa

183

1287

1.44

5.17

3.7

3.3

1.58

1.60

mg/l

0.18

168

1165

Other/unspecified rheumatoid arthritis

196

1395

1.42

5.16

3.4

2.8

1.77

1.62

mg/l

1.35

177

1238

Erectile dysfunction

146

985

1.51

5.14

6.2

3.9

1.79

mg/l

0.02

124

886

Other perinatal digestive system disorders

6.96

5.14

18.9

27.5

1.20

1.10

mg/l

0.34

Paralytic ileus

408

1.80

5.14

3.5

3.3

1.84

1.68

mg/l

0.77

355

Viral agents as the cause of diseases classified to other chapters

287

1.98

5.14

13.7

7.7

1.55

1.38

mg/l

0.72

262

Bullous disorders

106

667

1.62

5.11

4.0

3.6

1.88

1.64

mg/l

1.81

601

Delivery

423

2806

0.79

5.09

2.7

3.6

1.41

1.53

mg/l

2.36

389

2541

Asthma, including avohilmo

2370

11813

1.11

5.06

3.6

4.4

1.49

mg/l

0.17

2171

10897

malignant neoplasm of male genital organs

463

2226

1.26

5.04

2.8

2.9

1.69

1.76

mg/l

0.95

418

1977

Panic disorder

243

1798

1.36

5.04

4.3

3.9

1.34

1.29

mg/l

0.53

230

1701

Visual field defects

150

1023

1.49

5.00

5.5

3.6

1.74

1.60

mg/l

1.00

137

927

Scoliosis

163

1130

1.46

4.99

5.0

6.8

1.27

1.40

mg/l

1.70

147

1057

Other noninfective disorders of lymphatic vessels and lymph nodes

391

1.80

4.94

5.8

3.1

1.73

1.48

mg/l

1.16

356

Sequelae of other external causes

107

682

1.59

4.90

5.2

3.5

1.65

1.49

mg/l

1.02

101

622

Atopic dermatitis, strict definition

562

4531

1.22

4.87

7.1

6.5

1.30

1.28

mg/l

0.27

540

4279

Superficial injury of ankle and foot

245

1828

1.35

4.86

6.4

6.2

1.43

1.31

mg/l

1.08

226

1726

Primary open-angle glaucoma

511

4016

1.23

4.84

2.8

2.7

1.82

1.76

mg/l

0.68

450

3555

Use of rivastigmine

128

1888

0.67

4.83

2.0

2.4

1.71

1.88

mg/l

1.43

110

1606

Disorders of tyrosine metabolism

9.93

4.83

8.4

10.2

1.46

1.49

mg/l

—

Tumor necrosis factor alpha inhibitors

297

2280

1.31

4.82

3.2

5.0

1.33

1.34

mg/l

0.10

280

2150

Other disorders of pigmentation

499

1.69

4.82

4.3

4.7

1.86

1.47

mg/l

2.26

447

Generalized anxiety disorder

269

2033

1.33

4.81

3.1

4.1

1.20

1.27

mg/l

1.18

243

1921

Monoarthritis, not elsewhere classified

454

1.73

4.80

3.6

3.1

1.63

1.40

mg/l

1.11

417

COPD, hospital admissions 1, only main diagnosis

576

4091

1.22

4.80

2.5

3.0

1.90

1.75

mg/l

2.86

499

3663

Non-small cell lung cancer

151

1027

1.47

4.78

2.9

2.6

1.52

1.85

mg/l

5.68

140

876

Myocardial infarction, with ST-elevation

293

2250

1.31

4.75

3.7

2.6

2.06

1.75

mg/l

5.41

261

1989

Emotionally unstable personality disorder

202

1468

1.39

4.73

2.8

3.9

1.31

1.27

mg/l

0.30

187

1386

Seropositive rheumatoid arthritis, wide

422

3392

1.25

4.71

2.8

2.9

1.72

1.61

mg/l

1.65

381

3066

Hyperprolactinaemia

324

1.86

4.69

3.6

3.9

1.48

1.25

mg/l

1.60

299

Anorexia (incl.atypical)

104

665

1.58

4.69

5.2

5.7

1.30

1.29

mg/l

0.05

619

Malignant neoplasm of lip, including Hilmo

2.84

4.68

3.5

1.8

1.67

1.91

mg/l

0.57

Human immunodeficiency virus [HIV] disease resulting in malignant neoplasms, including avohilmo

12.35

4.67

2.5

2.2

1.27

1.41

mg/l

—

Complications of genitourinary prosthetic devices, implants and grafts

261

1.96

4.66

4.6

2.9

2.13

1.49

mg/l

3.98

231

Benign neoplasm: Rectum, anus and anal canal

344

2705

1.28

4.65

3.1

2.8

1.73

1.67

mg/l

0.46

314

2433

Allergic asthma (mode)

359

2765

1.27

4.65

3.2

3.3

1.26

1.29

mg/l

0.36

330

2559

Achalasia of cardia

193

2.14

4.65

3.1

2.7

1.58

1.63

mg/l

0.16

171

Bitten or struck by other mammals

205

1499

1.38

4.65

4.1

4.9

1.41

1.35

mg/l

0.54

184

1408

Personality disorders

457

3711

1.24

4.65

3.0

3.4

1.42

1.36

mg/l

0.82

418

3493

Striking against or struck by other objects

680

5731

1.19

4.62

4.5

5.2

1.45

1.41

mg/l

0.76

622

5354

Other inflammation of eyelid

248

1872

1.34

4.57

4.9

4.0

1.50

1.52

mg/l

0.21

233

1716

Benign neoplasm: Rectum

308

2395

1.30

4.57

3.0

2.8

1.69

1.66

mg/l

0.20

279

2163

Paralytic strabismus

124

831

1.51

4.56

4.0

4.1

1.63

1.60

mg/l

0.12

110

750

Blepharochalasis

471

3849

1.23

4.52

2.8

1.58

1.67

mg/l

1.52

425

3454

Macular pucker

262

1997

1.32

4.52

3.1

2.9

1.84

1.72

mg/l

1.03

228

1778

121

779

1.55

4.52

26.2

20.7

1.14

1.04

mg/l

2.23

121

767

Adalimumab

183

1321

1.40

4.51

3.1

5.3

1.34

mg/l

0.04

174

1250

Superficial injury of head

452

3680

1.23

4.46

3.9

4.8

1.55

1.49

mg/l

0.80

403

3369

Pain associated with micturition

197

1442

1.38

4.45

4.5

1.54

1.50

mg/l

0.23

184

1318

Pemphigoid

287

1.89

4.45

2.3

3.0

1.95

1.79

mg/l

0.60

248

Transient ischemic attack

875

6008

1.16

4.44

3.1

2.9

1.74

1.66

mg/l

1.70

783

5413

Malignant neoplasm of accessory sinuses

6.88

4.43

2.8

2.9

1.06

1.93

mg/l

—

Endometriosis of pelvic peritoneum

229

1558

1.35

4.41

2.4

3.0

1.24

1.40

mg/l

3.36

214

1445

Congenital malformations of posterior segment of eye

2.76

4.40

14.7

18.0

1.30

mg/l

0.00

Malignant neoplasm of renal pelvis

3.49

4.40

2.6

1.9

1.75

1.87

mg/l

0.25

Early syphilis

145

2.30

4.39

2.2

3.1

1.11

1.34

mg/l

2.16

134

Other/unspecified crystal arthropathies

2.86

4.38

4.8

2.4

1.66

1.73

mg/l

0.18

Injury of nerves and spinal cord at neck level

261

1.93

4.35

2.2

2.9

1.43

1.58

mg/l

0.62

235

Chronic iridocyclitis

592

1.60

4.35

5.5

4.7

1.40

1.47

mg/l

0.42

544

Disorders of muscles

180

1305

1.39

4.33

3.8

3.4

1.61

1.47

mg/l

1.13

165

1196

Congenital absence, atresia and stenosis of small intestine

5.69

4.33

17.9

15.9

1.04

1.10

mg/l

0.21

Polymyalgia rheumatica

211

1569

1.36

4.33

2.2

2.6

1.90

1.75

mg/l

1.34

177

1377

Human immunodeficiency virus [HIV] disease resulting in malignant neoplasms

13.40

4.32

2.7

2.4

1.32

1.41

mg/l

—

Poor fetal growth

167

1195

1.41

4.32

3.7

3.0

1.32

1.21

mg/l

1.29

156

1124

Scabies

625

1.58

4.31

7.0

4.7

1.64

1.39

mg/l

1.43

583

Speech disturbances, not elsewhere classified

153

1081

1.43

4.29

3.3

3.2

1.64

1.65

mg/l

0.06

137

965

Systemic disorders of connective tissue in diseases classified elsewhere

3.25

4.28

8.0

6.5

1.55

1.28

mg/l

0.38

Open wound of abdomen, lower back and pelvis

417

1.72

4.28

4.0

5.9

1.51

1.41

mg/l

0.40

388

Anogenital herpesviral [herpes simplex] infection, including avohilmo

177

1282

1.39

4.28

3.9

3.3

1.30

1.28

mg/l

0.13

164

1198

Other keratitis

199

1470

1.37

4.27

5.6

3.6

1.60

1.44

mg/l

1.61

188

1368

Persons encountering health services in circumstances related to reproduction

1153

6804

1.14

4.26

6.3

5.3

1.27

1.38

mg/l

6.82

1091

6402

Specific personality disorders

392

3164

1.25

4.26

2.9

3.4

1.38

1.36

mg/l

0.20

364

2983

Malignant neoplasm of breast, ER-negative, including Hilmo

260

1864

1.31

4.25

2.3

2.6

1.44

1.59

mg/l

2.75

235

1639

Herpesviral keratitis and keratoconjunctivitis

502

1.64

4.24

5.4

3.1

1.64

1.58

mg/l

0.22

457

Family history of malignant neoplasm

158

1125

1.42

4.22

3.2

2.3

1.32

1.26

mg/l

0.46

145

1031

Other noninflammatory disorders of vagina

122

829

1.49

4.20

3.4

3.1

1.51

1.43

mg/l

0.45

113

769

Disorders of synovium and tendon

970

7183

1.15

4.18

4.2

3.3

1.58

1.48

mg/l

3.19

884

6620

Volvulus

293

1.85

4.18

7.8

3.4

1.89

1.67

mg/l

0.66

261

Chronic sinusitis

753

6458

1.17

4.18

4.0

3.4

1.46

1.51

mg/l

1.24

691

5930

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

405

3290

1.24

4.16

2.9

1.73

1.60

mg/l

1.98

365

2981

Pain and other conditions associated with female genital organs and menstrual cycle

299

1954

1.29

4.15

5.1

3.5

1.28

1.35

mg/l

0.84

282

1818

Behavioural syndromes associated with physiological disturbances and physical factors

1825

11176

1.11

4.13

3.8

3.9

1.38

1.49

mg/l

7.78

1684

10308

Superficial injury of thorax

265

2051

1.30

4.12

3.8

3.7

1.64

1.53

mg/l

1.11

240

1889

Thyrotoxicosis

402

3267

1.24

4.12

3.0

3.1

1.62

1.51

mg/l

2.02

370

2974

Unspecified event, undetermined intent

317

1.81

4.11

3.2

5.6

1.57

1.39

mg/l

0.81

296

Other mycoses, not elsewhere classified/unspecified

3.27

4.11

12.3

1.6

1.82

1.34

mg/l

1.89

Asthma mixed form (mode)

475

1.64

4.08

3.5

1.53

1.39

mg/l

0.80

429

Melanocytic naevi of upper limb, including shoulder

267

1.88

4.07

9.0

5.0

1.83

1.43

mg/l

1.44

239

All dysplastic lesions of the cervix uteri, vagina or vulva

406

3223

1.23

4.07

3.7

2.9

1.41

1.31

mg/l

2.01

384

2992

Dentofacial anomalies [including malocclusion]

1295

9023

1.13

4.05

5.5

3.6

1.29

1.42

mg/l

8.99

1199

8405

Non-allergic asthma (mode)

285

2209

1.29

4.05

6.0

3.4

1.49

1.40

mg/l

1.14

267

1991

Psoriatic arthropathies

168

1220

1.39

4.04

2.6

2.8

1.53

1.39

mg/l

1.28

148

1132

Pneumothorax

120

821

1.48

4.03

3.3

3.1

1.52

1.59

mg/l

0.40

115

740

Unspecified protein-energy malnutrition

2.72

4.01

8.3

1.49

1.43

mg/l

0.21

Other conditions related to polyarteritis nodosa

4.77

3.99

1.8

2.3

1.27

1.53

mg/l

0.68

Non-selective monoamine reuptake inhibitors

605

4916

1.19

3.99

2.6

2.9

1.54

1.60

mg/l

1.13

528

4477

Intermittent heterotropia

134

938

1.45

3.98

15.1

11.6

1.26

1.22

mg/l

0.27

122

888

Viral agents as the cause of diseases classified to other chapters, including avohilmo

328

1.78

3.98

13.3

7.6

1.52

1.37

mg/l

0.64

301

Progressive systemic sclerosis

3.17

3.97

2.7

1.9

1.83

1.54

mg/l

0.69

Endometriosis of ovary

238

1716

1.31

3.97

3.0

2.9

1.34

1.46

mg/l

1.94

219

1575

Other/unspecified seropositive rheumatoid arthritis

409

3345

1.23

3.96

2.9

1.73

1.61

mg/l

1.86

368

3022

Migraine with aura

401

3270

1.23

3.96

5.0

4.2

1.26

1.33

mg/l

1.38

377

3047

Other misadventures during surgical and medical care

277

1.85

3.95

5.7

3.5

1.86

1.53

mg/l

1.67

248

Voice disturbances

438

3609

1.22

3.94

3.6

3.3

1.46

1.55

mg/l

1.60

390

3297

Benign neoplasm of major salivary glands

158

1141

1.40

3.94

3.5

2.9

1.62

mg/l

0.01

141

1033

Malignant neoplasm of brain, including Hilmo

504

1.61

3.93

14.5

4.5

1.29

1.53

mg/l

1.96

457

Need for immunization against other single infectious diseases

5.33

3.90

17.3

16.8

1.83

1.07

mg/l

1.69

Dislocation of lens

139

2.22

3.89

4.9

2.7

1.99

1.62

mg/l

1.49

129

Mixed and other personality disorders

136

960

1.43

3.88

2.9

3.2

1.53

1.35

mg/l

1.33

116

906

Other and unspecified urticaria

336

2700

1.25

3.86

6.7

5.7

1.41

1.39

mg/l

0.10

314

2507

Pleural plaque

151

1087

1.40

3.85

2.3

2.6

1.77

1.86

mg/l

0.69

136

932

Melanocytic naevi of other and unspecified parts of face

634

1.53

3.84

3.9

3.3

1.49

1.48

mg/l

0.01

580

Cerebral aneurysm, nonruptured

143

1022

1.42

3.81

4.2

3.0

1.55

1.54

mg/l

0.04

129

929

Benign neoplasm: salivary glands, exclude unknown (D119)

144

1031

1.41

3.80

3.5

2.9

1.59

1.60

mg/l

0.06

129

940

Dextrocardia

6.67

3.80

18.9

33.6

1.06

1.02

mg/l

—

Bullous pemphigoid

223

1.93

3.80

1.9

2.7

1.94

1.76

mg/l

0.72

193

Tonsillectomy and adenotomy

1077

6625

1.13

3.80

6.7

5.3

1.23

1.32

mg/l

4.26

1019

6260

Arthropathic psoriasis

190

1423

1.35

3.78

3.0

3.2

1.55

1.50

mg/l

0.29

167

1327

Periapical abscess

861

7534

1.15

3.75

3.9

1.50

1.49

mg/l

0.17

785

6966

Malignant neoplasm of bronchus and lung

261

1702

1.29

3.75

3.0

2.8

1.57

1.85

mg/l

6.22

245

1468

Leiomyosarcoma, including Hilmo

2.88

3.74

1.9

2.2

1.61

1.69

mg/l

0.18

Ovarian dysfunction

103

694

1.50

3.73

3.9

3.4

1.35

1.19

mg/l

1.63

641

Maternal care for other conditions predominantly related to pregnancy

283

2180

1.27

3.73

3.4

3.1

1.28

1.24

mg/l

0.48

263

2048

Perineal laceration during delivery

129

1465

0.71

3.72

2.2

3.5

1.09

1.25

mg/l

3.47

124

1378

Special screening examination for neoplasms

117

810

1.46

3.72

2.6

1.66

1.52

mg/l

0.89

109

730

Migraine without aura

330

2657

1.25

3.72

6.3

5.8

1.26

1.25

mg/l

0.07

316

2495

Giant cell arteritis

418

1.65

3.72

2.9

2.7

1.98

1.69

mg/l

1.39

371

Abnormal findings in secretions and smears from cervix uteri vagina vulva

712

4512

1.16

3.70

3.7

2.9

1.39

1.37

mg/l

0.35

677

4157

106

708

1.52

3.68

26.5

21.7

1.15

1.04

mg/l

2.23

106

697

Need for immunization against single bacterial diseases

2.80

3.66

18.7

21.0

1.47

1.18

mg/l

0.95

Scleritis and episcleritis

102

690

1.50

3.66

3.7

3.2

1.57

1.43

mg/l

0.92

639

Hypertrophy of tongue papillae

143

2.16

3.66

3.5

3.2

1.69

1.47

mg/l

0.47

128

Injuries to the wrist and hand

1979

11998

1.10

3.66

3.7

4.3

1.44

1.49

mg/l

2.45

1822

11065

Epilepsy

566

4796

1.18

3.64

5.5

5.6

1.54

1.48

mg/l

0.99

517

4430

Follow-up examination after treatment for malignant neoplasms

165

1217

1.37

3.64

3.1

2.5

1.75

1.68

mg/l

0.57

149

1054

HSIL lesion of the cervix uteri, vagina or vulva

274

2166

1.27

3.63

3.6

2.9

1.42

1.29

mg/l

1.92

261

2027

125

880

1.43

3.62

3.0

3.2

1.18

mg/l

0.01

120

831

Salpingitis and oophoritis

246

1921

1.29

3.62

3.5

2.8

1.49

1.45

mg/l

0.33

230

1752

Liposarcoma, including Hilmo

2.73

3.62

2.5

2.1

1.62

mg/l

0.01

Other and unspecified mood [affective] disorders

120

840

1.44

3.60

3.6

4.8

1.46

1.27

mg/l

1.49

114

788

Injury of intra-abdominal organs

308

1.76

3.60

4.7

4.6

1.65

1.40

mg/l

1.80

286

Wet age-related macular degeneration

263

1996

1.28

3.60

3.0

2.4

1.95

1.84

mg/l

1.18

223

1717

Any dementia, excluding more controls

420

3476

0.83

3.59

2.2

2.7

1.75

1.82

mg/l

0.80

347

3061

Superficial injury of hip and thigh

249

1950

1.29

3.57

3.5

1.65

1.61

mg/l

0.24

222

1745

Spinal stenosis

872

5634

1.14

3.56

2.7

2.9

1.69

1.64

mg/l

1.16

780

5101

Ptosis of eyelid

184

1386

1.34

3.55

3.3

3.4

1.53

1.65

mg/l

1.35

172

1250

Other sexually transmitted chlamydial diseases, including avohilmo

163

1205

1.36

3.55

3.7

4.0

1.14

1.16

mg/l

0.20

153

1130

Isolated patent ductus arteriosus

318

1.79

3.53

13.7

22.4

1.13

1.09

mg/l

0.19

312

Benign neoplasm: Stomach

154

1131

1.38

3.52

4.3

2.9

1.81

1.65

mg/l

1.38

142

1015

Mouth breathing

759

6609

1.15

3.52

5.9

5.1

1.47

1.48

mg/l

0.12

695

6162

Other disorders of penis

206

1581

1.32

3.48

6.2

6.4

1.57

1.48

mg/l

0.61

182

1467

Other specified/unspecified spondylopathies

259

1.81

3.48

2.1

2.9

1.94

1.75

mg/l

0.54

235

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

264

2090

1.27

3.48

3.7

3.4

1.32

1.33

mg/l

0.09

243

1946

Dermatographic urticaria

108

747

1.46

3.48

6.4

3.7

1.35

1.39

mg/l

0.20

696

Later onset COPD

443

2966

1.21

3.48

2.4

2.7

2.03

1.85

mg/l

3.26

384

2591

Car occupant injured in other and unspecified transport accidents

313

2530

1.25

3.45

4.1

3.8

1.55

1.42

mg/l

1.60

292

2355

Benign neoplasm: Parotid gland

129

925

1.41

3.42

3.7

2.9

1.61

mg/l

0.02

116

839

Congenital malformations of genital organs

174

1300

1.34

3.42

9.1

9.6

1.25

1.22

mg/l

0.35

166

1241

Status post-ami

395

2474

1.22

3.41

3.4

2.5

2.10

1.63

mg/l

15.91

356

2205

Malignant neoplasm of corpus uteri, including Hilmo

116

816

1.43

3.41

2.6

2.5

1.73

1.71

mg/l

0.07

704

Impacted cerumen

204

1570

1.31

3.40

5.6

4.9

1.67

1.60

mg/l

0.43

179

1426

Fall involving bed

398

1.64

3.39

3.7

6.7

1.90

1.65

mg/l

1.03

355

Paget disease

3.08

3.38

2.7

2.1

1.88

1.71

mg/l

0.33

Embedded and impacted teeth

484

3312

1.19

3.37

7.9

5.7

1.34

1.24

mg/l

2.50

462

3129

Amblyopia ex anopsia

680

1.48

3.37

16.0

12.1

1.39

1.27

mg/l

0.91

638

Raynaud syndrome

142

1038

1.38

3.36

2.2

3.4

1.30

1.46

mg/l

2.00

132

965

Sudden idiopathic hearing loss

162

1209

1.35

3.35

3.8

3.0

1.73

1.62

mg/l

0.67

143

1105

Hereditary hypogammaglobulinemia

3.24

3.35

23.1

4.7

1.64

1.33

mg/l

0.58

Primary angle-closure glaucoma

447

1.59

3.31

3.3

2.7

1.77

1.73

mg/l

0.12

392

Carcinoma in situ of other and unspecified digestive organs

520

1.54

3.29

3.2

2.9

1.63

1.68

mg/l

0.19

469

Fracture of neck

106

740

1.45

3.29

3.5

3.0

1.71

1.65

mg/l

0.25

662

Deep endometriosis

127

915

1.40

3.27

2.0

2.9

1.25

1.44

mg/l

3.06

115

832

Barrett oesophagus

585

1.51

3.27

2.8

3.1

1.73

1.62

mg/l

0.56

529

Male infertility

659

1.48

3.26

6.0

3.2

1.47

1.29

mg/l

0.93

623

Rare circulating lymphoid malignancy

2.99

3.26

15.8

4.7

1.49

1.96

mg/l

1.30

Other secondary gonarthrosis

635

1.49

3.24

5.2

3.0

1.65

1.58

mg/l

0.33

578

Mental retardation

126

905

1.41

3.24

12.9

16.5

1.13

1.18

mg/l

0.63

120

874

Eustachian salpingitis and obstruction

144

1063

1.37

3.22

5.4

4.0

1.38

1.27

mg/l

1.13

136

996

Benign leiomyoma with endometriosis

212

1652

1.29

3.22

3.0

2.8

1.59

1.53

mg/l

0.49

188

1498

Benign neoplasm: Descending colon

119

852

1.41

3.21

3.9

2.9

1.80

1.68

mg/l

0.79

105

771

Separation of retinal layers (serosa)

523

1.53

3.21

4.5

3.0

1.63

1.46

mg/l

0.89

485

Organ-limited amyloidosis

3.41

3.21

4.0

1.6

2.68

1.60

mg/l

1.89

Ascorbic acid deficiency

5.43

3.21

36.0

13.6

1.03

1.14

mg/l

—

Dermatophytosis, including avohilmo

1219

10780

1.11

3.19

3.4

3.7

1.51

1.50

mg/l

0.11

1121

9926

Nutritional and metabolic disorders in diseases classified elsewhere

8.31

3.17

50.1

23.0

1.44

0.93

mg/l

—

Arthropathy in hypersensitivity reactions classified elsewhere

4.98

3.17

12.7

11.2

0.93

1.15

mg/l

—

Hereditary sideroblastic anaemia

3.89

3.16

4.9

1.9

1.41

1.75

mg/l

0.75

therapeutic use

328

1.68

3.16

5.4

3.3

2.12

1.57

mg/l

3.42

294

Carbimazole or st.post thyroidectomy, condition for graves disease

322

2639

1.23

3.16

2.9

3.1

1.53

1.47

mg/l

0.72

302

2424

Hyperhidrosis

297

1.71

3.15

5.3

3.8

1.28

1.29

mg/l

0.02

269

Adenomyosis (Endometriosis of uterus)

189

1453

1.31

3.14

2.4

2.9

1.45

1.51

mg/l

0.53

171

1322

Acute nasopharyngitis (common cold)

222

1733

1.28

3.14

4.6

3.6

1.45

1.36

mg/l

0.79

210

1633

Factitial dermatitis

2.82

3.14

3.1

3.6

1.72

1.39

mg/l

0.73

Injury of eye and orbit

261

2094

1.26

3.14

4.7

4.2

1.41

1.43

mg/l

0.21

242

1957

Retinal breaks without detachment

258

2067

1.26

3.14

3.5

2.8

1.60

1.56

mg/l

0.27

235

1896

Familial hypercholesterolemia, with ischemic heart disease

136

1000

1.37

3.13

3.9

2.5

1.99

1.70

mg/l

3.66

125

878

Rheumatism, unspecified

195

1510

1.30

3.12

2.5

2.8

1.55

1.49

mg/l

0.43

170

1378

Childhood allergy (age < 16)

290

1937

1.24

3.11

9.9

11.0

1.12

mg/l

0.02

279

1861

Other epidermal thickening

535

1.52

3.11

5.3

5.2

1.88

1.51

mg/l

2.43

488

Smoking dependency

147

1096

1.35

3.10

3.1

1.68

1.52

mg/l

1.45

140

1019

Acute myeloid leukaemia, helper endpoint

106

2.23

3.07

6.7

5.0

1.31

1.70

mg/l

2.28

Acute myeloid leukaemia, including Hilmo

106

2.23

3.07

6.7

5.0

1.31

1.70

mg/l

2.28

Acute myeloid leukaemia

106

2.23

3.07

6.7

5.0

1.31

1.70

mg/l

2.28

Anisometropia and aniseikonia

425

1.58

3.06

14.8

7.7

1.38

1.36

mg/l

0.08

389

Mental and behavioural disorders due to tobacco

147

1099

1.35

3.05

3.1

3.0

1.68

1.52

mg/l

1.45

140

1022

Family history of certain disabilities and chronic diseases leading to disablement

464

1.55

3.05

3.1

2.7

1.15

1.20

mg/l

0.34

426

Single delivery by forceps and vacuum extractor

138

1109

0.74

3.04

2.1

3.9

1.07

1.31

mg/l

5.81

127

1039

Other, unspecified and serous retinal detachments

355

1.63

3.03

4.1

3.4

1.62

1.67

mg/l

0.19

325

Propionic acid derivatives

502

2958

0.85

3.03

4.1

6.9

1.45

1.62

mg/l

4.57

454

2759

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

700

6061

1.14

3.02

4.3

4.9

1.34

1.33

mg/l

0.07

652

5682

Other and unspecified visual disturbances

172

1318

1.32

3.01

2.5

3.7

1.51

mg/l

0.03

156

1206

Normotensive glaucoma

133

984

1.37

2.97

3.0

2.7

1.72

1.74

mg/l

0.05

118

865

Heterophoria

141

1053

1.35

2.96

8.9

7.6

1.39

1.34

mg/l

0.29

129

989

Aggressive periodontitis

258

1.74

2.96

2.7

3.0

1.45

1.53

mg/l

0.31

234

Sequelae of cerebrovascular disease

588

4355

1.16

2.95

3.5

2.8

1.93

1.71

mg/l

6.04

524

3886

Pediculosis, acariasis and other infestations, including avohilmo

314

2588

1.22

2.94

5.4

5.6

1.48

1.33

mg/l

2.06

294

2440

Assault

242

1941

1.26

2.94

4.1

4.0

1.45

1.34

mg/l

1.28

229

1832

Nosocomial condition (hospital)

2.61

2.94

4.9

2.3

1.90

1.53

mg/l

0.79

Colorectal cancer

325

2576

1.22

2.93

2.9

2.6

1.86

1.78

mg/l

0.82

290

2252

Endometriosis ASRM stages 3,4

308

2534

1.22

2.93

2.7

2.8

1.33

1.43

mg/l

1.85

282

2319

Myocardial infarction, unclassifiable

333

2463

1.21

2.92

3.7

2.6

2.11

1.81

mg/l

6.08

304

2163

Endometriosis of rectovaginal septum and vagina

106

758

1.41

2.90

1.9

2.9

1.28

1.50

mg/l

3.34

699

Other arthrosis

880

5245

1.13

2.90

3.1

2.8

1.61

1.47

mg/l

4.76

801

4799

Malignant neoplasm of rectum, including Hilmo

162

1240

1.32

2.86

2.5

2.7

1.82

1.79

mg/l

0.19

146

1073

Non-small cell lung cancer, adenocarcinoma

586

1.47

2.85

2.9

2.7

1.59

1.83

mg/l

1.97

506

Other congenital malformations of limb(s)

124

2.10

2.85

14.3

15.8

1.12

1.09

mg/l

0.12

118

Scabies, including avohilmo

267

2174

1.24

2.84

5.5

6.0

1.45

1.30

mg/l

1.77

249

2061

Enthesopathies of lower limb, excluding foot

389

3284

1.19

2.83

3.5

3.4

1.43

1.47

mg/l

0.56

350

3042

Fracture of forearm

993

8020

1.12

2.82

4.5

4.2

1.54

1.47

mg/l

1.91

907

7351

Alcohol abuse, main dg, excluding more controls

253

2050

1.24

2.82

4.0

3.4

1.55

1.46

mg/l

0.91

233

1918

Fall on same level involving ice and snow

1039

9368

1.11

2.82

3.9

3.6

1.57

1.51

mg/l

1.33

946

8569

Acute gastritis

112

814

1.39

2.81

3.2

3.1

1.82

1.59

mg/l

1.70

102

728

Maternal care related to the fetus and amniotic cavity and possible delivery problems

470

3216

0.85

2.79

2.7

3.4

1.23

1.35

mg/l

3.94

445

2985

Endometriosis ASRM stages 1,2

237

1908

1.25

2.79

2.4

3.0

1.24

1.35

mg/l

1.88

220

1765

Sequelae of injuries, of poisoning and of other consequences of external causes

401

3399

1.19

2.79

3.0

3.4

1.49

mg/l

0.03

368

3153

Benign neoplasm: Skin of lower limb, including hip

309

1.65

2.78

8.4

3.1

1.79

1.52

mg/l

1.43

278

Diplopia

212

1688

1.27

2.77

3.5

3.6

1.51

1.56

mg/l

0.40

186

1540

Fibromyalgia

133

995

1.35

2.77

2.8

1.29

1.35

mg/l

0.73

123

919

Haemangioma, any site

142

1074

1.33

2.76

5.6

5.1

1.44

1.48

mg/l

0.23

133

992

Other and unspecified injuries of lower leg

135

1014

1.34

2.76

3.7

5.2

1.46

1.38

mg/l

0.49

122

947

Anaemia due to enzyme disorders

5.48

2.74

9.7

14.7

1.02

1.40

mg/l

—

Traumatic subdural haemorrhage

211

1570

1.26

2.74

4.5

2.8

1.99

1.71

mg/l

3.36

183

1419

Artificial joint operation, meniscal resection

1649

9707

1.09

2.74

2.7

3.1

1.59

1.57

mg/l

0.47

1486

8884

Benign neoplasm of bone and articular cartilage

136

1024

1.34

2.73

4.2

4.0

1.34

1.46

mg/l

1.27

127

952

Melanoma of uvea

112

2.12

2.73

3.3

2.6

1.83

1.62

mg/l

0.47

Benign neoplasm: Sigmoid colon

307

2548

1.21

2.72

3.3

2.8

1.75

1.67

mg/l

0.77

286

2292

Diabetes mellitus in pregnancy

430

2322

1.18

2.72

3.6

3.2

1.41

1.21

mg/l

6.71

404

2188

Mental retardation, wide definition

126

935

1.36

2.71

12.9

16.0

1.13

1.20

mg/l

0.92

120

902

Cluster headache, wide

430

1.53

2.70

2.6

3.2

1.26

1.36

mg/l

0.44

395

Perforation of oesophagus

2.67

2.68

4.6

2.3

1.40

1.68

mg/l

0.61

Fibroblastic disorders

380

3219

1.19

2.68

3.4

2.8

1.65

1.61

mg/l

0.42

350

2917

Pituitary-dependent Cushing's disease

3.55

2.67

2.5

2.3

1.83

1.49

mg/l

—

Severe visual impairment, monocular

113

2.10

2.67

2.6

3.4

1.70

1.54

mg/l

0.38

101

Brain meningioma, including Hilmo

439

1.52

2.66

2.7

1.55

1.71

mg/l

0.72

388

Psoriasis (vulgaris), strict definition

440

1.52

2.66

2.8

3.1

1.37

1.42

mg/l

0.24

408

Liposarcoma

2.73

2.66

3.1

2.1

1.67

1.59

mg/l

0.12

Parkinson's disease, strict definition

134

1761

0.76

2.66

2.0

2.6

1.47

1.78

mg/l

5.61

116

1552

Congenital malformations of eye, ear, face and neck

128

961

1.35

2.65

9.8

10.2

1.37

1.26

mg/l

0.93

120

911

Melanocytic naevi of scalp and neck

259

1.69

2.65

6.7

3.9

1.50

1.43

mg/l

0.31

231

Interstitial emphysema and related conditions originating in the perinatal period

2.84

2.64

38.3

18.0

1.34

1.01

mg/l

1.42

Other/unspecified reactive arthropathies

106

773

1.39

2.64

3.7

4.4

1.52

1.48

mg/l

0.17

711

Persistent mood disorders

297

2465

1.21

2.63

3.6

3.1

1.56

1.46

mg/l

1.20

273

2251

Abnormal involuntary movements

224

1807

1.25

2.63

4.0

4.2

1.52

1.54

mg/l

0.10

203

1667

Bronchitis, not specified as acute or chronic

136

1030

1.33

2.63

3.4

3.3

1.55

1.51

mg/l

0.23

122

945

Multiple delivery

983

0.68

2.63

2.5

3.6

1.31

1.45

mg/l

0.88

910

Benign neoplasm: Conjunctiva

369

1.57

2.63

4.0

3.5

1.57

1.52

mg/l

0.17

332

Malignant neoplasm of breast, HER-negative

226

1750

1.25

2.62

2.3

2.6

1.47

1.61

mg/l

2.17

201

1536

Tobacco use

639

1.43

2.62

4.1

3.0

1.74

1.50

mg/l

1.67

583

Other specified/unspecified soft tissue disorders

474

1.49

2.60

4.1

2.6

1.63

1.57

mg/l

0.21

425

Malignant neoplasm of other endocrine glands and related structures, including Hilmo

2.99

2.60

5.5

1.9

1.40

1.33

mg/l

0.11

Parkinson's disease

148

1913

0.77

2.60

2.1

2.7

1.55

1.78

mg/l

2.93

130

1693

Polyarthritis, unspecified

394

1.54

2.59

3.9

3.8

1.75

1.45

mg/l

1.88

360

Other disorders of the musculoskeletal system and connective tissue

232

1883

1.24

2.58

3.1

1.61

1.58

mg/l

0.22

206

1717

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

468

1.50

2.57

3.1

3.4

1.50

1.61

mg/l

0.50

427

Benign thyroid growths and nodules

470

3773

1.16

2.57

2.9

1.65

1.57

mg/l

1.24

420

3397

Follicular cysts of skin and subcutaneous tissue

300

2501

1.21

2.56

4.3

3.4

1.57

1.52

mg/l

0.43

288

2297

Entropion and trichiasis of eyelid

127

957

1.34

2.56

3.0

2.8

1.94

1.79

mg/l

1.02

111

831

Other noninflammatory disorders of uterus, except cervix

296

1635

1.21

2.56

3.2

2.9

1.66

1.57

mg/l

1.09

273

1482

Short Achilles tendon (acquired)

301

0.43

2.55

1.7

2.6

1.78

1.43

mg/l

0.48

280

Dementia

547

4277

0.87

2.55

2.2

2.8

1.71

1.81

mg/l

2.10

451

3801

Use of levodopa decarboxylase inhibitor

133

1738

0.76

2.55

2.3

2.7

1.51

1.79

mg/l

4.59

114

1528

Oxicams

325

2200

0.83

2.53

2.0

4.2

1.52

1.80

mg/l

6.86

296

2020

Shoulder lesions

1342

7363

1.09

2.53

3.0

1.58

1.52

mg/l

1.64

1225

6763

Memory loss

1046

0.69

2.53

3.1

2.6

1.42

1.73

mg/l

3.74

934

Postmenopausal bleeding

367

1618

1.19

2.53

2.5

2.9

1.57

1.58

mg/l

0.09

334

1467

Other erythematous conditions

405

1.53

2.52

6.4

4.8

1.66

1.49

mg/l

0.71

371

Leukaemia of unspecified cell type

109

2.09

2.52

29.4

4.9

1.20

1.50

mg/l

1.55

Pleural plaque with presence of asbestos

112

831

1.36

2.52

2.5

2.6

1.76

1.93

mg/l

1.21

717

Monoamine oxidase A inhibitors

178

1407

1.27

2.51

3.0

2.9

1.54

1.56

mg/l

0.10

160

1288

Supernumerary ureter

3.68

2.50

2.0

20.1

1.29

1.15

mg/l

—

Glycogen storage disease

7.40

2.48

5.0

40.1

1.85

1.34

mg/l

—

Other/unspecified synovitis and tenosynovitis

178

1409

1.27

2.48

4.2

3.1

1.66

1.47

mg/l

2.21

163

1290

Leiomyosarcoma

2.63

2.48

1.8

2.3

1.69

1.77

mg/l

0.15

Malignant neoplasm of eye, brain and central nervous system

472

1.48

2.47

14.2

4.6

1.13

1.53

mg/l

5.37

427

Tick-borne viral encephalitis

0.00

2.46

0.0

3.8

—

1.49

—

Temporal arteritis

367

1.55

2.46

3.3

2.6

1.93

1.68

mg/l

1.17

323

Pain in thoracic spine

253

2084

1.22

2.46

3.6

3.4

1.51

1.47

mg/l

0.30

231

1925

Parkinson's disease, including avohilmo

157

1998

0.78

2.45

2.1

2.7

1.52

1.77

mg/l

3.57

138

1770

Arteriovenous malformation of peripheral vessels

2.45

6.1

7.8

1.33

1.26

mg/l

0.14

Allergic urticaria

139

1069

1.31

2.45

7.8

6.4

1.46

1.35

mg/l

0.86

133

1003

!Aliquae complicationes praecoces traumatis

573

1.43

2.44

4.6

3.6

1.80

1.51

mg/l

1.85

524

Early complications of trauma

573

1.43

2.44

4.6

3.6

1.80

1.51

mg/l

1.85

524

Viral meningitis

400

1.52

2.44

3.5

3.2

1.33

1.37

mg/l

0.13

369

Sequelae of other and unspecified infectious and parasitic diseases

640

1.41

2.44

4.3

3.0

1.61

1.39

mg/l

1.35

598

Carcinoma in situ, bladder

433

1.50

2.44

2.7

2.8

1.77

1.79

mg/l

0.06

374

Episcleritis

598

1.42

2.43

4.1

3.3

1.56

1.43

mg/l

0.82

551

Malignant neoplasm of corpus uteri

101

742

1.37

2.41

2.5

1.70

1.73

mg/l

0.11

636

Calculus of lower urinary tract

616

1.41

2.41

3.3

2.9

1.60

1.73

mg/l

0.87

545

Other and unspecified mononeuropathies, also in other diseases

337

1.57

2.41

4.5

2.9

1.89

1.60

mg/l

1.15

303

Atopic dermatitis

1073

7779

1.10

2.41

4.9

4.6

1.35

1.37

mg/l

0.39

1009

7264

Thyrotoxicosis with toxic multinodular goitre

625

1.41

2.40

2.5

3.0

1.68

1.60

mg/l

0.40

563

Malignant neoplasm of pancreas, including Hilmo

111

829

1.35

2.39

2.7

2.6

1.57

1.82

mg/l

2.81

103

722

Dislocation, sprain and strain of joints and ligaments of knee

1093

9016

1.10

2.38

2.9

3.6

1.35

1.43

mg/l

3.23

1016

8371

Haemangioma and lymphangioma, any site

151

1179

1.29

2.38

5.8

5.1

1.45

1.47

mg/l

0.12

142

1093

Left hemicolectomy

252

1.66

2.38

2.5

3.2

1.72

1.71

mg/l

0.03

226

Spontaneous rupture of synovium and tendon

131

1004

1.32

2.37

3.3

2.7

1.69

1.56

mg/l

0.86

116

911

Ocular pain

138

1066

1.31

2.36

7.0

5.1

1.41

1.42

mg/l

0.03

130

988

Sequelae of other and unspecified infectious and parasitic diseases, including avohilmo

644

1.40

2.36

4.3

3.0

1.61

1.40

mg/l

1.33

602

Assault by other specified means

112

2.02

2.35

3.5

1.15

1.25

mg/l

0.46

104

Alzheimer’s disease (Late onset), excluding more controls

140

1172

0.77

2.34

2.0

2.7

1.66

1.81

mg/l

1.27

114

1046

Injury of blood vessels at lower leg level

2.67

2.32

2.5

3.5

1.97

1.54

mg/l

0.62

Sleep disorders, other/unspecified

421

1.49

2.32

4.0

5.0

1.30

1.33

mg/l

0.19

387

Exposure to other and unspecified inanimate mechanical forces

140

1087

1.30

2.32

6.2

5.8

1.61

1.38

mg/l

1.98

131

1013

Viral encephalitis, not elsewhere classified/unspecified, including avohilmo

231

1.68

2.30

7.9

4.5

1.53

1.49

mg/l

0.12

206

Oesophageal obstruction

374

1.52

2.28

3.2

2.6

1.64

1.74

mg/l

0.33

328

LSIL lesion of the cervix uteri, vagina or vulva

184

1479

1.25

2.28

4.0

2.8

1.40

1.32

mg/l

0.87

174

1380

Contusion of other and unspecified parts of foot

717

1.37

2.27

5.6

7.3

1.34

1.28

mg/l

0.30

672

Other diseases of peritoneum

456

1.46

2.27

2.6

3.1

1.62

1.59

mg/l

0.08

415

Other female pelvic inflammatory diseases

208

1695

1.23

2.27

2.9

2.8

1.48

1.45

mg/l

0.19

183

1548

Other sexually transmitted chlamydial diseases

708

1.37

2.27

3.3

3.5

1.17

1.18

mg/l

0.09

664

Necrosis of pulp, including avohilmo

1050

9481

1.10

2.27

3.4

3.6

1.51

1.45

mg/l

1.59

951

8818

Pustulosis palmaris et plantaris

448

1.47

2.27

3.0

3.2

1.62

1.50

mg/l

0.50

412

Impacted teeth

343

2509

1.18

2.26

8.8

5.9

1.29

1.21

mg/l

1.44

327

2371

Neurofibromatosis, type 1

2.27

2.26

5.8

5.5

1.24

1.29

mg/l

0.21

Vulvovaginal ulceration/inflammation in other diseases

692

1.37

2.25

6.3

3.7

1.50

1.30

mg/l

1.19

648

Heartburn

172

1375

1.26

2.24

3.4

3.2

1.61

1.47

mg/l

1.16

162

1262

Other enthesopathy of foot (+metatarsalgia)

157

1242

1.27

2.24

3.3

3.4

1.48

1.45

mg/l

0.22

146

1141

Abrasion of teeth

583

5173

1.13

2.23

3.2

3.1

1.42

1.50

mg/l

1.66

546

4743

Palatinal maxillary operation

166

1.81

2.23

21.7

16.5

1.14

1.04

mg/l

0.48

161

Malignant neoplasm of colon, including Hilmo

242

1999

1.21

2.21

3.1

2.6

1.86

1.80

mg/l

0.42

217

1727

Allergic contact dermatitis

197

1602

1.24

2.21

2.8

3.7

1.36

1.39

mg/l

0.28

178

1483

Giant cell arteritis with polymyalgia rheumatica

377

1.51

2.21

3.3

2.7

1.93

1.71

mg/l

0.97

330

Glaucoma-related operations

610

1.39

2.20

2.8

2.9

1.63

1.70

mg/l

0.30

535

Other conditions originating in the perinatal period

3.26

2.19

38.4

30.2

2.33

1.16

mg/l

—

Other benign neoplasm of uterus: Other parts/unspecified

337

1.53

2.19

2.1

2.3

1.81

1.65

mg/l

0.72

283

Schizophrenia or delusion, excluding more controls

493

4279

1.14

2.18

3.2

3.0

1.50

1.42

mg/l

1.30

454

3967

Premature rupture of membranes

195

1703

0.81

2.18

2.5

3.2

1.15

1.28

mg/l

2.93

184

1596

Inguinal hernia

1116

6798

1.09

2.17

4.6

3.8

1.59

1.53

mg/l

1.46

1020

6261

Sequelae of infectious and parasitic diseases

110

835

1.33

2.17

4.1

2.9

1.71

1.52

mg/l

1.20

103

762

Status epilepticus

437

1.46

2.15

6.4

5.9

1.72

1.46

mg/l

1.12

394

Malignant neoplasm of colon

199

1625

1.23

2.15

3.1

2.7

1.89

1.81

mg/l

0.49

176

1398

Trigeminal neuralgia

656

1.37

2.14

2.3

3.0

1.52

1.53

mg/l

0.03

598

Benign neoplasm: Small intestine

446

1.45

2.13

3.8

3.1

1.75

1.63

mg/l

0.46

403

Malignant neoplasm of other and ill-defined sites, including Hilmo

116

1.93

2.13

3.6

3.9

1.52

1.72

mg/l

0.42

Acute alcohol intoxication, ICD10

349

3002

1.17

2.13

3.7

1.56

1.49

mg/l

0.85

323

2802

Supervision of normal pregnancy

199

1390

0.81

2.12

2.3

3.7

1.10

1.29

mg/l

5.98

187

1306

Superficial injury of forearm

172

1386

1.25

2.12

4.2

5.6

1.42

1.39

mg/l

0.20

157

1291

Other and unspecified injuries of ankle and foot

564

1.40

2.12

6.3

6.9

1.48

1.29

mg/l

1.03

524

Metatarsalgia

145

1146

1.27

2.11

3.2

3.4

1.47

1.45

mg/l

0.09

135

1052

Other symptoms and signs involving general sensations and perceptions

514

1.42

2.11

4.4

4.9

1.38

1.53

mg/l

1.03

468

Ankylosis of teeth

2.83

2.10

8.8

3.2

1.70

1.42

mg/l

—

Dysplasia of cervi uteri

306

1826

1.18

2.09

3.7

3.0

1.37

1.41

mg/l

0.32

291

1696

Benign neoplasm: Other parts of oropharynx

2.04

2.09

3.5

2.5

1.34

1.48

mg/l

0.39

Cluster headache, strict

398

1.47

2.09

2.6

3.2

1.21

1.34

mg/l

0.60

365

Other nonautoimmune haemolytic anaemias

3.33

2.08

2.9

2.2

1.70

1.57

mg/l

—

Asthma/COPD (KELA code 203)

1806

11287

1.07

2.08

3.7

4.4

1.51

1.46

mg/l

1.56

1644

10433

Other disorders of the genitourinary system

175

1417

1.24

2.07

3.2

3.0

1.70

1.61

mg/l

0.62

158

1276

Alcohol dependence

455

3998

1.14

2.07

3.4

3.0

1.62

1.57

mg/l

0.71

420

3691

Somnolence, stupor and coma

500

1.42

2.05

5.0

4.1

1.72

1.61

mg/l

0.51

450

Non-small cell lung cancer, squamous

400

1.46

2.03

2.8

2.5

1.43

1.93

mg/l

4.88

339

Other and unspecified abdominal hernia

476

1.42

2.03

6.3

3.3

1.76

1.61

mg/l

0.54

424

Female infertility, cervical, vaginal, other or unspecified origin

338

1854

1.17

2.02

2.9

3.0

1.28

1.40

mg/l

2.71

312

1722

Pectus carinatum, including avohilmo

3.24

2.01

14.8

10.1

1.40

1.08

mg/l

—

FESS (DNB20)

196

1612

1.22

2.01

3.0

3.3

1.39

1.47

mg/l

0.68

173

1502

Sciatica+with lumbago

898

7258

1.10

2.01

2.8

3.1

1.52

1.51

mg/l

0.01

808

6679

Pustular psoriasis

519

1.40

2.00

2.9

3.5

1.62

1.53

mg/l

0.41

480

Psoriatic arthropathies, ICD10

161

1298

1.25

2.00

2.6

3.1

1.50

mg/l

0.03

143

1213

Ethmoidectomy

203

1679

1.22

1.97

3.0

3.3

1.40

1.47

mg/l

0.64

180

1563

Superficial injury of wrist and hand

373

3246

1.15

1.97

4.6

5.9

1.39

1.37

mg/l

0.19

347

3038

Other psoriatic arthropathies

157

1265

1.25

1.97

2.6

3.1

1.51

1.49

mg/l

0.12

140

1181

Early lumbar disc prolapse operation

111

1426

0.77

1.96

3.4

3.2

1.30

mg/l

0.02

102

1359

Impingement syndrome of shoulder

281

3288

0.85

1.95

2.9

3.0

1.59

1.55

mg/l

0.35

252

3009

Event of undetermined intent

111

859

1.30

1.95

2.9

4.9

1.45

1.37

mg/l

0.56

100

793

Female infertility

365

1893

1.16

1.94

3.0

1.31

1.40

mg/l

1.88

336

1754

Other bursopathies

203

1683

1.21

1.93

3.2

3.0

1.69

1.56

mg/l

1.25

179

1524

Sequelae of infectious and parasitic diseases, including avohilmo

110

851

1.30

1.93

4.1

2.9

1.71

1.52

mg/l

1.20

103

777

Psychotic depression

686

1.34

1.92

3.2

3.7

1.51

1.46

mg/l

0.24

639

False labour

295

2138

0.85

1.91

2.3

3.6

1.08

1.28

mg/l

8.92

278

2006

Secondary sideroblastic anaemia

3.32

1.91

3.0

2.3

2.46

1.62

mg/l

—

Pilonidal cyst

141

1127

1.26

1.91

3.4

3.8

1.54

1.31

mg/l

2.06

129

1058

Inguinal or femoral hernia, bilateral

182

1496

1.23

1.90

5.0

3.3

1.73

1.70

mg/l

0.18

169

1361

Endometriosis of intestine

121

1.84

1.90

2.6

3.3

1.25

1.23

mg/l

0.03

114

Carcinoma in situ of prostate

2.31

1.90

2.8

1.56

1.65

mg/l

0.18

Unspecified/other endometriosis

117

895

1.29

1.89

2.7

3.2

1.25

1.29

mg/l

0.26

108

832

Dementia, including avohilmo

605

4590

0.90

1.89

2.3

2.8

1.72

1.81

mg/l

1.62

499

4098

Colorectal adenocarcinoma

265

2224

1.18

1.89

2.6

2.7

1.88

1.80

mg/l

0.67

235

1932

L02BB Anti-androgens

1136

0.75

1.88

2.5

2.6

1.99

1.91

mg/l

0.30

989

Lesion of ulnar nerve

225

1890

1.20

1.87

3.0

3.1

1.73

1.52

mg/l

2.32

203

1752

Colon adenocarcinoma

157

1272

1.24

1.87

2.6

1.91

1.83

mg/l

0.42

137

1092

Other orthopaedic follow-up care

551

1.37

1.87

3.7

2.8

1.73

1.38

mg/l

2.74

500

Delivery, wide proxy

378

2298

0.87

1.86

2.7

3.5

1.42

1.51

mg/l

1.80

343

2055

Torsion of ovary, ovarian pedicle and fallopian tube

196

0.45

1.86

1.4

3.3

1.23

1.33

mg/l

—

185

Viral encephalitis, not elsewhere classified/unspecified

230

1.59

1.85

7.9

4.5

1.55

1.49

mg/l

0.19

206

Malignant neoplasm of penis

2.67

1.83

2.2

2.4

1.71

1.84

mg/l

—

Carcinoma in situ of other and unspecified sites

469

1.40

1.83

2.6

2.8

1.77

1.80

mg/l

0.11

403

Assault by bodily force

132

1053

1.26

1.83

3.5

4.1

1.45

1.32

mg/l

1.14

124

993

Obstructed labour due to malposition and malpresentation of fetus

211

2328

0.84

1.83

2.5

3.3

1.28

1.29

mg/l

0.13

203

2188

Speech therapy

410

3613

1.14

1.83

4.8

3.6

1.59

1.58

mg/l

0.12

366

3291

Shigellosis

2.88

1.82

2.3

2.2

1.56

1.41

mg/l

—

Varicose veins of other sites

105

815

1.30

1.82

3.6

1.35

1.46

mg/l

1.03

748

Maternal care for known or suspected fetal abnormality and damage

206

1456

1.20

1.80

3.0

3.2

1.20

1.27

mg/l

1.13

201

1379

Antenatal screening

217

1447

0.84

1.79

2.5

3.8

1.16

1.29

mg/l

2.91

208

1360

Overexertion and strenuous or repetitive movements

157

1281

1.23

1.79

3.0

3.4

1.39

1.46

mg/l

0.55

151

1195

Injury of muscle and tendon at lower leg level

256

2186

1.18

1.78

3.5

3.2

1.55

1.53

mg/l

0.17

241

2026

Other/unspecified enthesopathies of lower limb, excluding foot

119

942

1.27

1.77

4.1

3.5

1.31

1.44

mg/l

1.62

110

882

Carcinoma in situ of vagina

2.29

1.77

4.7

2.9

2.21

1.31

mg/l

1.24

Conditions involving the integument and temperature regulation of fetus and newborn

2.93

1.76

18.1

22.1

1.10

1.13

mg/l

—

Other and unspecified firearm discharge, undetermined intent

4.18

1.76

2.0

4.2

1.18

1.38

mg/l

—

Malignant neoplasm of lip

2.27

1.76

2.4

1.9

1.94

2.02

mg/l

0.09

Other infective otitis externa

741

1.31

1.75

5.3

3.9

1.58

1.50

mg/l

0.35

680

Gluteal tendinitis

499

1.38

1.74

2.9

3.1

1.47

1.49

mg/l

0.06

462

Maternal infectious and parasitic diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

155

1.70

1.74

2.1

3.1

0.94

1.21

mg/l

3.97

145

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

108

847

1.29

1.74

4.0

5.5

1.38

mg/l

0.01

787

Pyoderma

210

1.60

1.73

10.2

5.1

1.65

1.51

mg/l

0.28

190

Schizophrenia

187

2237

0.83

1.73

2.7

3.2

1.57

1.43

mg/l

1.31

173

2094

Sleep disorders

1663

10762

1.07

1.73

2.8

3.6

1.37

1.50

mg/l

10.54

1533

9912

Unspecified mental disorder

667

6061

1.10

1.73

3.0

3.2

1.49

1.44

mg/l

0.90

607

5617

Long labour

233

2320

0.85

1.72

2.4

3.2

1.28

1.30

mg/l

0.12

218

2169

Acute alcohol intoxication

432

3837

1.13

1.72

3.7

3.5

1.62

1.55

mg/l

0.85

403

3541

Injuries to the neck

373

3283

1.14

1.72

2.9

3.9

1.46

1.45

mg/l

0.06

346

3049

Inguinal hernia, bilateral

178

1478

1.21

1.72

5.0

3.3

1.72

1.70

mg/l

0.08

165

1346

Epidermolysis bullosa

3.05

1.71

6.1

22.9

1.24

1.30

mg/l

—

Right hemicolectomy

639

1.33

1.71

3.6

2.9

1.92

1.69

mg/l

1.19

567

Other bursitis of elbow

1.90

1.69

4.0

2.7

1.64

1.62

mg/l

0.04

Other conditions of integument specific to fetus and newborn

3.15

1.69

11.4

24.7

1.06

1.19

mg/l

—

Juvenile Open Angle Glaucoma

2.17

1.69

7.5

2.7

1.67

1.39

mg/l

0.58

Other trisomies and partial trisomies of the autosomes, not elsewhere classified

2.79

1.68

16.6

20.8

1.53

1.15

mg/l

—

Obstructed labour due to maternal pelvic abnormality

137

1683

0.81

1.68

2.7

3.1

1.40

1.45

mg/l

0.32

124

1549

Bell's palsy

183

1527

1.21

1.68

4.8

3.5

1.60

1.51

mg/l

0.67

161

1403

Other benign neoplasms of uterus

477

1.37

1.67

2.1

2.4

1.73

1.63

mg/l

0.44

414

Inflammatory diseases of prostate (prostatitis)

210

1776

1.19

1.66

2.9

1.62

mg/l

0.02

187

1624

Postmenopausal atrophic vaginitis

350

1666

1.15

1.66

2.9

1.44

1.56

mg/l

1.96

309

1514

Infections specific to the perinatal period

372

1.45

1.66

19.1

22.0

1.16

1.05

mg/l

0.82

367

Other salmonella infections

402

1.41

1.65

4.5

3.2

1.63

1.49

mg/l

0.47

366

Appendectomy

1115

9873

1.08

1.65

3.6

3.3

1.49

1.46

mg/l

0.74

1043

9117

Preterm labour and delivery

329

2880

1.15

1.65

3.3

3.1

1.43

1.40

mg/l

0.36

308

2660

Perforation of tympanic membrane

151

1240

1.23

1.64

5.6

4.3

1.47

1.48

mg/l

0.07

144

1135

Arthropathy in Crohn disease

113

1.81

1.63

3.4

3.2

1.32

1.39

mg/l

0.19

102

Benign neoplasm: Appendix

113

1.81

1.63

4.2

2.8

1.65

1.58

mg/l

0.20

HSIL lesion of the cervix uteri

227

1935

1.18

1.63

3.6

2.9

1.38

1.27

mg/l

1.24

217

1817

Unspecified urinary incontinence

122

980

1.25

1.63

4.2

1.69

1.55

mg/l

0.85

106

882

Benign neoplasm: Floor of mouth

2.43

1.63

4.1

2.5

1.29

1.49

mg/l

—

Unspecified lump in breast

203

1715

1.19

1.63

2.7

2.8

1.37

1.47

mg/l

1.31

191

1555

Benign neoplasm: Skin of eyelid, including canthus

223

1901

1.18

1.61

3.1

2.9

1.57

1.63

mg/l

0.52

212

1710

Malignant neoplasm of brain

362

1.42

1.61

15.6

4.5

1.17

1.54

mg/l

3.05

327

Enterobiasis

2.19

1.59

3.2

14.7

1.20

1.29

mg/l

0.18

Livedoid vasculitis

2.36

1.59

4.0

2.2

1.58

1.72

mg/l

—

Medical abortion

897

4475

1.09

1.59

2.9

3.1

1.41

1.44

mg/l

0.50

822

4080

Bus occupant injured in other and unspecified transport accidents

1.94

1.58

3.2

2.1

1.56

1.36

mg/l

0.64

Contusion of toe(s) without damage to nail

347

1.43

1.58

4.1

5.9

1.29

1.24

mg/l

0.19

321

Intracerebral haemorrhage

183

1537

1.20

1.58

6.3

3.0

1.77

1.75

mg/l

0.10

169

1342

Early lumbar disc prolapse, operated

107

1337

0.80

1.56

3.2

3.1

1.30

1.28

mg/l

0.11

1276

Benign neoplasm: Long bones of lower limb

390

1.40

1.56

6.2

3.5

1.30

1.40

mg/l

0.54

357

Complications of labour and delivery

728

4412

0.91

1.55

2.7

3.2

1.34

1.42

mg/l

2.37

673

4053

Other puerperal infections

719

1.29

1.55

2.9

3.0

1.17

1.22

mg/l

0.35

672

Excessive vomiting in pregnancy

781

1.27

1.55

3.6

3.0

1.40

1.26

mg/l

1.10

727

All dysplastic lesions of the cervix uteri

328

2840

1.14

1.54

3.9

2.9

1.39

1.29

mg/l

1.59

314

2645

Polyp of the female genital tract

393

1972

1.13

1.53

3.1

3.0

1.55

1.50

mg/l

0.53

360

1800

108

1.80

1.53

8.1

4.4

1.79

1.22

mg/l

0.97

Inflammatory disease of uterus

174

1460

1.20

1.52

2.5

3.0

1.33

1.35

mg/l

0.09

161

1357

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

514

4649

1.11

1.52

3.3

1.48

1.49

mg/l

0.11

470

4291

Disorders of synovium and tendon in diseases classified elsewhere

242

1.51

1.52

4.3

3.2

1.82

1.55

mg/l

0.91

222

Benign neoplasm: Connective and other soft tissue of trunk, unspecified

2.06

1.52

1.4

2.8

1.36

1.50

mg/l

0.34

Toxic colitis

2.54

1.51

5.6

2.4

1.38

1.45

mg/l

—

Migraine without aura and triptan purchases

241

2080

1.16

1.51

5.7

4.5

1.21

1.28

mg/l

1.03

227

1966

Benign neoplasm of meninges

143

1180

1.22

1.51

2.8

2.9

1.58

1.62

mg/l

0.25

132

1072

Cluster headache, wide,, including avohilmo

626

1.30

1.50

2.6

3.3

1.28

1.38

mg/l

0.62

584

Viral haemorrhagic fevers, not elsewhere classified/unspecified

117

946

1.25

1.50

3.1

1.55

1.54

mg/l

0.06

106

869

Restless leg syndrome

211

1805

1.17

1.49

2.9

3.1

1.43

1.54

mg/l

1.11

184

1651

Precocious central puberty

1.85

1.47

27.8

10.9

1.29

1.05

mg/l

0.88

Autoimmune hyperthyroidism

593

1.31

1.47

3.1

2.9

1.52

1.35

mg/l

1.21

549

Insomnia

1617

10629

1.06

1.46

2.7

3.5

1.35

1.50

mg/l

11.81

1488

9787

Unspecified parasitic disease

1.84

1.46

5.6

2.7

1.88

1.47

mg/l

0.80

Unspecified parasitic disease, including avohilmo

1.84

1.46

5.6

2.7

1.88

1.47

mg/l

0.80

Other osteochondropathies

109

878

1.25

1.46

6.7

3.7

1.31

1.44

mg/l

1.58

101

815

Benign neoplasm of thyroid gland

336

1.41

1.45

2.8

2.6

1.44

1.50

mg/l

0.20

303

Focal epilepsy, strict definition

335

2967

1.13

1.45

6.0

5.8

1.51

1.49

mg/l

0.17

302

2734

Otalgia

142

1177

1.21

1.44

7.1

8.4

1.43

1.39

mg/l

0.19

127

1111

Other benign neoplasms of connective and other soft tissue

142

1177

1.21

1.44

2.2

3.5

1.54

1.53

mg/l

0.07

128

1081

Triptan medication for migraine, min. 3 purchases

894

6199

1.08

1.43

3.2

3.8

1.19

1.37

mg/l

18.06

825

5792

Other specified/unspecified nutritional deficiencies

1.90

1.43

4.5

2.6

1.70

1.41

mg/l

0.57

Apocrine sweat disorders, other sweat gland disorders

2.33

1.43

1.2

2.0

1.48

1.51

mg/l

—

Other and unspecified nonorganic psychotic disorders

313

2765

1.14

1.42

3.3

3.4

1.39

1.36

mg/l

0.31

290

2598

Postpartum haemorrhage

254

2403

0.87

1.42

2.7

3.3

1.16

1.30

mg/l

4.42

241

2246

Other disorders of carbohydrate metabolism

2.15

1.42

8.1

10.5

1.71

1.16

mg/l

1.27

Nontoxic multinodular goitre

255

2223

1.15

1.41

2.9

2.8

1.68

1.59

mg/l

0.73

223

1977

Postprocedural musculoskeletal disorders, not elsewhere classified

105

846

1.25

1.41

3.6

3.0

1.70

1.64

mg/l

0.30

765

Amoebiasis

2.06

1.41

5.5

10.2

1.72

1.34

mg/l

0.58

Anomalies of pupillary function

247

1.48

1.40

3.4

6.1

1.35

1.37

mg/l

0.04

225

Congenital heart conduction disorder

3.13

1.39

10.0

22.6

1.06

1.15

mg/l

—

Other disorders of Eustachian tube

348

1.39

1.38

4.0

2.9

1.62

1.47

mg/l

0.41

314

Other symptoms and signs involving cognitive functions and awareness

775

6356

1.08

1.38

3.1

3.2

1.65

1.64

mg/l

0.07

699

5757

Focal epilepsy

359

3205

1.12

1.38

5.9

1.50

1.48

mg/l

0.22

324

2956

Crushing injury of wrist and hand

196

0.50

1.37

6.9

3.9

1.68

1.49

mg/l

—

178

Palatinal maxillary canine

136

1.67

1.37

26.1

16.2

1.23

1.05

mg/l

0.70

131

Additional codes for the location of defect, injury or illness

707

1.27

1.36

4.8

4.7

1.55

1.51

mg/l

0.19

648

Malignant neoplasm of heart, mediastinum and pleura, including Hilmo

151

1.61

1.36

7.2

2.9

1.14

1.76

mg/l

5.15

128

Benign neoplasm: other/unspecified salivary gland

265

1.45

1.36

2.5

2.8

1.63

1.68

mg/l

0.13

235

Other hammer toe(s) (acquired)

224

1764

1.16

1.35

2.7

2.5

1.67

1.54

mg/l

1.47

196

1581

Cramp and spasm

593

1.29

1.35

3.9

4.4

1.39

1.47

mg/l

0.40

548

Atrioventricular septal defect

1.93

1.35

17.9

16.5

1.16

1.13

mg/l

0.10

Malignant neoplasm of rectum

120

986

1.22

1.34

2.4

2.7

1.83

1.79

mg/l

0.21

109

852

Pectus carinatum

2.69

1.34

19.3

10.4

1.64

1.06

mg/l

—

Unspecified dementia

102

1128

0.81

1.34

2.4

1.93

1.94

mg/l

0.06

961

Palmar fascial fibromatosis [Dupuytren]

232

2019

1.15

1.34

3.3

2.7

1.70

mg/l

0.00

213

1802

Nasal polyp

235

2692

0.87

1.34

3.0

1.50

1.59

mg/l

1.12

217

2465

Other cestode infections

0.00

1.34

0.0

2.6

—

1.43

—

Appendicitis, broad definition

1294

10947

1.06

1.33

3.6

3.3

1.52

1.49

mg/l

0.64

1198

10110

Coxarthrosis, primary

970

7524

1.07

1.33

3.0

2.8

1.74

1.66

mg/l

1.89

872

6765

Atypical virus infections of central nervous system

106

1.74

1.32

1.9

2.9

1.17

1.44

mg/l

1.40

Other and unspecified hereditary haemolytic anaemias

2.98

1.32

10.6

9.1

1.09

1.29

mg/l

—

Medial epicondylitis

439

0.68

1.32

2.9

3.0

1.59

1.43

mg/l

0.64

411

Postprocedural disorders of nervous system

800

1.25

1.31

4.0

3.7

1.17

1.31

mg/l

1.63

752

Diseases of appendix

1304

11003

1.06

1.30

3.7

3.3

1.52

1.49

mg/l

0.59

1208

10158

Contact with machinery

129

1545

0.83

1.30

2.6

3.1

1.50

1.59

mg/l

0.54

118

1423

Pulmonary eosinophilia, not elsewhere classified

114

1.70

1.30

3.1

2.6

1.56

1.59

mg/l

0.05

Ovarian dysfunction, other/unspecified

2.05

1.29

4.4

3.6

1.08

1.21

mg/l

0.40

Changes in corneal membranes

2.11

1.29

1.8

2.1

1.56

1.35

mg/l

—

Birth injury to scalp

3.09

1.29

49.4

27.0

1.08

1.05

mg/l

—

Osteochondrodysplasia with defects of growth of tubular bones and spine

2.37

1.29

1.9

18.7

1.16

1.14

mg/l

—

HSIL lesion of the vagina

146

1.60

1.28

3.7

2.2

1.97

1.34

mg/l

1.80

131

Benign neoplasm: Cerebral meninges

128

1066

1.21

1.28

2.9

3.0

1.60

1.62

mg/l

0.11

119

971

Lichen sclerosus et atrophicus

149

1258

1.19

1.27

2.5

2.9

1.38

1.48

mg/l

0.97

134

1134

Chronic diseases of tonsils and adenoids

1459

8710

1.06

1.27

5.3

4.6

1.33

1.45

mg/l

8.43

1355

8115

Hyperkinetic disorders (excl. ADHD)

461

1.33

1.27

10.1

16.4

1.13

1.08

mg/l

0.46

451

Malignant neoplasm of eye and adnexa

1.86

1.27

11.6

4.8

1.07

1.66

mg/l

4.33

Injuries involving multiple body regions

458

1.32

1.27

2.9

3.6

1.63

1.45

mg/l

0.65

415

Other congenital malformations of skin, including avohilmo

125

1040

1.21

1.26

5.5

6.3

1.36

1.38

mg/l

0.16

119

971

Transient global amnesia

1080

0.80

1.26

2.4

2.8

1.57

1.70

mg/l

0.79

968

Anti-inflammatory and antirheumatic products, non-steroids

538

2959

0.91

1.25

4.2

6.9

1.49

1.62

mg/l

2.76

493

2760

Aneurysms, operations, SAH

238

2087

1.14

1.25

4.0

2.8

1.63

1.61

mg/l

0.13

214

1879

Abnormal findings on diagnostic imaging of central nervous system

600

1.28

1.25

5.1

5.6

1.37

1.42

mg/l

0.25

554

Atypical virus infections of central nervous system, including avohilmo

108

1.70

1.24

1.9

2.9

1.17

1.44

mg/l

1.42

Pollen allergy

340

3006

1.12

1.24

4.3

8.5

1.18

1.23

mg/l

0.64

320

2870

Temporomandibular joint disorders, including avohilmo

698

6266

1.08

1.24

3.0

3.7

1.26

1.40

mg/l

6.65

643

5832

Dementia in Alzheimer disease

199

1917

0.87

1.23

2.2

2.4

1.80

1.93

mg/l

1.25

157

1649

Other maternal disorders predominantly related to pregnancy

754

4377

1.08

1.23

3.3

3.1

1.43

1.36

mg/l

1.55

696

4049

Focal brain injury

762

1.24

1.23

3.8

3.0

1.76

1.56

mg/l

1.14

689

Benign neoplasm of brain and other parts of central nervous system

781

1.24

1.22

5.2

4.2

1.43

1.52

mg/l

0.55

715

Alcohol abuse, main dg

253

2233

1.14

1.22

4.0

1.55

1.48

mg/l

0.73

233

2088

Injury of other and unspecified intrathoracic organs

100

818

1.23

1.21

3.5

3.0

1.73

1.56

mg/l

1.04

743

Other extrapyramidal and movement disorders in other diseases

383

3463

1.11

1.21

3.2

1.51

1.59

mg/l

1.23

346

3138

Pregnancy, childbirth and the puerperium

346

2013

0.89

1.20

3.1

3.7

1.45

1.52

mg/l

0.88

308

1795

Kela-code for severe mental illness

584

5387

1.09

1.20

3.0

3.1

1.50

1.45

mg/l

0.67

527

4979

Chronic respiratory disease originating in the perinatal period

1.85

1.20

13.4

24.1

1.12

1.04

mg/l

0.36

Exposure to excessive natural heat

0.00

1.19

0.0

2.1

—

1.46

—

Endometriosis diagnosis and infertility diagnosis occurring together

127

1066

1.20

1.18

2.4

2.9

1.14

1.30

mg/l

3.05

118

996

Benign neoplasm: Choroid

776

1.23

1.18

3.1

1.67

1.60

mg/l

0.35

698

D07AA Corticosteroids, weak (group I)

261

2311

1.13

1.17

6.8

7.9

1.41

1.32

mg/l

1.06

248

2180

Malignant neoplasm of prostate, including Hilmo

399

2130

1.11

1.17

2.8

2.9

1.82

1.80

mg/l

0.16

354

1885

Other/unspecified postprocedural disorders of ear and mastoid process

0.00

1.16

0.0

1.5

—

1.64

—

Spondylopathies in diseases classified elsewhere

134

1.59

1.16

6.0

3.2

1.49

1.68

mg/l

0.65

124

Abnormal serum enzyme levels

509

4512

1.09

1.16

4.2

3.4

1.60

1.68

mg/l

1.22

484

4089

Open wound of thorax

183

1.50

1.15

4.4

3.5

1.84

1.45

mg/l

0.93

169

Uterine polyps

361

1901

1.11

1.14

3.0

2.9

1.52

1.51

mg/l

0.06

327

1731

Purulent endophthalmitis

1.82

1.13

5.2

2.0

1.69

1.71

mg/l

0.03

Benign neoplasm of breast

146

1247

1.18

1.12

2.9

3.0

1.40

1.48

mg/l

0.78

126

1132

Alcohol withdrawal state with delirium

108

899

1.21

1.12

3.2

2.9

1.69

1.61

mg/l

0.41

103

826

Other bursitis of hip

209

1.45

1.12

2.1

2.7

1.36

1.54

mg/l

0.72

190

Other peripheral vertigo

125

1055

1.19

1.11

2.8

3.0

1.54

1.63

mg/l

0.65

115

946

Macular hole

646

1.25

1.11

3.3

2.7

1.78

1.72

mg/l

0.18

579

Disorders of pituitary gland, other and/or unspecified

1.87

1.11

10.4

2.4

1.41

1.42

mg/l

0.01

Open wound of wrist and hand

826

7481

1.07

1.11

3.5

4.0

1.41

1.47

mg/l

1.62

752

6949

Tic disorders

261

1.41

1.11

11.2

15.4

1.12

1.05

mg/l

0.37

251

Other specified disorders of external ear

451

1.30

1.10

3.7

3.1

1.68

1.64

mg/l

0.10

410

Injury of nerves at shoulder and upper arm level

112

1.63

1.10

2.7

3.0

1.30

1.44

mg/l

0.51

102

Intentional self-harm by sharp object

303

1.37

1.10

4.6

5.4

1.26

1.21

mg/l

0.14

283

Juvenile cataract

1.93

1.10

36.1

8.0

1.46

1.33

mg/l

0.25

1.92

1.10

4.5

2.1

1.92

1.52

mg/l

0.65

Injury of muscle and tendon at hip and thigh level

161

1390

1.16

1.10

4.3

3.9

1.40

1.47

mg/l

0.53

156

1287

Digeorge syndrome

2.61

1.09

12.4

28.5

1.25

1.00

mg/l

—

Hemiplegia

576

1.26

1.09

11.4

3.9

1.60

1.58

mg/l

0.08

527

Qualitative platelet defects

1.99

1.09

1.9

9.8

1.10

1.33

mg/l

—

Alzheimer’s disease (Atypical or mixed), excluding more controls

117

733

1.20

1.08

2.4

1.89

1.88

mg/l

0.01

643

Migraine with aura and triptan purchases

229

2028

1.13

1.08

3.4

4.5

1.16

1.31

mg/l

4.37

213

1905

Radiculopathy

235

2085

1.13

1.07

3.0

2.8

1.65

1.62

mg/l

0.15

206

1880

Female genital prolapse

370

1863

1.11

1.07

2.7

2.8

1.42

1.52

mg/l

1.92

318

1696

Other hyperalimentation

2.19

1.07

1.4

2.1

1.62

1.31

mg/l

—

Maternal care for known or suspected abnormality of pelvic organs

320

1945

1.11

1.07

2.9

3.2

1.27

1.30

mg/l

0.31

303

1815

Other salmonella infections, including avohilmo

489

1.28

1.06

4.3

3.4

1.58

1.46

mg/l

0.45

445

Other otitis externa (chronic)

795

1.21

1.06

6.6

4.0

1.49

1.50

mg/l

0.05

726

Leiomyoma of uterus

858

4515

1.07

1.06

2.8

1.51

1.45

mg/l

1.35

776

4105

Divergent concomitant strabismus

112

942

1.20

1.05

5.5

5.4

1.41

1.40

mg/l

0.04

104

883

Dislocation, sprain and strain of joints and ligaments of head

517

1.27

1.05

9.7

8.8

1.41

1.29

mg/l

0.49

485

Disorders of vestibular function (Vertigo)

735

6701

1.07

1.04

2.9

3.0

1.56

1.61

mg/l

0.91

670

6029

Thyrotoxicosis with diffuse goitre

185

1620

1.15

1.04

2.8

3.2

1.53

1.43

mg/l

0.93

174

1489

Mental disorders, not otherwise specified

116

980

1.19

1.04

3.3

3.6

1.45

1.35

mg/l

0.83

107

922

Liveborn infants according to place of birth

214

1.43

1.04

14.7

21.3

0.97

1.00

mg/l

0.25

208

Fall on and from stairs and steps

413

3784

1.09

1.04

4.2

3.9

1.54

1.52

mg/l

0.16

379

3465

Malignant neoplasm of heart, mediastinum and pleura

106

1.62

1.04

9.6

2.9

1.15

1.82

mg/l

3.57

Hereditary corneal dystrophies

385

1.31

1.04

4.1

2.9

1.49

1.58

mg/l

0.31

348

Monocytic leukaemia

1.94

1.03

5.3

3.8

1.28

1.58

mg/l

—

Cluster headache, strict, including avohilmo

599

1.24

1.03

2.6

3.4

1.24

1.37

mg/l

0.81

559

Other and unspecified injuries of abdomen, lower back and pelvis

188

1.46

1.03

2.8

3.1

1.46

1.40

mg/l

0.15

167

Motor neuron disease ALS

177

0.56

1.02

5.7

2.8

1.49

1.63

mg/l

—

151

Degenerative macular diseases, drug-induced

2.06

1.01

3.3

2.5

1.82

1.70

mg/l

—

Complications predominantly related to the puerperium

320

2900

1.11

1.01

3.1

3.0

1.36

1.34

mg/l

0.23

296

2697

Organic, including symptomatic, mental disorders

816

5391

1.07

1.01

2.7

2.9

1.75

1.74

mg/l

0.13

701

4848

Prominent ears

110

0.45

1.01

11.4

9.8

1.21

1.07

mg/l

—

103

Other nonscarring hair loss

107

1.61

1.01

4.1

2.7

1.42

1.41

mg/l

0.02

Retinoschisis and retinal cysts

248

1.39

1.01

2.4

3.7

1.78

1.64

mg/l

0.28

225

Malignant neoplasm of pancreas

646

1.23

1.00

2.5

2.6

1.50

1.83

mg/l

3.45

553

Osteitis due to dental implant

1.67

0.99

5.0

2.7

1.79

1.55

mg/l

0.57

Acquired pure red cell aplasia [erythroblastopenia]

1.91

0.99

6.9

3.2

2.28

1.41

mg/l

—

Other/unspecified enthesopathies, not elsewhere classified

116

986

1.18

0.98

3.1

2.8

1.57

1.52

mg/l

0.24

110

897

Benign paroxysmal vertigo

437

4026

1.09

0.98

3.1

3.0

1.60

1.61

mg/l

0.09

400

3629

Postinfectious hypothyroidism

1.89

0.98

3.7

1.9

1.91

1.36

mg/l

—

Vascular dementia (sudden onset)

0.00

0.98

0.0

1.7

—

2.27

—

Congenital iodine-deficiency syndrome/hypothyroidism

310

1.33

0.98

3.8

4.8

1.93

1.46

mg/l

1.62

279

Tinnitus

353

3223

1.10

0.98

3.2

3.0

1.40

1.55

mg/l

3.16

320

2965

ILD and respiratory illness in diseases classified elsewhere

1.82

0.96

4.5

2.1

1.92

1.52

mg/l

0.65

Follicular adenocarcinoma of thyroid gland, including Hilmo

1.67

0.95

5.9

3.9

1.83

1.58

mg/l

0.50

Lateral epicondylitis

150

1720

0.87

0.95

2.6

2.8

1.34

1.44

mg/l

1.08

130

1594

Certolizumab pegol

185

0.59

0.95

2.3

3.4

1.47

1.32

mg/l

0.21

165

Transitory disorders of carbohydrate metabolism specific to fetus and newborn

518

1.26

0.95

19.0

24.8

1.06

mg/l

0.02

513

Other secondary coxarthrosis

382

1.29

0.95

3.5

2.8

1.62

1.56

mg/l

0.21

345

Personal history of allergy to drugs, medicaments and biological substances

109

1.58

0.95

3.8

3.1

1.41

1.25

mg/l

0.62

541

1.24

0.94

4.9

2.9

1.47

1.64

mg/l

1.22

464

Dacryoadenitis

1.74

0.94

19.1

3.3

1.66

1.41

mg/l

0.55

L02BX Other hormone antagonists and related agents

711

0.80

0.94

3.1

2.7

1.87

mg/l

0.00

629

Deaf mutism, not elsewhere classified

1.77

0.94

9.7

3.6

1.93

1.40

mg/l

—

Benign neoplasm of soft tissue of retroperitoneum and peritoneum

1.77

0.94

2.0

2.3

1.52

1.45

mg/l

—

Contact with other sharp object(s)

108

918

1.18

0.93

3.4

4.6

1.25

1.36

mg/l

0.97

103

860

Other parasitologically confirmed or unspecified malaria

2.22

0.93

4.0

2.1

1.50

1.62

mg/l

—

1126

0.84

0.93

3.1

2.9

1.95

1.71

mg/l

1.40

1011

Viral haemorrhagic fevers, not elsewhere classified/unspecified, including avohilmo

250

2250

1.11

0.93

5.6

6.0

1.51

1.48

mg/l

0.18

230

2091

Atopic conjunctivitis

590

1.23

0.92

9.2

7.6

1.30

1.33

mg/l

0.12

551

Ankylosing spondylitis

133

1151

1.16

0.92

2.8

3.3

1.49

1.48

mg/l

0.03

126

1077

Unspecified maternal hypertension

1.62

0.91

2.2

3.0

1.47

1.20

mg/l

0.93

Other effects of reduced temperature

2.14

0.91

2.0

2.7

1.15

1.58

mg/l

—

Convergent concomitant strabismus

755

1.20

0.91

9.5

7.6

1.30

1.28

mg/l

0.08

711

Other and unspecified injuries of neck

104

0.47

0.90

4.0

3.9

1.09

1.26

mg/l

—

Congenital malformations of oesophagus, including avohilmo

1.65

0.90

3.0

13.2

1.02

1.29

mg/l

1.57

Artificial joint re-operation

802

1.19

0.90

3.8

2.9

1.71

1.69

mg/l

0.05

718

Hair colour and hair shaft abnormalities

1.91

0.89

3.9

3.2

2.47

1.62

mg/l

—

Alopecia areata

307

1.31

0.88

6.1

7.3

1.23

1.32

mg/l

0.52

279

Chalazion

167

1475

1.14

0.87

3.5

4.1

1.41

1.48

mg/l

0.62

157

1369

Fibrosarcoma

1.75

0.87

7.6

4.7

1.13

1.62

mg/l

1.70

Transitory endocrine and metabolic disorders specific to fetus and newborn

532

1.25

0.87

18.7

24.3

1.06

mg/l

0.02

527

Toxic effect of alcohol

238

1.36

0.87

5.8

3.4

1.82

1.45

mg/l

1.21

219

Other adrenocortical overactivity

104

1.58

0.87

12.8

11.3

1.46

1.04

mg/l

1.08

Nail dystrophy

1.70

0.87

3.4

2.8

1.70

1.44

mg/l

0.95

Cholesteatoma of middle ear

593

0.79

0.87

4.5

3.3

1.83

1.63

mg/l

0.64

532

Hallux valgus (acquired)

453

3003

1.08

0.86

2.6

1.51

1.47

mg/l

0.40

404

2736

Sixth [abducent] nerve palsy

388

1.27

0.86

5.4

4.8

1.66

1.60

mg/l

0.19

349

Contusion of ankle

559

1.22

0.86

8.7

6.7

1.63

1.32

mg/l

1.00

517

Drug-induced thyroiditis

2.00

0.86

2.3

3.3

1.82

1.44

mg/l

—

Other acantholytic disorders

1.99

0.86

9.3

2.8

2.51

1.82

mg/l

—

Other and unspecified nonscarring hair loss

1.65

0.86

4.6

2.6

1.22

1.31

mg/l

0.21

Spondylolisthesis/Spondylolysis

273

2483

1.10

0.85

2.8

3.3

1.53

1.54

mg/l

0.06

253

2279

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

895

8135

1.05

0.85

3.5

4.1

1.34

1.42

mg/l

2.61

824

7525

Other endophthalmitis

1.79

0.85

7.1

2.8

1.71

1.46

mg/l

—

Acute appendicitis

1198

10626

1.05

0.85

3.7

3.3

1.52

1.48

mg/l

0.68

1109

9817

Other superficial injuries of ankle and foot

105

1.56

0.84

3.0

8.9

1.63

1.22

mg/l

1.20

Adenocarcinoma and papilloma adenocarcinoma of rectum

114

984

1.16

0.83

2.5

2.7

1.87

1.79

mg/l

0.37

102

851

Fracture at wrist and hand level

616

5774

1.07

0.83

3.5

4.4

1.48

1.44

mg/l

0.55

574

5369

Medical treatment for female infertility

243

2180

1.11

0.83

2.6

3.1

1.13

1.25

mg/l

3.76

229

2059

Foreign object accidentally left in body during surgical and medical care

1.92

0.83

7.5

2.7

1.41

1.55

mg/l

—

Pedal cyclist injured in noncollision transport accidents

141

1603

0.88

0.83

4.9

1.34

1.42

mg/l

0.70

132

1505

Use of galantamine

863

0.83

0.82

2.0

2.4

1.52

1.87

mg/l

4.87

734

Lichen planus

178

1587

1.13

0.82

2.5

3.1

1.63

1.59

mg/l

0.23

159

1437

LSIL lesion of the cervix uteri

131

1146

1.15

0.81

4.1

2.8

1.38

1.28

mg/l

0.93

125

1071

Erosion and ectropion of cervix uteri

250

1.33

0.81

1.4

3.3

1.61

1.51

mg/l

0.27

228

Carcinoma in situ of breast, intraductal

914

0.84

0.80

3.0

2.8

1.39

1.51

mg/l

0.96

830

Hereditary ataxia

156

1.43

0.80

5.9

6.5

1.87

1.51

mg/l

0.61

141

Other hypertrichosis

1.86

0.80

14.7

1.9

1.69

1.18

mg/l

—

Neuroendocrine tumor and carcinoma of lung

1.69

0.79

3.2

3.0

1.45

1.69

mg/l

0.43

Undefined dementia

105

1121

0.86

0.79

2.4

1.96

1.92

mg/l

0.19

945

Spontaneous abortion

529

3779

0.94

0.79

3.0

1.38

1.39

mg/l

0.20

484

3487

Etanercept

823

1.17

0.79

4.9

6.0

1.46

1.36

mg/l

0.73

770

Brachial plexus disorders

125

1093

1.15

0.78

2.6

3.3

1.31

1.37

mg/l

0.31

114

1018

MS-disease / Multiple Sclerosis

814

0.83

0.78

1.8

3.2

1.25

1.35

mg/l

0.48

762

Acute and transient psychotic disorders

165

1470

1.13

0.78

3.5

3.2

1.62

1.43

mg/l

1.95

152

1381

Other and unspecified disorders of vitreous body

636

5868

1.06

0.78

3.1

2.9

1.55

1.62

mg/l

1.27

573

5309

Carcinoma in situ of cervix uteri, endocervix

115

1.50

0.78

4.1

2.5

1.44

1.31

mg/l

0.26

104

Postpartum hemorraghe, all women as controls

254

2713

0.91

0.77

2.7

3.1

1.16

1.27

mg/l

3.19

241

2554

Neuroendocrine tumor and carcinoma of pancreas

1.72

0.77

2.8

2.6

1.59

1.56

mg/l

—

Arthropod-borne viral fevers and viral haemorrhagic fevers

133

1171

1.14

0.76

3.5

3.1

1.56

mg/l

0.00

121

1076

Sequelae of injuries of upper limb

143

1265

1.13

0.76

2.4

3.6

1.56

1.48

mg/l

0.49

130

1182

Reiter disease

1.63

0.76

1.6

2.8

1.64

1.45

mg/l

0.25

Diseases of inner ear

861

7842

1.05

0.76

3.0

1.57

1.60

mg/l

0.65

785

7101

Failed induction of labour

550

1.20

0.75

2.5

3.3

1.26

1.22

mg/l

0.19

512

Benign mammary dysplasia

136

1536

0.88

0.74

3.0

2.9

1.61

1.51

mg/l

0.68

127

1385

Injury of muscle and tendon at shoulder and upper arm level

520

5528

0.94

0.74

2.6

3.0

1.57

1.61

mg/l

0.41

474

5070

Achilles tendinitis

159

1420

1.12

0.74

2.9

3.3

1.48

1.51

mg/l

0.18

143

1314

Unattended death

108

0.55

0.73

3.2

2.7

1.64

1.65

mg/l

—

Idiopathic peripheral autonomic neuropathy

1.79

0.72

1.7

2.8

0.97

1.66

mg/l

—

Acute poliomyelitis

143

1.42

0.71

2.0

2.6

1.16

1.44

mg/l

1.96

128

Acute poliomyelitis, including avohilmo

143

1.42

0.71

2.0

2.6

1.16

1.44

mg/l

1.96

128

Noise effects on inner ear

532

0.80

0.71

3.3

3.0

1.63

1.61

mg/l

0.07

484

Vasomotor and allergic rhinitis

644

5962

1.06

0.71

4.1

5.1

1.31

1.39

mg/l

2.21

605

5575

Dementia in other diseases classified elsewhere

521

0.80

0.71

1.8

3.0

1.57

1.76

mg/l

0.63

453

Neonatal aspiration syndromes

1.95

0.71

20.6

29.2

0.95

1.02

mg/l

—

Cervical polyps

1051

0.86

0.70

3.3

1.60

1.49

mg/l

0.56

978

Other congenital malformations of female genitalia

1.55

0.70

3.5

5.5

1.56

1.15

mg/l

0.95

Primary coxarthrosis, bilateral

425

3981

1.07

0.69

2.9

2.7

1.77

1.71

mg/l

0.70

379

3532

Fibrosarcoma, including Hilmo

1.58

0.69

14.5

5.4

1.12

1.56

mg/l

1.73

Other abortion

1.58

0.69

3.0

2.4

1.74

1.30

mg/l

0.62

Sequelae of injuries of lower limb

131

1162

1.13

0.69

3.6

3.1

1.50

1.47

mg/l

0.20

123

1084

Pedestrian injured in transport accident

853

1.15

0.69

4.0

3.8

1.58

1.49

mg/l

0.48

784

Oral lichen planus or lichen planus, and hypothyroidism or thyroxine medication

649

1.18

0.68

2.5

3.1

1.45

1.58

mg/l

0.56

593

Pediculosis and phthiriasis

1.66

0.68

7.1

2.5

1.91

1.28

mg/l

—

Focal epilepsy, mode (most common among epilepsy diagnosis)

299

2768

1.08

0.67

5.2

5.7

1.50

1.49

mg/l

0.09

269

2558

Other specified/unspecified inflammatory spondylopathies

567

1.19

0.67

2.4

3.1

1.46

1.36

mg/l

0.39

533

Mandibular retrognathia

110

965

1.14

0.67

15.5

9.7

1.14

1.24

mg/l

1.58

103

921

Cervical disc disorders

565

5349

1.06

0.66

2.7

3.0

1.51

1.57

mg/l

1.03

503

4892

Spermatocele

111

978

1.14

0.66

2.9

1.81

1.68

mg/l

0.62

889

Thiamine deficiency

1.64

0.66

2.6

2.7

2.00

1.39

mg/l

—

Coxarthrosis, primary, with hip surgery

712

6287

1.05

0.66

2.8

1.76

1.69

mg/l

1.20

633

5614

Senile degeneration of the brain, not elsewhere classified

1.62

0.66

4.3

2.3

1.76

1.78

mg/l

—

Malignant neoplasm of ovary, including Hilmo

522

1.19

0.65

4.9

2.9

1.58

1.59

mg/l

0.04

454

Other complications of labour and delivery, not elsewhere classified

103

1039

0.88

0.65

2.4

3.3

1.07

1.20

mg/l

2.48

978

Vitiligo

137

1.40

0.65

4.7

5.0

1.41

1.29

mg/l

0.23

127

Acute appendicitis, with complications

288

2668

1.08

0.65

3.8

3.0

1.79

1.54

mg/l

3.89

262

2461

Vestibular neuronitis

120

1064

1.13

0.65

3.1

1.49

1.59

mg/l

0.75

108

972

Non-small cell lung cancer, adenocarcinoma, helper endpoint

736

1.16

0.65

2.9

2.8

1.59

1.76

mg/l

1.20

654

Reduction defects of lower limb

1.76

0.64

32.4

7.5

1.52

1.40

mg/l

—

Biological medicines for asthma

269

1.27

0.64

1.9

4.0

1.19

1.37

mg/l

1.27

250

Motor neuron disease (with DMD)

198

1.32

0.64

5.1

4.6

1.26

1.57

mg/l

0.96

172

Alzheimer disease, excluding more controls

200

1419

0.91

0.64

2.4

2.8

1.70

1.77

mg/l

0.50

161

1278

Schizophrenia, schizotypal and delusional disorders

498

4704

1.06

0.64

3.2

3.3

1.51

1.43

mg/l

1.21

459

4362

Fatigue fracture of vertebra

101

0.58

0.64

2.5

14.5

1.21

1.31

mg/l

—

Injury of cranial nerves

1.55

0.64

2.2

2.7

1.19

1.30

mg/l

0.26

Benign neoplasm of ovary

205

1875

1.10

0.63

3.1

3.0

1.52

1.53

mg/l

0.06

183

1697

Unspecified renal colic

1.58

0.63

8.9

4.0

1.52

1.42

mg/l

0.31

Abscess of external ear

138

1.39

0.63

7.8

4.6

1.65

1.37

mg/l

0.65

123

Benign neoplasm: Retina

1.62

0.63

3.8

2.5

1.22

1.52

mg/l

—

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

116

1029

1.13

0.63

2.5

2.7

1.88

1.79

mg/l

0.48

104

886

Chondrocostal junction syndrome [Tietze]

406

1.21

0.62

2.8

3.2

1.31

1.47

mg/l

0.97

371

Carcinoma in situ of skin of eyelid, including canthus

1.71

0.62

5.0

1.9

2.18

1.79

mg/l

—

Cervicobrachial syndrome

282

3035

0.93

0.61

2.6

3.0

1.40

1.48

mg/l

1.02

260

2795

Benign neoplasm: Skin of other and unspecified parts of face

135

1211

1.12

0.61

5.0

3.1

1.79

1.61

mg/l

1.35

122

1081

Assault by drugs, medicaments and biological substances

0.00

0.61

0.0

3.6

—

1.37

—

Residual foreign body in soft tissue

638

1.17

0.61

4.8

3.3

1.44

mg/l

0.01

594

Congenital malformations of breast

139

1.38

0.61

5.1

3.0

1.35

1.22

mg/l

0.22

123

Sequelae of tuberculosis, including avohilmo

163

0.67

0.60

2.5

2.1

2.17

1.93

mg/l

0.34

134

Glaucoma, exfoliation

134

1203

1.12

0.60

2.4

1.92

1.83

mg/l

0.46

113

1028

Torsion of testis

281

1.26

0.60

9.4

10.0

1.24

1.23

mg/l

0.05

269

Allergic conjunctivitis

940

8689

1.04

0.60

3.6

4.3

1.34

1.42

mg/l

2.80

865

8045

Benign neoplasm: Pharynx, unspecified

1.46

0.60

2.7

2.5

1.30

1.45

mg/l

0.54

Pedal cyclist injured in transport accident

316

3382

0.93

0.60

4.2

4.5

1.35

1.44

mg/l

1.49

288

3148

Helminthiases

201

1.31

0.59

4.8

6.9

1.21

1.39

mg/l

0.96

182

Whooping cough

1.59

0.59

18.4

4.2

1.80

1.11

mg/l

—

Other fall from one level to another

388

3648

1.07

0.59

5.6

6.1

1.41

1.43

mg/l

0.11

356

3412

Lesion of radial nerve

446

1.19

0.59

2.6

3.0

1.60

1.53

mg/l

0.19

411

Congenital malformations of oesophagus

1.52

0.58

3.3

14.1

0.98

1.28

mg/l

1.71

Benign neoplasm: Spinal meninges

106

1.43

0.58

2.3

2.4

1.34

1.50

mg/l

0.34

Other specified transport accidents

1.51

0.58

3.6

6.0

1.44

1.22

mg/l

0.51

Malignant neoplasm of prostate

376

2088

1.07

0.58

2.7

2.9

1.83

1.81

mg/l

0.18

332

1846

Respiratory tuberculosis, bacteriologically and histologically confirmed

202

1.30

0.58

4.0

2.8

1.50

1.71

mg/l

0.75

178

Hallux rigidus

147

1621

0.90

0.57

2.4

2.6

1.52

1.53

mg/l

0.02

128

1472

Sacroiliitis, not elsewhere classified

549

1.17

0.57

2.8

3.6

1.35

1.31

mg/l

0.16

519

Other contact dermatitis

104

924

1.13

0.57

5.6

3.5

1.49

1.47

mg/l

0.12

855

Congenital lens malformations

1.57

0.56

6.4

8.9

2.05

1.21

mg/l

—

Retrobulbar neuritis in diseases classified elsewhere

1.65

0.56

1.3

2.5

1.20

1.24

mg/l

—

Laparoscopic right hemicolectomy

644

1.15

0.56

2.5

2.8

1.87

1.72

mg/l

0.67

572

Other disorders of peripheral nervous system

1.49

0.55

2.0

2.3

1.57

1.53

mg/l

0.06

Presbyopia

109

974

1.12

0.55

2.6

3.0

1.37

1.44

mg/l

0.41

104

912

Xanthelasma of eyelid

1.48

0.55

3.2

3.0

1.70

1.48

mg/l

0.35

Polypectomy (DHB20)

847

0.87

0.55

3.6

2.9

1.53

1.59

mg/l

0.23

782

Congenital cataract

1.48

0.54

5.1

9.2

1.91

1.18

mg/l

—

Benign neoplasm: Orbit, unspecified

1.54

0.53

3.6

2.8

1.38

1.49

mg/l

—

Injury of nerves and spinal cord at thorax level

1.45

0.53

3.3

3.0

1.42

1.48

mg/l

—

Labour and delivery complicated by umbilical cord complications

480

0.83

0.53

1.9

3.3

1.21

1.34

mg/l

0.76

445

Benign neoplasm: Ill-defined sites within the digestive system

1.45

0.53

2.1

2.4

1.30

1.50

mg/l

—

Parkinson's disease, strict definition, excluding more controls

134

1377

0.91

0.53

2.0

2.7

1.47

1.73

mg/l

4.22

116

1243

Contact with other and unspecified heat and hot substances

100

1.42

0.53

7.6

4.6

2.07

1.34

mg/l

1.73

Intussusception

223

1.26

0.53

5.9

5.2

1.39

1.49

mg/l

0.43

208

Chronic suppurative otitis media

826

1.13

0.52

8.1

5.4

1.50

1.44

mg/l

0.27

757

Other and unspecified nerve root and plexus disorders, also in other diseases

313

2940

1.07

0.52

2.7

3.0

1.57

1.49

mg/l

0.81

283

2722

Dissection of cerebral arteries, nonruptured

1.46

0.52

2.5

2.6

1.45

1.36

mg/l

0.13

Malignant neoplasm of ovary

387

1.19

0.52

3.9

3.1

1.58

1.63

mg/l

0.18

341

Lumbosacral plexus disorders

1.53

0.52

3.3

2.2

1.08

1.45

mg/l

—

Chondropathies

221

2051

1.08

0.52

6.0

4.1

1.30

1.43

mg/l

2.59

200

1915

Schizophrenia or delusion

493

4693

1.05

0.52

3.2

3.3

1.50

1.43

mg/l

0.99

454

4355

Chronic suppurative otitis media, including avohilmo

121

1093

1.11

0.52

8.8

7.7

1.45

1.43

mg/l

0.11

114

1013

Motorcycle rider injured in noncollision transport accidents

413

0.82

0.52

3.1

4.3

1.47

1.33

mg/l

0.40

385

Dislocation, sprain and strain of joints and ligaments of elbow

100

895

1.12

0.51

9.0

7.5

1.29

1.30

mg/l

0.05

845

Persistent delusional disorders

101

905

1.12

0.50

3.4

2.8

1.55

1.52

mg/l

0.16

832

Impaction of intestines

1.51

0.50

3.2

2.4

1.57

1.61

mg/l

—

Sequelae of tuberculosis

156

0.70

0.50

2.5

2.1

2.17

1.94

mg/l

0.32

128

Other congenital malformations of tongue, mouth and pharynx

315

1.21

0.50

18.3

19.3

1.15

1.09

mg/l

0.45

306

Galactorrhea

107

0.65

0.49

5.0

2.8

1.21

1.33

mg/l

—

Stenosis and insufficiency of lacrimal passages

119

1078

1.11

0.49

3.4

3.9

1.47

1.55

mg/l

0.66

108

976

Pregnancy examination and test

153

1035

0.91

0.49

2.5

3.7

1.17

1.25

mg/l

0.84

146

967

Other and unspecified spinal muscular atrophies

1.41

0.49

6.7

3.9

2.05

1.58

mg/l

0.66

Disorders of brain, other and unspecified

119

1.36

0.49

12.9

3.3

1.23

1.56

mg/l

1.36

106

Family history of other specific disorders

119

1.35

0.48

7.6

3.1

1.33

1.25

mg/l

0.19

108

Pedestrian injured in collision with pedal cycle

364

1.19

0.47

2.3

3.3

1.45

1.48

mg/l

0.12

330

Labour and delivery complicated by fetal stress [distress]

251

1744

0.93

0.47

2.5

3.3

1.15

1.22

mg/l

1.09

234

1635

Trichomoniasis, including avohilmo

1.43

0.47

4.3

3.1

1.78

1.45

mg/l

0.53

Artrosis, including avohilmo

1471

7835

1.03

0.47

2.9

3.2

1.56

1.51

mg/l

1.33

1340

7238

Generalized pustular psoriasis

1.45

0.46

2.3

5.7

1.73

1.50

mg/l

—

Impacted maxillary canine

219

1.25

0.46

21.8

16.2

1.27

1.11

mg/l

0.62

212

Neuralgia and neuritis, unspecified

589

1.14

0.46

2.6

2.8

1.58

1.48

mg/l

0.36

545

Allergic rhinitis

521

4923

1.05

0.46

4.2

6.3

1.27

1.31

mg/l

0.69

492

4639

Other appendicitis

117

1064

1.10

0.46

4.5

3.1

1.53

1.49

mg/l

0.24

109

991

Other and/or unspecified nontoxic goitre

876

0.89

0.46

2.9

3.1

1.51

1.54

mg/l

0.13

797

Parkinson's disease, excluding more controls

148

1479

0.92

0.46

2.1

2.8

1.55

1.71

mg/l

1.68

130

1341

Ganglion

298

2813

1.06

0.45

3.4

3.1

1.39

1.43

mg/l

0.41

275

2591

Optic neuritis

431

1.16

0.45

3.0

3.3

1.54

1.36

mg/l

0.71

395

Spirochaetal infections, other/unspecified

124

1133

1.10

0.45

3.7

4.1

1.38

1.55

mg/l

1.65

115

1038

Open wound of neck

1.38

0.44

2.5

3.7

1.54

1.37

mg/l

0.29

Other superficial mycoses, including avohilmo

151

1393

1.09

0.44

3.7

4.4

1.32

1.36

mg/l

0.29

142

1305

Gastrointestinal stromal tumor and sarcoma

1.38

0.44

2.2

2.5

1.52

1.78

mg/l

0.46

Plantar fascial fibromatosis

130

1192

1.09

0.44

3.3

2.8

1.49

1.46

mg/l

0.19

119

1100

Congenital malformations of breast, including avohilmo

148

1.29

0.44

5.1

2.9

1.35

1.23

mg/l

0.22

132

Arthropod-borne viral fevers and viral haemorrhagic fevers, including avohilmo

272

2564

1.06

0.43

5.5

5.6

1.51

1.50

mg/l

0.12

249

2374

Multiple gestation

956

0.90

0.43

3.2

1.29

mg/l

0.01

899

Other degenerative diseases of the nervous system

356

2731

0.95

0.43

2.4

2.8

1.59

1.60

mg/l

0.08

301

2495

Noonan syndrome

1.58

0.43

10.8

25.3

1.14

1.03

mg/l

—

Fetus and newborn affected by complications of placenta, cord and membranes

1.40

0.43

9.5

25.5

1.01

1.14

mg/l

—

Reduction defects of lower limb, including avohilmo

1.58

0.42

32.4

6.9

1.52

1.37

mg/l

—

Disorders of other and unspecified cranial nerves

1.42

0.42

3.1

2.8

1.77

1.63

mg/l

—

Anaphylactic shock due to adverse effect of correct drug or medication properly administered

131

1.31

0.42

5.7

2.4

1.74

1.33

mg/l

0.85

120

severe traumatic brain injury, does not include concussion

328

3113

1.06

0.42

4.2

3.0

1.81

1.68

mg/l

1.39

291

2792

Hereditary motor and sensory neuropathy

1.37

0.42

4.3

5.3

1.32

1.50

mg/l

0.66

Benign neoplasm: Anus and anal canal

304

1.19

0.42

4.7

2.8

2.13

1.68

mg/l

1.35

271

Hip and thigh

1.54

0.42

18.8

5.3

1.47

1.60

mg/l

—

Hereditary factor VIII deficiency

1.54

0.42

23.0

15.2

1.22

1.33

mg/l

—

Haemorrhage in early pregnancy

330

3043

1.05

0.42

2.6

3.0

1.38

1.33

mg/l

0.50

309

2817

Use of interferon beta-1a

228

0.79

0.41

2.2

3.0

1.15

1.30

mg/l

0.61

211

Other congenital malformations of ear

161

0.74

0.41

6.9

14.5

1.13

1.09

mg/l

0.19

152

Placenta praevia

445

0.85

0.41

2.0

3.3

1.17

1.26

mg/l

0.48

419

Arnold-Chiari syndrome

114

1.33

0.41

20.3

8.8

1.23

1.16

mg/l

0.21

108

Carcinoma in situ of oral cavity

1.50

0.41

2.0

2.4

1.10

1.66

mg/l

—

Deep bite that required surgery

138

0.72

0.41

3.9

3.2

1.00

1.31

mg/l

—

129

Respiratory tuberculosis, confirmed

195

1.24

0.41

4.2

2.9

1.46

1.71

mg/l

0.97

171

Schizoid personality disorder

194

0.77

0.41

2.2

3.0

1.62

1.40

mg/l

0.44

177

Subarachnoid haemorrhage

110

1202

0.91

0.41

4.0

2.9

1.72

1.65

mg/l

0.39

100

1068

Toxic effect of corrosive substances

1.35

0.41

4.8

1.22

1.33

mg/l

—

Multifocal fibrosclerosis

1.35

0.40

4.9

2.3

2.12

1.53

mg/l

—

Respiratory conditions due to inhalation of chemicals, gases, fumes and vapours

1.38

0.40

3.0

2.3

1.95

1.50

mg/l

0.97

Other disorders affecting eyelid function

103

0.67

0.40

2.4

2.8

1.23

1.46

mg/l

—

Demyelinating diseases of the central nervous system

971

0.90

0.40

2.2

3.2

1.28

1.37

mg/l

0.55

909

Other and unspecified hypertrophic disorders of skin

1.42

0.40

6.6

3.7

1.40

1.39

mg/l

—

Desensitization to allergens

697

0.89

0.39

3.7

9.4

1.05

1.22

mg/l

3.00

661

Flat foot [pes planus] (acquired)

123

1133

1.09

0.39

3.5

3.6

1.62

1.41

mg/l

1.59

112

1045

Contact with heat and hot substances

789

1.11

0.39

4.1

7.3

1.61

1.38

mg/l

1.76

737

Seropositive rheumatoid arthritis, strict definition

193

1810

1.07

0.39

2.6

2.9

1.66

1.56

mg/l

0.93

170

1653

Melanocytic naevi of ear and external auricular canal

1.36

0.38

2.4

2.8

1.22

1.44

mg/l

—

Ankyloglossia

391

1.16

0.38

16.8

19.3

1.09

mg/l

0.01

380

Other obstructed labour

761

1.11

0.38

3.4

3.2

1.41

1.39

mg/l

0.08

708

Other and unspecified injuries of head

106

972

1.09

0.38

3.7

5.3

1.69

1.49

mg/l

1.60

878

Inhalation and ingestion of other objects causing obstruction of respiratory tract

1.32

0.37

9.0

7.2

1.27

1.33

mg/l

—

Injury of nerves at wrist and hand level

493

0.87

0.37

4.0

3.1

1.62

1.43

mg/l

0.85

454

1.40

0.37

5.4

4.6

2.07

1.78

mg/l

—

Twin gestation

924

0.91

0.37

3.3

3.2

1.30

1.29

mg/l

0.05

868

Foreign body in alimentary tract

744

1.11

0.37

3.8

5.7

1.42

1.50

mg/l

0.36

680

Benign neoplasm: Ciliary body

1.49

0.36

1.7

2.6

1.03

1.55

mg/l

—

Respiratory tuberculosis, confirmed, including avohilmo

198

1.22

0.36

4.2

2.9

1.46

1.71

mg/l

0.97

174

Triptan medication for migraine, single purchase ok

1238

8583

0.98

0.36

3.5

4.0

1.28

1.42

mg/l

10.46

1150

7997

Migraine, single triptan purchase ok & required. ICD-code if available is included

1238

8583

0.98

0.36

3.5

4.0

1.28

1.42

mg/l

10.46

1150

7997

Lichen ruber planus, wide definition including periferal and oral lichen planus

311

2965

1.05

0.36

2.3

3.0

1.44

1.58

mg/l

2.40

281

2708

Endometroid carcinoma of ovary

1.44

0.36

1.2

3.7

1.84

1.58

mg/l

—

Unequal limb length (acquired)

108

1.31

0.36

12.7

8.0

1.08

1.14

mg/l

0.20

103

Other noninflammatory disorders of cervix uteri

479

1.13

0.35

2.1

2.9

1.59

1.52

mg/l

0.26

438

Evidence of alcohol involvement determined by level of intoxication

108

1.31

0.35

3.3

7.4

1.10

1.32

mg/l

0.60

101

Burns and corrosions of multiple body regions

126

0.71

0.35

2.2

4.9

1.67

1.43

mg/l

—

117

Congenital malformations of eyelid, lacrimal apparatus and orbit

181

1.23

0.35

13.8

18.9

1.08

1.14

mg/l

0.37

173

Postpartum hemorraghe, parous women as controls

254

2237

0.95

0.35

2.7

2.9

1.16

1.26

mg/l

2.69

241

2116

Acute otitis externa, noninfective

181

1.22

0.35

8.0

3.0

1.93

1.46

mg/l

0.94

163

Dental pulpitis, including avohilmo

1643

10306

1.02

0.35

3.2

3.7

1.46

1.45

mg/l

0.17

1517

9578

Neuroendocrine tumor and carcinoma of stomach

1.38

0.35

1.2

1.9

2.09

1.56

mg/l

—

Other disorders of patella

228

2160

1.06

0.34

2.7

2.9

1.37

1.35

mg/l

0.16

210

2009

Maternal care for other known or suspected fetal problems

281

1676

1.05

0.34

2.8

3.4

1.21

1.25

mg/l

0.51

259

1570

Osteomalacia

1.33

0.34

2.4

2.5

1.52

1.39

mg/l

0.16

Crushed, pushed or stepped on by crowd or human stampede

118

1094

1.08

0.34

3.3

7.0

1.24

1.28

mg/l

0.31

113

1029

Transient synovitis

109

1.30

0.34

38.0

10.2

1.22

1.15

mg/l

0.14

103

Hypertrophy of breast in women and men

249

2367

1.05

0.34

3.6

3.2

1.49

1.41

mg/l

0.75

232

2188

Burn and corrosion confined to eye and adnexa

275

0.83

0.33

3.0

3.1

1.25

1.41

mg/l

0.65

252

Pedal cyclist injured in collision with pedestrian or animal

0.69

0.33

5.0

3.0

1.35

1.36

mg/l

—

Oter anti-inflammatory and antirheumatic agents, non-steroids

344

1974

0.96

0.33

2.6

4.1

1.66

1.84

mg/l

3.03

309

1801

Injury of muscle and tendon at wrist and hand level

206

1949

1.06

0.33

3.1

3.4

1.44

1.51

mg/l

0.76

191

1820

Yaws, including avohilmo

1.32

0.33

7.2

4.3

1.39

1.41

mg/l

—

Foreign body on external eye

209

2205

0.95

0.32

4.0

3.6

1.48

mg/l

0.01

192

2064

Acute hepatitis B

1.29

0.32

1.7

3.1

1.32

1.39

mg/l

—

Other dermatomyositis

1.29

0.32

3.8

2.3

1.11

1.37

mg/l

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

181

1708

1.06

0.32

2.6

3.0

1.57

1.53

mg/l

0.24

166

1576

Pediculosis and phthiriasis, including avohilmo

1.32

0.32

5.7

5.2

1.52

1.23

mg/l

0.74

Reduction defects of upper limb

1.37

0.32

2.7

16.6

1.05

1.04

mg/l

—

Hypertrophy of breast

184

1946

0.94

0.31

2.8

3.1

1.39

1.37

mg/l

0.15

167

1800

Burns and corrosions confined to eye and internal organs

337

0.86

0.31

3.5

3.4

1.24

1.43

mg/l

1.08

310

Benign neoplasm: Other/unspecified site

165

1.22

0.31

2.3

2.9

1.56

1.54

mg/l

0.03

148

Conductive hearing loss, unspecified

112

1041

1.08

0.31

9.8

5.3

1.47

mg/l

0.02

100

964

Pregnancy with abortive outcome

892

4527

1.03

0.31

3.0

3.1

1.42

1.44

mg/l

0.33

817

4126

Thyroiditis

781

1.09

0.31

2.2

3.7

1.32

1.45

mg/l

1.42

723

Foreign body entering into or through eye or natural orifice

121

1129

1.07

0.31

7.1

5.2

1.48

1.44

mg/l

0.24

114

1047

Contraceptive management

617

4442

0.97

0.31

3.9

3.5

1.29

1.38

mg/l

2.77

582

4174

Other and unspecified hydrocephalus

212

1.19

0.30

12.5

5.8

1.84

1.47

mg/l

1.02

188

Ulcer of oesophagus, drug-induced

1.28

0.30

2.9

2.7

1.94

1.76

mg/l

—

Non-small cell lung cancer, squamous, helper endpoint

524

1.11

0.30

2.8

1.43

1.88

mg/l

4.40

453

Mixed conductive and sensorineural hearing loss

141

1499

0.94

0.29

4.3

3.5

1.59

1.66

mg/l

0.48

130

1358

Trochanteric bursitis

188

1784

1.06

0.29

3.0

2.9

1.53

mg/l

0.01

169

1619

Whooping cough, including avohilmo

176

1.20

0.29

13.3

5.6

1.46

1.18

mg/l

0.80

161

Alzheimer’s disease (Atypical or mixed)

120

1264

0.94

0.28

2.4

2.3

1.87

1.94

mg/l

0.30

1071

Other and unspecified vaccines and biological substances

1.33

0.28

2.6

5.3

1.13

1.25

mg/l

—

Nontoxic single thyroid nodule

776

1.08

0.28

3.1

1.64

1.51

mg/l

0.57

717

Intentional self-harm by jumping from a high place

1.28

0.28

4.6

2.7

1.31

1.26

mg/l

—

Pedal cyclist injured in other and unspecified transport accidents

163

1544

1.06

0.27

3.8

4.6

1.36

1.45

mg/l

0.89

145

1434

Nontraumatic intracranial haemmorrhage

275

2639

1.04

0.27

5.4

3.0

1.77

1.70

mg/l

0.56

252

2339

Vaginal lichen planus

1.24

0.27

2.4

2.1

1.34

mg/l

—

Congenital malformations of ovaries, fallopian tubes and broad ligaments

518

1.10

0.27

3.4

3.2

1.31

1.30

mg/l

0.08

484

Endometroid carcinoma of ovary, including Hilmo

1.24

0.27

1.1

3.0

1.77

1.69

mg/l

—

Radial styloid tenosynovitis [de Quervain]

595

1.09

0.27

2.7

3.1

1.50

1.36

mg/l

0.70

559

Contracture of joint

128

0.78

0.27

3.5

3.9

1.17

1.41

mg/l

—

116

Single delivery by caesarean section

222

1326

0.95

0.26

3.1

3.9

1.23

1.35

mg/l

2.34

207

1243

Surgical ablation of atrial fibrillation

0.69

0.26

5.2

2.8

2.19

1.53

mg/l

—

Nontoxic diffuse goitre

319

1.13

0.26

2.4

2.6

1.65

1.50

mg/l

0.33

289

Vascular dementia (other)

0.70

0.26

1.6

2.0

1.81

2.24

mg/l

—

Sequelae of intentional self-harm, assault and events of undetermined intent

0.66

0.26

5.8

8.1

1.31

1.25

mg/l

—

Degenerative myopia

0.66

0.26

1.0

3.4

1.36

1.49

mg/l

—

Asymmetry of jaw

169

1.19

0.26

4.3

6.0

1.19

1.29

mg/l

0.34

155

Fenamates

226

1606

0.96

0.25

2.5

4.3

1.44

1.75

mg/l

7.54

208

1478

Caught, crushed, jammed or pinched in or between objects

747

0.92

0.25

3.4

6.1

1.45

1.41

mg/l

0.15

698

Disorders of acoustic nerve

292

1.13

0.25

5.0

3.4

1.50

1.51

mg/l

0.04

264

Benign neoplasm: Brain, supratentorial

198

1.17

0.25

8.8

5.0

1.28

1.39

mg/l

0.47

178

Pemphigus

1.19

0.25

8.4

2.4

2.14

1.42

mg/l

—

Carpal tunnel syndrome

973

8262

1.02

0.24

2.9

1.67

1.52

mg/l

6.30

879

7564

Acetic acid derivatives and related substances

467

2485

0.97

0.24

2.5

4.4

1.63

1.73

mg/l

1.27

422

2294

Acute appendicitis, no complications

910

8863

1.02

0.24

3.6

3.4

1.43

1.45

mg/l

0.39

847

8220

Ménière disease

114

1074

1.06

0.24

2.2

2.9

1.48

1.62

mg/l

1.39

104

961

Toxic effects of substances chiefly nonmedicinal as to source

164

1562

1.05

0.24

4.0

5.2

1.50

1.42

mg/l

0.58

154

1460

Congenital retinoschisis

1.37

0.24

2.4

10.7

1.50

1.41

mg/l

—

Chronic crepitant synovitis/bursitis of hand and wrist/periarthritis of wrist

152

1.19

0.24

2.2

2.7

1.64

1.52

mg/l

0.24

137

Viral conjunctivitis

246

1.14

0.24

7.6

4.6

1.72

1.34

mg/l

0.68

224

Other vitreous opacities

475

1.10

0.24

3.0

1.80

1.60

mg/l

0.53

428

Melanoma in situ of upper limb, including shoulder

1.26

0.23

9.1

2.2

2.10

1.57

mg/l

0.91

Frostbite with tissue necrosis

1.26

0.22

4.0

3.0

1.76

1.44

mg/l

—

Glaucoma secondary to drugs

1.26

0.22

9.0

2.3

1.92

1.40

mg/l

—

Hypersomnia

153

1.18

0.22

3.8

3.3

1.41

1.42

mg/l

0.03

137

Oral lichen planus, including avohilmo , including avohilmo

825

1.07

0.22

2.3

3.1

1.22

1.53

mg/l

4.46

760

Benign lipomatous neoplasm of of intra-abdominal organs

1.23

0.22

4.2

1.9

1.63

1.31

mg/l

—

Injury of blood vessels at hip and thigh level

1.23

0.22

1.2

2.2

2.27

1.62

mg/l

—

Unspecified multiple injuries

1.23

0.22

1.2

3.2

1.34

1.39

mg/l

—

Miliaria rubra

0.00

0.22

0.0

3.0

—

1.68

—

Postpartum haemorrhage due to anatomy

968

0.94

0.22

2.1

2.9

1.10

1.20

mg/l

1.29

921

Other and unspecified disorders of refraction

0.00

0.22

0.0

2.8

—

1.72

—

Other congenital malformations of integument

0.00

0.22

0.0

27.6

—

1.01

—

Flexion deformity

0.00

0.22

0.0

2.7

—

1.44

—

Osteolysis

0.00

0.21

0.0

1.5

—

1.28

—

Malignant neoplasm of placenta, including Hilmo

0.00

0.21

0.0

1.4

—

1.29

—

Examination and encounter for administrative purposes

109

1031

1.06

0.21

3.4

2.7

1.77

1.61

mg/l

1.01

918

Other sex chromosome abnormalities, female phenotype, not elsewhere classified

0.00

0.21

0.0

18.7

—

1.38

—

Benign neoplasm: Bones of skull and face

104

0.76

0.21

3.0

3.5

1.85

1.38

mg/l

—

Poisoning by medicine, drug-induced

145

0.82

0.21

1.8

3.0

1.33

1.32

mg/l

0.02

132

Fasciculation

134

0.82

0.21

3.4

3.1

1.45

1.41

mg/l

0.07

120

Trichomoniasis

1.26

0.20

4.9

3.0

1.89

1.44

mg/l

—

Other neurotic disorders

518

1.08

0.20

3.0

1.66

1.56

mg/l

0.36

469

Gonarthrosis, primary, with knee surgery

905

6917

1.02

0.20

2.6

2.9

1.73

1.66

mg/l

1.71

802

6236

Hereditary angioödema type 1

0.00

0.20

0.0

2.4

—

1.48

—

Lumbosacral root disorders, not elsewhere classified

123

0.81

0.20

3.1

2.8

1.72

1.48

mg/l

—

105

Other and unspecified atrophic disorders of skin

1.26

0.20

8.2

2.5

1.74

1.47

mg/l

—

Other specified/unspecified dorsopathies

393

1.10

0.20

3.3

3.2

1.52

1.54

mg/l

0.06

363

Other disorders of breast

145

1516

0.96

0.20

3.3

3.0

1.36

1.40

mg/l

0.38

133

1388

Burns and corrosions of external body surface, specified by site

164

1573

1.04

0.20

4.5

6.1

1.51

1.42

mg/l

0.87

155

1477

Acute hepatitis B, including avohilmo

1.21

0.20

1.7

3.0

1.32

1.38

mg/l

—

Glucosamine medication

635

5171

0.98

0.20

2.4

2.8

1.70

1.71

mg/l

0.18

555

4591

Hydrocephalus

912

0.94

0.20

9.1

4.5

1.50

1.64

mg/l

0.79

807

Cervicalgia

299

2902

1.03

0.19

2.7

3.2

1.55

1.52

mg/l

0.26

264

2654

Exclusion endpoint for supernumerary teeth

222

1.13

0.19

11.6

15.7

1.19

1.17

mg/l

0.05

210

Superficial injury of shoulder and upper arm

167

1604

1.04

0.19

3.1

4.1

1.50

1.49

mg/l

0.04

147

1486

Typhoid and paratyphoid fevers

1.16

0.19

1.8

2.6

1.50

1.43

mg/l

—

Effects of other external causes

385

1.09

0.19

5.0

4.9

1.24

1.30

mg/l

0.32

358

Dislocation, sprain and strain of joints and ligaments at neck level

209

2019

1.04

0.18

2.7

3.9

1.36

1.38

mg/l

0.11

195

1892

Reduction defects of upper limb, including avohilmo

1.20

0.18

2.7

14.8

1.05

1.07

mg/l

—

Other intervertebral disc disorders

1382

8128

1.01

0.18

2.9

3.1

1.56

1.52

mg/l

1.07

1258

7480

Lymphangioma, anys site

100

1.21

0.18

8.3

8.1

1.34

1.21

mg/l

0.30

Contact with lifting and transmission devices, not elsewhere classified

227

0.88

0.18

2.7

3.3

1.42

1.48

mg/l

0.15

208

Benign neoplasm: Brain, unspecified

1.17

0.18

7.6

3.3

1.71

1.50

mg/l

—

Systemic atrophies primarily affecting the central nervous system

503

1.08

0.18

7.0

5.0

1.60

1.64

mg/l

0.11

454

Gonarthrosis,primary

1480

8810

1.01

0.17

2.7

3.0

1.68

1.59

mg/l

3.43

1341

8031

Carcinoma in situ of cervix uteri, exocervix

1.15

0.17

2.0

2.5

1.47

1.33

mg/l

—

Other and unspecified injuries of forearm

1.23

0.17

8.9

7.7

1.62

1.25

mg/l

—

Typhoid and paratyphoid fevers, including avohilmo

1.11

0.17

1.7

2.7

1.41

mg/l

—

Cardiomyopathies, Secondary/extrinsic

0.75

0.17

31.6

4.2

1.80

1.26

mg/l

—

Migraine, unspecified, drug-induced

0.73

0.17

3.8

2.3

1.55

1.32

mg/l

—

Habitual aborter

167

1.14

0.17

3.4

2.9

1.23

1.22

mg/l

0.02

156

Cerebral amyloid angiopathy

1.18

0.17

4.5

2.3

1.99

1.67

mg/l

—

Congenital malformations of eyelid, lacrimal apparatus and orbit, including avohilmo

215

1.12

0.17

13.4

17.9

1.06

1.13

mg/l

0.54

206

Exposure to other and unspecified man-made environmental factors

225

1.11

0.16

5.7

4.5

1.21

1.36

mg/l

0.96

208

Contact with venomous snakes and lizards

130

0.84

0.16

2.3

5.3

1.13

1.37

mg/l

1.04

121

Traumatic amputation of wrist and hand

535

0.93

0.16

2.3

3.4

1.61

1.60

mg/l

0.02

491

Polymorphous light eruption

1.11

0.16

2.4

3.6

1.27

1.34

mg/l

—

Retained placenta and membranes, without haemorrhage

133

1279

1.04

0.16

2.7

3.1

1.38

1.42

mg/l

0.19

125

1184

Other abnormal products of conception

387

2482

1.02

0.16

2.7

3.1

1.19

1.29

mg/l

2.15

364

2338

Villonodular synovitis (pigmented)

0.78

0.16

1.7

2.3

1.30

1.43

mg/l

—

Malignant neoplasm of stomach, including Hilmo

535

1.07

0.15

2.9

2.7

1.85

1.82

mg/l

0.08

460

Other mental disorders due to brain damage and dysfunction and to physical disease

155

1496

1.04

0.15

3.5

2.6

1.69

1.76

mg/l

0.41

140

1325

Other benign neoplasm of uterus: Corpus uteri

0.75

0.15

2.2

2.6

1.69

1.47

mg/l

—

Ectopic pregnancy

184

1900

0.97

0.15

2.8

3.0

1.51

1.38

mg/l

1.12

168

1753

Burn and corrosion of head and neck

276

0.90

0.15

3.5

4.4

1.25

1.38

mg/l

0.83

252

Suggestive for eosinophilic asthma

108

1127

0.96

0.15

3.5

2.9

1.45

1.58

mg/l

1.11

102

1042

Narcolepsy and cataplexy

1.13

0.15

4.1

3.5

1.42

1.25

mg/l

—

Vascular dementia

102

1027

0.96

0.15

2.2

2.4

1.91

1.96

mg/l

0.21

874

Maternal care for known or suspected malpresentation of fetus

213

1474

1.03

0.15

2.8

3.2

1.15

1.26

mg/l

1.85

203

1382

Serous carcinoma of ovary, including Hilmo

255

1.10

0.15

4.2

3.2

1.39

1.63

mg/l

1.67

229

Fall on and from ladder

104

997

1.04

0.14

2.8

3.3

1.49

1.66

mg/l

1.33

908

0.79

0.14

2.9

2.8

1.62

1.35

mg/l

—

Contact with other specified venomous animals

0.78

0.14

1.3

4.2

1.38

1.44

mg/l

—

Increased muscle tone

0.78

0.14

3.0

7.5

1.90

1.30

mg/l

—

Contact with nonpowered hand tool

557

1.06

0.14

4.3

3.2

1.52

1.49

mg/l

0.12

514

Juvenile osteochondrosis

421

1.07

0.14

11.9

6.5

1.29

1.27

mg/l

0.05

390

Guttate psoriasis

160

1.13

0.14

4.3

2.9

1.56

1.47

mg/l

0.18

144

Exposure to other and unspecified forces of nature

1.20

0.14

5.8

4.9

1.75

1.46

mg/l

—

Other congenital malformations of upper alimentary tract

103

1.17

0.14

37.7

9.9

1.37

1.40

mg/l

0.08

Other enthesopathies

435

4270

1.02

0.13

2.9

3.1

1.46

1.47

mg/l

0.14

393

3921

Ankylosing spondylitis, strict definition

549

1.06

0.13

2.9

3.0

1.38

1.35

mg/l

0.12

512

Migraine without aura, drug-induced

107

0.84

0.13

4.9

2.4

1.59

1.32

mg/l

—

Carcinoma in situ of cervix uteri

104

1001

1.04

0.13

3.5

3.0

1.44

1.27

mg/l

1.16

928

Benign neoplasm of other and unspecified female genital organs

423

1.07

0.12

2.6

3.1

1.69

1.49

mg/l

0.63

387

Cervicocranial syndrome

140

1357

1.03

0.12

2.7

3.1

1.53

mg/l

0.02

125

1249

Panniculitis, unspecified

114

1.14

0.12

7.0

2.9

1.75

1.47

mg/l

0.55

105

Diseases caused by chlamydiae

1.16

0.11

10.0

3.0

1.62

1.24

mg/l

1.50

Fetus and newborn affected by maternal factors and by complications of pregnancy, labour and delivery

556

1.05

0.11

22.1

24.2

1.08

1.05

mg/l

0.22

550

Inhalation and ingestion of food causing obstruction of respiratory tract

126

0.87

0.11

5.9

8.1

1.37

1.41

mg/l

0.09

112

Prolapse and hernia of ovary and fallopian tube

319

0.93

0.11

2.4

2.3

1.55

1.79

mg/l

0.85

275

Meralgia paraesthetica

396

1.06

0.11

2.6

3.0

1.70

1.52

mg/l

0.60

358

Type 1 diabetes, wide definition, subgroup 2

146

0.89

0.10

21.3

10.8

2.24

1.47

mg/l

1.06

130

Deviated nasal septum

515

5211

0.99

0.10

2.8

3.3

1.48

1.57

mg/l

1.69

471

4805

Congenital musculoskeletal deformities of head, face, spine and chest

212

1.09

0.10

12.8

14.9

1.36

1.16

mg/l

0.59

202

Burns and corrosions

209

2046

1.02

0.10

4.4

5.8

1.48

1.42

mg/l

0.63

198

1918

Unspecified organic or symptomatic mental disorder

1.17

0.10

1.8

2.5

2.03

1.52

mg/l

—

Patellar tendinitis

222

1.08

0.10

7.6

4.3

1.20

1.35

mg/l

0.68

209

Mucinous and mucinous cystic tumor, including Hilmo

1.11

0.10

6.4

2.1

1.84

1.47

mg/l

—

Serous carcinoma of ovary

1.11

0.10

1.8

3.0

1.52

1.63

mg/l

—

Other menopausal disorders

312

1768

0.98

0.09

2.3

2.9

1.26

1.50

mg/l

8.62

285

1620

Polycystic ovarian syndrome, broad definition

111

1078

1.03

0.09

2.9

3.4

1.24

1.20

mg/l

0.37

106

1016

Supervision of high-risk pregnancy

230

1355

1.02

0.09

3.0

3.6

1.20

1.30

mg/l

1.71

217

1275

Coxibs

486

2582

0.99

0.09

2.4

4.7

1.48

1.71

mg/l

7.20

432

2385

Lesion of medial popliteal nerve

1.04

0.09

2.4

1.8

1.05

1.41

mg/l

—

Somnolence

155

1.10

0.09

7.6

6.4

1.44

1.39

mg/l

0.10

140

Vascular dementia (subcortical)

360

1.06

0.09

1.6

2.6

1.70

1.92

mg/l

0.88

304

Fetus and newborn affected by noxious influences transmitted via placenta or breast milk

1.14

0.09

37.1

33.0

1.15

1.02

mg/l

—

Drug-induced headache, not elsewhere classified

1.05

0.08

4.2

2.7

1.28

1.36

mg/l

—

Operations for atrial fibrillation

175

0.91

0.08

3.1

2.8

2.10

1.63

mg/l

0.89

153

Peritonsillar abscess

295

2995

0.98

0.08

3.0

3.5

1.36

1.42

mg/l

0.64

279

2809

Other operation for atrial fibrillation

0.83

0.08

2.6

2.4

1.97

1.84

mg/l

—

Discontinuity and dislocation of ear ossicles

0.83

0.08

5.6

3.4

1.60

1.37

mg/l

—

Other and unspecified injuries of wrist and hand

519

1.04

0.08

3.4

6.5

1.42

1.36

mg/l

0.19

484

Effects of foreign body entering through natural orifice

397

3922

1.01

0.08

5.4

4.8

1.44

1.45

mg/l

0.10

365

3660

Congenital ptosis

1.05

0.08

8.6

13.4

1.11

1.16

mg/l

—

Synovial cyst of popliteal space [Baker]

845

0.97

0.08

2.5

3.0

1.73

1.58

mg/l

0.83

766

Benign lipomatous neoplasm

408

4128

0.99

0.08

2.9

3.0

1.56

1.57

mg/l

0.03

379

3770

Other acquired deformities of musculoskeletal system and connective tissue

551

0.96

0.08

2.7

3.4

1.34

1.50

mg/l

0.83

502

Contact with blunt object, undetermined intent

0.85

0.07

3.7

2.4

1.35

1.40

mg/l

—

Carcinoma in situ of breast, lobular

0.81

0.07

6.5

2.4

2.01

1.42

mg/l

—

Cutis laxa senilis

1.05

0.07

2.3

2.6

1.12

1.39

mg/l

—

Sequelae of injuries of head

702

0.97

0.07

3.2

3.3

1.36

1.49

mg/l

0.94

652

Lesion of femoral nerve

1.04

0.07

2.0

2.5

1.17

1.44

mg/l

—

Congenital ptosis, including avohilmo

1.03

0.07

7.6

11.7

1.10

1.14

mg/l

—

Other or unspecified paralytic strabismus

1.03

0.07

2.9

2.6

1.55

1.37

mg/l

—

Injury of nerves at ankle and foot level

0.87

0.07

3.9

2.6

1.23

1.32

mg/l

—

Graves disease, strict definition

115

1176

0.98

0.07

2.7

3.4

1.45

1.42

mg/l

0.16

109

1099

Lichen planus, including avohilmo

251

2475

1.01

0.07

2.4

3.0

1.50

1.58

mg/l

0.76

225

2259

Other acute disseminated demyelination

0.85

0.06

6.6

3.4

1.24

1.33

mg/l

—

Motorcycle rider injured in other and unspecified transport accidents

838

1.03

0.06

3.6

4.6

1.28

1.32

mg/l

0.27

792

Calcific tendinitis

102

0.88

0.06

2.6

2.5

1.55

1.48

mg/l

—

Bitten or stung by nonvenomous insect and other nonvenomous arthropods

467

0.96

0.06

3.8

8.0

1.34

1.36

mg/l

0.08

436

Benign neoplasm: Cranial nerves

325

1.05

0.06

5.4

3.4

1.55

mg/l

0.01

287

Other diseases caused by chlamydiae

109

1.10

0.06

9.8

2.9

1.82

1.30

mg/l

1.24

Nonspecific lymphadenitis

679

0.97

0.06

7.7

4.0

1.39

1.38

mg/l

0.03

631

Congenital musculoskeletal deformities of head, face, spine and chest, including avohilmo

237

1.06

0.06

11.9

14.9

1.31

1.17

mg/l

0.40

225

Previous suicide attempt

131

0.91

0.05

3.0

6.8

1.58

1.20

mg/l

0.50

120

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

950

1.02

0.05

2.9

3.1

1.53

1.54

mg/l

0.06

875

Dystonia

637

0.97

0.05

2.7

4.1

1.41

1.48

mg/l

0.30

588

Vascular dementia (multiple infarctions)

110

0.91

0.05

3.1

2.1

1.88

2.25

mg/l

—

Extrapyramidal and movement disorders

576

5721

1.01

0.05

3.0

3.2

1.53

1.64

mg/l

2.67

517

5151

Dependent personality disorder

218

1.06

0.05

2.6

3.2

1.75

1.49

mg/l

0.53

200

Disturbances of smell and taste

485

1.03

0.05

3.1

3.3

1.48

1.55

mg/l

0.21

447

Nontoxic goitre/thyroid nodule

365

3681

0.99

0.05

3.0

2.9

1.66

1.59

mg/l

0.72

323

3313

Migraine with aura, drug-induced

120

0.91

0.05

7.6

2.4

1.81

1.40

mg/l

0.54

107

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

458

4613

0.99

0.05

3.3

4.5

1.35

1.39

mg/l

0.68

424

4316

Benign lipomatous neoplasm of other sites/unspecified

101

992

1.02

0.04

2.6

2.9

1.60

1.63

mg/l

0.12

889

Primary gonarthrosis, bilateral

779

6551

0.99

0.04

2.5

2.9

1.75

1.65

mg/l

2.30

688

5913

Puerperal sepsis

136

1341

1.01

0.04

3.1

2.9

1.49

1.45

mg/l

0.27

122

1238

Colon adenocarcinoma, helper endpoint

157

1551

1.01

0.04

2.6

2.7

1.91

1.76

mg/l

1.06

137

1370

Postpartum care and examination

145

898

1.01

0.04

3.3

3.5

1.22

1.25

mg/l

0.16

134

836

Benign neoplasm: Connective and other soft tissue of upper limb, including shoulder

543

0.98

0.04

2.2

3.2

1.42

1.50

mg/l

0.47

498

Disorders of breast

639

5594

1.00

0.03

3.1

1.44

1.43

mg/l

0.06

591

5096

Other abnormal auditory perceptions

129

0.93

0.03

5.2

4.7

1.16

1.29

mg/l

0.70

119

Lesion of plantar nerve

667

1.02

0.03

2.0

3.0

1.63

1.57

mg/l

0.23

609

Acute myringitis

1.09

0.03

10.3

6.8

1.36

1.22

mg/l

—

Vascular dementia (mixed)

189

0.95

0.03

1.9

2.5

1.83

2.04

mg/l

0.41

157

Benign neoplasm: Short bones of lower limb

112

1.07

0.03

4.1

3.3

1.65

1.43

mg/l

0.38

100

Assault by sharp object

221

1.04

0.03

7.3

3.5

2.03

1.34

mg/l

1.83

203

Rotator cuff syndrome

980

6763

1.00

0.02

2.9

1.59

1.54

mg/l

0.98

894

6194

Hypersensitivity pneumonitis due to organic dust

178

0.95

0.02

9.1

3.1

1.72

1.57

mg/l

0.22

161

Struck by thrown, projected or falling objec

729

0.99

0.01

4.6

5.0

1.28

1.42

mg/l

1.04

675

Gestational diabetes (for exclusion)

421

2885

1.00

0.01

2.9

3.2

1.26

1.25

mg/l

0.13

392

2720

Thyroiditis, unspecified

157

0.95

0.01

2.2

3.3

1.35

1.40

mg/l

0.24

143

Use of disulfiram, acamprosate or naltrexone

123

1222

1.01

0.01

2.8

3.2

1.39

1.47

mg/l

0.50

114

1145

Cleft palate

136

0.95

0.00

8.2

10.6

1.17

1.21

mg/l

0.11

129

Idiopathic urticaria

244

1.03

0.00

6.0

4.8

1.41

1.32

mg/l

0.28

224

Schizoaffective disorder

924

1.01

0.00

3.5

3.3

1.49

1.37

mg/l

0.69

862

Infections of genitourinary tract in pregnancy

952

1.00

0.00

3.3

2.9

1.54

1.34

mg/l

1.47

874

Inflammatory disease of cervix uteri

595

0.99

0.00

1.9

2.9

1.48

1.51

mg/l

0.12

540

Outcome of delivery

176

1082

1.00

0.00

2.4

3.5

1.12

1.26

mg/l

3.75

165

1012

Diseases caused by chlamydiae, including avohilmo

155

1.03

0.00

8.9

4.8

1.39

1.17

mg/l

0.90

146

Assault by blunt object

185

0.97

0.00

3.1

3.7

1.56

1.31

mg/l

0.68

173

Degeneration of the brain due to alcohol

275

0.98

0.00

2.9

3.1

1.64

1.69

mg/l

0.12

249

Degeneration of nervous system due to alcohol

274

0.98

0.00

2.9

3.2

1.64

1.70

mg/l

0.13

248

Other demyelinating diseases of the central nervous system

394

0.99

0.00

2.0

3.3

1.25

1.36

mg/l

0.54

363

Melanocytic naevi of eyelid, including canthus

1.01

0.00

3.2

2.3

1.59

1.48

mg/l

—

Use of teriflunomide

1.01

0.00

2.2

2.6

1.24

1.25

mg/l

—

Spinal enthesopathy

236

1.02

0.00

2.1

2.8

1.74

1.83

mg/l

0.19

203

Other diseases caused by chlamydiae, including avohilmo

169

1.01

0.00

8.8

4.6

1.55

1.21

mg/l

0.94

157

Other deformities of toe(s)

353

0.99

0.00

3.1

2.7

1.82

1.53

mg/l

0.90

326

Other disorders of amniotic fluid and membranes

144

1394

1.00

0.00

2.2

3.2

1.13

1.28

mg/l

2.35

138

1311

Dislocation, sprain and strain of joints and ligaments of lumbar spine and pelvis

415

0.99

0.00

2.2

4.8

1.21

1.36

mg/l

1.11

382

Lumbar disc prolapse

1049

7764

1.00

0.00

2.8

3.1

1.52

1.51

mg/l

0.14

954

7149

Melanoma in situ of eyelid, including canthus

0.00

0.0

7.2

—

2.55

—

Ectopic hormone secretion, not elsewhere classified

0.00

0.0

15.4

—

1.20

—

IPHG Phlebitis and thrombophlebitis of intracranial venous sinuses

0.00

0.0

2.2

—

1.03

—

Benign neoplasm: Lower jaw bone

0.97

0.00

7.3

4.6

1.99

1.32

mg/l

—

Mesothelioma

1.00

0.00

1.9

2.2

1.54

1.90

mg/l

—

Bacterial vaccines

0.00

0.0

12.4

—

0.98

—

Findings of drugs and other substances, not normally found in blood

0.94

0.00

5.0

2.5

1.93

1.46

mg/l

—

Carcinoma in situ of other/unspecified digestive organs

0.00

-0.00

0.0

2.8

—

2.01

—

Occupant of pick-up truck or van injured in other and unspecified transport accidents

0.95

-0.00

11.2

3.0

1.86

1.39

mg/l

—

Drug photoallergic response

0.00

-0.00

0.0

2.0

—

1.55

—

Vasomotor rhinitis (mode)

840

1.00

-0.00

4.3

3.4

1.44

1.55

mg/l

0.69

769

Unspecified drowning and submersion

0.00

-0.00

0.0

3.3

—

2.08

—

Leptospirosis, including avohilmo

0.00

-0.00

0.0

1.6

—

1.64

—

Leptospirosis

0.00

-0.00

0.0

1.6

—

1.64

—

Pedal cyclist injured in collision with train or tram

0.00

-0.00

0.0

2.8

—

1.37

—

Benign neoplasm: Mesothelial tissue of peritoneum

0.00

-0.00

0.0

1.4

—

1.41

—

Retained (old) foreign body following penetrating wound of orbit

0.00

-0.00

0.0

2.6

—

1.34

—

Carcinoma in situ, other and unspecified urinary organs

0.00

-0.00

0.0

2.4

—

2.11

—

Other chronic cystitis, drug-induced

0.00

-0.00

0.0

3.0

—

1.78

—

Motor- or nonmotor-vehicle accident in traffic area

1.01

-0.00

6.8

4.2

2.07

1.36

mg/l

—

Infantile papular acrodermatitis [Gianotti-Crosti]

0.00

-0.00

0.0

6.6

—

1.04

—

Pedestrian injured in collision with railway train or railway vehicle

0.00

-0.00

0.0

2.7

—

1.01

—

Assault by unspecified chemical or noxious substance

0.00

-0.00

0.0

1.9

—

1.20

—

Congenital malformations of ear causing impairment of hearing

0.87

-0.00

6.0

11.8

1.65

1.11

mg/l

—

Benign neoplasm: Brain, infratentorial

0.96

-0.00

8.5

8.7

1.14

1.31

mg/l

—

Follicular adenocarcinoma of thyroid gland

0.98

-0.00

5.5

4.4

1.90

1.57

mg/l

—

Other specified/unspecified diseases of inner ear

1.00

-0.00

2.0

2.5

1.44

1.63

mg/l

—

Melanocytic naevi of lip

0.99

-0.00

2.6

2.5

1.24

1.40

mg/l

—

Prophylactic surgery

0.92

-0.00

3.7

2.6

1.12

1.22

mg/l

—

Drug-induced tremor

1.01

-0.00

2.7

3.8

1.54

1.46

mg/l

—

Sequelae of burns, corrosions and frostbite

0.95

-0.00

2.0

5.4

1.74

1.35

mg/l

—

Defects in post-translational modification of lysosomal enzymes

0.00

-0.00

0.0

1.2

—

1.26

—

Other intestinal obstruction of newborn

0.00

-0.00

0.0

47.3

—

1.06

—

Transitory neonatal disorders of calcium and magnesium metabolism

0.00

-0.00

0.0

42.2

—

0.89

—

Other specified disorders of skin and subcutaneous tissue in diseases classified elsewhere

0.00

-0.00

0.0

2.4

—

1.92

—

Other birth injuries to central nervous system

0.00

-0.00

0.0

1.6

—

1.62

—

Total (external) ophthalmoplegia

0.00

-0.00

0.0

2.2

—

1.56

—

Maze procedure for atrial fibrillation

0.97

-0.00

1.7

2.2

2.13

1.56

mg/l

—

Moderate visual impairment, monocular

0.87

-0.00

2.8

4.2

1.48

1.43

mg/l

—

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Cystatin C [Mass/volume] in Serum or Plasma

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS